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3 Summary 
SUMMARY 
The “Permeability transition” (PT) is one of the most studied events that may 
trigger cell death and is due to a Ca2+- and ROS-dependent opening of a nonspecific 
pore, called PTP, whose molecular nature has been long debated. Recently, our 
research group has demonstrated that PTP forms from FoF1 ATP synthase dimers, 
demonstrating the ability of this complex to switch from the key enzyme for the 
aerobic synthesis of ATP into a potential cell death mediator.  
The goal of this PhD thesis has been to define which structural changes of ATP 
synthase are responsible for the pH modulation of PTP. Indeed, it is well known from 
nineties that the optimum matrix pH for PT occurrence is about 7.3, and a decrease 
leads to decreased probability of PTP opening. The pH effect has been ascribed to 
reversible protonation of His residues located on the PTP that can be blocked by the 
histidine modifying reagent diethyl pyrocarbonate (DPC). Moreover, in mammalian 
cells, similarly to the drug Cyclosporin A (CsA), acidic pH also promotes release from 
the inner membrane of the matrix protein Cyclophilin D (CyPD), which is a well-
known PTP activator. 
As our group demonstrated that CyPD binds to the ATP Synthase OSCP 
subunit, mainly through electrostatic interactions and resulting in partial enzyme 
inhibition, the hypothesis has been advanced that the unique histidine located on 
OSCP, His112 according to bovine numbering, may be responsible for both the pH 
effects on CyPD (un)binding to ATP synthase and on PTP/ATP synthase opening. 
OSCPHis112 is exposed to the solvent and is located in the flexible linker region 
between the structured N- and C-terminal domains of OSCP. 
The results obtained by ATP synthase immunoprecipitation from bovine heart 
mitochondria showed that acidic pH induces CyPD release that is prevented by DPC, 
perfectly matching the effect of DPC on CyPD-PTP interaction. DPC also prevented 
the binding at low pH of the inhibitor protein IF1 to ATP synthase, but this effect is 
probably not relevant to PTP modulation. ESI-MS and ESI-MS/MS analyses of the 
OSCP isolated from DPC-treated mitochondria revealed that the 95-113 peptide 
shows a mass shift of +72 Da, which is indicative of carbethoxylation of the unique 
His112. These data therefore strongly support the hypothesis that OSCP His112 is 
part of the binding site of CyPD on the protein, so that its protonation by lowering 
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pH favors CyPD release. Of note, this region contains several residues of glutamic 
acid conferring a low potential surface, which is complementary to the mainly high 
potential surface of CyPD. Consistently to this model, DPC inhibits the ATPase 
activity of ATP synthase only when CyPD is released from OSCP, i.e. in the presence 
of CsA and in mitochondria from CyPD-null mice.  Replacement of OSCPHis112 with 
a Gln in HEK cells, by the CRISPR/Cas9 system, showed its involvement even in the 
effect of low pH on PTP opening. Indeed, the PTP open probability is not affected by 
acidic pH only in mutated cells, while DPC reverts the pH inhibition exclusively in 
wild type cells. Finally, evaluation of the structural stability of the ATP Synthase 
dimers at low pH by Blue-native PAGE excluded their destabilization, which could 
affect PTP formation. 
In summary, these data provide a convincing model for the pH modulation of 
PTP, as well as a compelling evidence that ATP synthase and PTP are the same 
molecular entity. 
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RIASSUNTO 
La transizione di permeabilità (PT) mitocondriale è uno degli eventi coinvolti 
nella morte cellulare tra i più studiati e implica l’apertura nella membrana 
mitocondriale interna di un poro aspecifico, definito PTP, indotta da ioni calcio in 
presenza di stress ossidativo, la cui natura molecolare è stata a lungo dibattuta. 
Recentemente, il gruppo di ricerca presso cui è stata svolta la presente tesi di 
dottorato ha dimostrato che il PTP si forma da complessi dimerici dell’enzima FoF1 
ATP Sintetasi, trasformando l’enzima essenziale per la sintesi aerobica di ATP in 
mediatore di morte cellulare.  
L’obiettivo della presente tesi è stato quello di definire le basi molecolari della 
modulazione del PTP da parte del pH di matrice rispetto alle proprietà strutturali di 
ATP Sintetasi. E’ infatti noto dagli anni ’90 che le probabilità di apertura del PTP 
sono massime a pH 7.3 e diminuiscono rapidamente al diminuire del pH. Tale effetto 
è stato imputato alla protonazione di residui di istidine del PTP, in quanto 
l’inibizione veniva bloccata dal reagente specifico per le istidine dietilpirocarbonato 
(DPC).  Inoltre, era stato dimostrato che in cellule di mammifero un pH acido 
favorisce, similmente alla Ciclosporina A (CsA), il rilascio dal PTP della proteina di 
matrice Ciclofilina D (CyPD), che, quando legata al PTP, è un ben noto attivatore del 
poro.   
 Poiché studi recenti dello stesso gruppo avevano dimostrato che in 
mammifero la ciclofilina D interagisce, prevalentemente mediante interazioni 
elettrostatiche, con la subunità OSCP di ATP Sintetasi, inducendo un’inibizione 
parziale dell’attività catalitica dell’enzima, si è ipotizzato che l’unico residuo di 
istidina di OSCP, His112 in base alla numerazione in bovino, fosse coinvolto nella 
modulazione pH-dipendente sia del legame della CyPD che della probabilità di 
apertura del PTP/ATP Sintetasi.  OSCPHis112 è esposto al solvente ed è localizzato 
nella parte non strutturata della proteina, legante i domini ad α-elica N- e C-
terminali. 
I risultati ottenuti mediante immunoprecipitazione di ATP Sintetasi da 
mitocondri di cuore bovino hanno dimostrato che pH  acidi inducono il rilascio della 
CyP e che tale rilascio viene bloccato dalla presenza di DPC, in perfetto accordo con 
quanto precedentemente osservato rispetto al PTP. L’analisi ESI-MS e ESI-MS/MS 
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della subunità OSCP isolata da mitocondri trattati con DPC ha stabilito che il peptide 
95-113 di OSCP subisce un aumento della sua massa molecolare corrispondente a 72 
Da, indicativo della carbetossilazione dell’unica istidina. Questi dati suggeriscono 
quindi che OSCPHis112 sia coinvolta nel sito di legame della CyPD, in quanto 
l’interazione viene sfavorita dalla sua protonazione. His112 è infatti localizzato in una 
regione caratterizzata dalla presenza di numerosi residui di acido glutammico avente 
un potenziale di superficie negativo, che è complementare al potenziale di superficie 
della CyPD prevalentemente positivo. In accordo con questo modello, il DPC è 
risultato un inibitore dell’attività catalitica di ATP Sintetasi esclusivamente quando la 
CyPD non è legata ad OSCP, come in presenza di CsA o nei topi KO per la CyPD (Ppif-
/-). Inoltre, la sostituzione di OSCPHis112 con un residuo di Gln mediante il sistema 
di mutagenesi CRISPR/Cas9 in una linea cellulare umana (HEK293T) ha permesso 
di verificare che la stessa istidina è coinvolta nell’effetto del pH sull’apertura del PTP, 
in quanto solo nelle cellule mutate la probabilità di apertura del PTP non diminuisce 
a pH acido, e, in accordo, il DPC reverte l’inibizione a pH acido esclusivamente nelle 
cellule wild type. Infine, l’analisi della stabilità strutturale dei dimeri di ATP Sintetasi 
in funzione del pH mediante  Blue-native PAGE ha consentito di escludere una loro 
destabilizzazione a pH acidi, che avrebbe potuto influire sulla formazione del PTP.  
In conclusione, questi risultati, oltre a fornire un modello convincente per la 
modulazione pH-dipendente del PTP, costituiscono altresì una prova molecolare 
importante che ATP Sintetasi e il PTP sono la stessa entità molecolare. 
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ABBREVIATIONS 
Å Ångström (1Å = 0.1 nm) 
ADP  Adenosine diphosphate 
ANT Adenine nucleotide translocator 
ApoM Apomyoglobin 
ATP  Adenosine triphosphate 
BHM Bovine heart mitochondria 
BSA Bovine serum albumin 
Ca2+ Calcium ion 
CsA Cyclosporin A 
CyPD Cyclophilin D 
CRC Calcium retention capacity 
Da Dalton 
DPC Diethylpyrocarbonate 
DDM n-DODECIL-β-maltoside 
E. coli  Escherichia coli 
EDTA  Ethylene diamine tetraacetic acid 
EGTA Ethylene glyol-bis (β-aminoethyl ether) N,N,N’tetracetic acid 
ESI-MS Electrospray ionisation mass spectometry 
ERK2 Extracellular signal regulated kinase 
FCCP Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone 
g Gravitational force 
Gln Glutamine 
GSK-3 Glycogen synthase kinase 3 
H Histidine 
HBHM Heavy bovine heart mitochondria 
HEK293T Human embryonic  kidney 293T cell line 
His Histidine 
Hsp90 Heat shock protein 90 
IF1 Inhibitor factor 1 
IMM Inner mitochondrial membrane 
IP Immunoprecipitation 
IR Ischaemia-reperfusion 
LC-MS/MS Liquid chromatography-tandem mass spectometry 
MOPS 3-(N-Morpholino)propanesulfonic acid 
NADH Nicotinamide adenine dinucleotide hydrate 
NBD-Cl 4-Fluoro-7-nitrobenzofurazan 
OCR Oxygen consumption rate 
OMM Outer mitochondrial membrane 
OSCP Oligomycin sensitivity conferral protein 
PC Cardiac preconditioning 
Pi Inorganic phosphate 
PiC Phosphate carrier protein 
  
8 Abbreviations 
PKC Protein kinase C 
PT Permeability transition 
PTP Permeability transition pore 
Q Glutamine 
RP-HPLC Reversed phase liquid chromatography 
ROS Reactive oxygen species 
SDS Sodium dodecyl sulfate 
SDS-PAGE  Sodium dodecyl sulfate -polyacrylamide gel electrophoresis 
TEMED N,N,N‘,N‘-tetramethylene diamine 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol 
TSPO Translocator protein 
VDAC Voltage-dependent anion channel  
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13 Introduction 
1.1 Structural organization of mitochondria 
Mitochondria are cytoplasmic organelles of variable size, with a diameter 
between 0.5 and 5 μm, responsible of the aerobic production of ATP by the oxidative 
phosphorylation system (OXPHOS). They also participate in intermediary 
metabolism of lipids, nucleotides, heme and urea and are involved in the early stages 
of cell death (Wallace et al. 1999) These organelles, which are present only in the 
eukaryotic cells, may vary greatly in terms of number and size, depending on the cell 
type. Their number varies from a few hundred to several thousand in more 
metabolically active cells, such as heart, muscle and kidney cells, where they occupy 
20-25% of the cell volume. 
While the first electron microscopy (EM) images suggested that mitochondria 
were separate entities in the cytoplasm, the use of specifically addressing 
recombinant probes definitely demonstrated that within living cells they form a 
dynamic network (Rizzuto et al. 1998), which is subject to ongoing arrangements by 
the fusion and fission machinery (Westermann 2008). Moreover, mitochondria 
continuously move along cytoskeletal tracks and are in close association with 
membranes of the endoplasmic reticulum (Rutter & Rizzuto 2000; Mannella 2000). 
Mitochondria are delimited by two membranes, the inner and outer 
membrane. The space between the two membranes is called intermembrane space 
(Figure 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Tomography volume of mouse heart 
mitochondrion. A) Three-dimensional volume of a mouse 
heart mitochondrion determined by cryo-ET. The outer 
membrane (grey) envelops the inner membrane (light blue). 
The inner membrane is highly folded into lamellar cristae, 
which criss-cross the matrix. B) Tomographic slice through the 
map volume From (Kühlbrandt 2015). 
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The outer membrane (OMM), which forms a continuous envelope around the 
mitochondrion, has a smooth surface and is highly permeable to small molecules and 
ions through channels that cross the lipid bilayer. The inner membrane (IMM) 
instead, is impermeable to most molecules of small size and to ions, including 
protons and possesses numerous invaginations called cristae , which significantly 
enhance its surface (Figure 1.1). It is well established that the IMM is a dynamic 
structure able to quickly change its shape in response to metabolic alterations 
(Hackenbrock 1966) or osmotic stress, such as those induced by the opening of an 
aspecific pore, originally defined as permeability transition pore (PTP) (Hunter et al. 
1976), whose nature has only recently been defined. 
The IMM accomodates large copy numbers of the five complexes of the 
OXPHOS (complexes I-V). Complexes I to IV are oxidoreductases which, with the 
exception of complex II, couple electron transport with translocation of protons 
across the inner membrane. The generated proton motive force is used by ATP 
synthase (complex V) for the endergonic synthesis of ATP from ADP and phosphate. 
Complex I or NADH dehydrogenase is the first and major entrance point of electrons 
to the respiratory chain. It transfers electrons from NADH molecules to a lipophilic 
quinone, ubiquinone, which in man has a side chain of 10 isoprenoid units (Q10). 
Complex II or succinate dehydrogenase transfers electrons from succinate to 
ubiquinone. From reduced ubiquinone electrons are transferred to complex III, or 
cytochrome c reductase, which exists in the membrane as a functional dimer. The 
small protein cytochrome c mediates electron transfer from cytochrome c reductase 
to cytochrome c oxidase (complex IV). Finally, electrons are transferred to molecular 
oxygen which is reduced to water (Figure 1.2) ATP synthesized by complex V is 
exchanged with cytosolic ADP through a specific adenine nucleotide translocator 
(ANT) of  the IMM (Pebay-Peyroula et al. 2003). The IMM also contains channels,  
and transporters that translocate inorganic ions and metabolites, including 
phosphate, thereby determining the compartmentalization of the metabolic functions 
of mitochondria (Kunji 2004; Robinson et al. 2008)  
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Globally, mitochondria contain 800 (yeast) to 1500 (human) different 
proteins. Although the majority of mitochondrial proteins are encoded in the nucleus 
and post-translationally imported into the organelle by a complex protein-import 
machinery (Baker et al. 2007), some subunits of the OXPHOS (13 in human) are 
encoded by the mitochondrial genome (mtDNA). This is a circular double-stranded 
molecule of approximately 16.5 kb without introns and histone proteins and also 
encodes rRNA and tRNA. On average, mtDNA is present in two copies per organelle 
and is maternally inherited. 
Defects in mtDNA are associated with mitochondrial diseases, which 
encompass a wide variety of degenerative diseases, but also with aging, and cancer 
(Wallace 1999). Deficiencies in OXPHOS appear to be the main pathogenic factors, 
although other mechanisms are involved, such as generation of reactive oxygen 
species (ROS) by the respiratory complexes and/or altered apoptotic signaling that 
are implicated in neurodegenerative diseases (McKenzie et al. 2004). 
 
 
 
 
Figure 1.2: Schematic representation of the OXPHOS system. This figure 
shows individual components of the OXPHOS system. The position of the matrix 
and cristae or inner membrane is indicated .From (Davies & Daum 2013). 
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1.2 FoF1 ATP Synthase (Complex V) 
The mitochondrial ATP synthase, also named FoF1 ATP synthase or complex V, 
is a 600 kDa multisubunits complex localized in the IMM that uses the energy of the 
transmembrane proton gradient to drive the synthesis of ATP from ADP and Pi. Its 
molecular structure and catalytic mechanism were mostly understood by the seminal 
work of the Nobel Laureates Mitchell (in 1979), Boyer and Walker (in 1997) that 
revealed its complexity and the functional steps driving the synthesis of ATP. 
ATP synthase is also present in the thylakoid membrane of chloroplasts, and 
in the plasma membrane of bacteria., It is extremely conserved, in spite of its 
structural complexity and of the early divergence of bacteria, plants and animals 
(Nelson 1992). Proton translocation and ATP synthesis are coupled by a unique 
mechanism, subunit rotation. The electrochemical energy contained in the proton 
gradient is converted into mechanical energy in form of subunit rotation and back 
into chemical energy as ATP (Stock et al. 2000; Capaldi & Aggeler 2002; Weber & 
Senior 2003). The enzyme is also able to work in the direction of ATP hydrolysis, 
sustaining the formation of the proton gradient, when there is loss of membrane 
potential. 
Traditionally, ATP synthase is divided into two subcomplexes, the membrane-
embedded F0 subcomplex through which the protons flow, and the peripheral F1 
subcomplex that carries the nucleotide binding sites. These sectors are linked by 
central and peripheral stalks (Stock et al. 2000; Rubinstein et al. 2003; Rubinstein et 
al. 2005) (Figure 1.3A). Approximately 85 % of the structure of the whole complex is 
known at high resolution from X-ray crystal structures of constituent domains, which 
have been assembled into a mosaic structure within the constraints of a cryo-EM 
map at 18 Å resolution (Baker et al. 2012). Interestingly, 3D classification of images 
revealed seven distinct states of the enzyme that show different modes of bending 
and twisting in the intact ATP synthase (Zhou et al. 2015).  
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1.2.1 Fo domain 
The membrane bound domain, named FO due to the interaction with the 
specific inhibitor oligomycin, is the site of the proton channel, and during evolution, 
it has undergone variations in its polypeptide composition. In the simplest form of 
the enzyme, typical of bacteria like Escherichia coli, F0 consists of three different 
subunits, named a, b and c (Fillingame et al. 2000), with molecular masses of 30.3, 
17.2 and 8.3 kDa respectively and stoichiometry ab2c10-15  (Watt et al. 2010). The c 
subunits form a ring structure connected to F1 by the central stalk. The a subunit 
associates with the c-ring peripherally forming at the interface two half 
transmembrane water channels through which protons are transported via the 
conserved carboxylic acid present on each c subunit (cAsp61 in E.coli and almost 
always a glutamate in other species). Subunit a also associates with the lateral stalk, 
which is formed by the homo-dimer of subunits b and by δ subunit located at the top 
of F1. Chloroplast and cyanobacteria F0 are composed of four subunits because the 
two b subunits are not identical (Fromme et al. 1987). The animal mitochondrial 
enzyme has a more complicated structure. Ten subunits have been originally 
identified, named a, b, c, F6, d, e, A6L, f, g and oligomycin sensitivity conferring 
protein (OSCP) (Collinson et al. 1994). The a, b and c subunits share great similarity 
Figure 1.3:  The mitochondrial FoF1 ATP synthase. A) subunit 
organization. Subunits are color-coded and labelled. F1 is the globular catalytic 
domain made of subunits α3,β3 and the three central stalk subunits, γ,δ and ε. The 
Fo domain is comprised of the c oligomer, subunit a, A6L, e, f, and g and the 
peripheral stalk subunits b, d, F6 and OSCP. From (Antoniel et al. 2014) B) 3D 
structure of the whole complex From (Zhou et al. 2015). 
A B 
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with the bacterial subunits, except for subunit c stoichiometry which comprises 10 
copies in yeast and only 8 copies in all vertebrates and all or most invertebrates (Watt 
et al. 2010). Electron cryomicroscopy of Polytomella (Allegretti et al. 2015) and 
bovine (Zhou et al. 2015) ATP synthase recently established that subunit a forms four 
long, horizontal membrane-intrinsic α-helices, arranged in two hairpins at an angle 
of approximately 70° relative to the c-ring helices. OSCP is analogous to E.coli δ-
subunit, whereas the remaining subunits are unique of the mitochondrial complex 
(Table 1). The membrane-embedded part of FO also comprises subunits e, f, g and is 
connected to F1 by a complex peripheral stalk (or “stator stalk”), composed by one 
copy each of subunit b, d, F6 and OSCP (Weber 2006; Rees et al. 2009) and possibly 
by subunit A6L (Lee et al. 2015). Besides these subunits, two hydrophobic proteins, 
namely MLQ/6.8-kDa proteolipid(Chen et al. 2007; Meyer et al. 2007), and 
AGP/DAPIT (Ohsakaya et al. 2011), are associated to the F0 part and interact with 
the e and g subunits (Lee et al. 2015). Subunit DAPIT is encoded only in the genomes 
of metazoans and subunit 6.8PL is restricted to vertebrates (Lee et al. 2015). 
Moreover, in animal mitochondria the e and g subunits interact with the matrix 
metalloprotein Factor B, named subunit s, which is also in contact with the ADP/ATP 
carrier (Lee et al. 2008). All together, the mitochondrial membrane domain is 
constituted by approximately 30 trans-membrane α-helices (Carroll et al. 2009). 
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1.2.2 F1 domain 
The structure of the F1 complex is highly conserved. In all cases it is composed 
of five different subunits, α through ε, with stoichiometry α3β3γδε (Walker et al. 
1984; Walker 1985). This protein complex has a total mass of 371kDa and has the 
shape of a flattened sphere having heigh of 80Å and width of 100Å. 
In the F1 sector the α- and β-subunits, which carry the nucleotide binding 
sites, are arranged alternatively, forming a hexagonal cylinder around the coiled-coil 
structure of the γ subunit. The α, β and γ subunits from different sources are highly 
conserved sharing great homology. Conversely, the small δ and ε subunits are not 
analogous in enzymes of different origin; bacterial and chloroplast δ and ε 
correspond to OSCP and δ subunit respectively of the mitochondrial ATP synthase, 
while the ε subunit of the mitochondrial complex has no counterpart in the bacterial 
enzyme (Walker et al. 1991; Abrahams et al. 1994) (Table 1).  
Despite differences among complexes of different origin, the mechanism of 
active proton transport and ATP synthesis/hydrolysis is highly conserved, as 
supported by the pioneering use of mitochondrial and chloroplast subunits as 
functional replacement in the bacterial complexes (Richter et al. 1986; Lill et al. 
1993; Burkovski et al. 1994; Puri et al. 2005).  
The steady state catalytic mechanism for ATP synthesis/hydrolysis requires all 
the catalytic sites, which are located in the β subunits at each β-α interface and 
interact each other in a highly cooperative manner. The ATP (and sometimes ADP) 
molecules bound to the α subunits at α-β interfaces are not-exchangeable and 
therefore these sites are considered as non-catalytic, whose role is still unknown. 
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Mitochondria 
E.coli, 
P.modestum 
and A.woodii 
Chloroplast, 
cyanobacteria
2
 
and 
rhodobacteria
3
 Bovine Yeast 
α α (ATP 1) α α 
β β (ATP 2) β β 
γ γ (ATP 3) γ γ 
δ δ (ATP 16) ε ε 
ε ε (ATP 15) - - 
OSCP OSCP (ATP 5) δ δ 
b 4 or b (ATP 4) b
4
 b and b’ (I and II) 
A6L 8 iATP8p (aap 1) - - 
F6 h (ATP 14) - - 
a a (ATP 6) or 6 a a (IV) 
c 9 or c (ATP 9) c c (III) 
 
d (ATP 7) - - 
e e (Tim 11) - - 
f f (ATP 17) - - 
g g (ATP 20) - - 
- i/j (ATP 18) - - 
- k (ATP 19) - - 
MLQ/6-8 kDa - - - 
AGP/DAPIT - - - 
1Subunit equivalence is based on  sequence homology .2Synechococcus, 3Rhodospirillum 
rubrum and Rhodopsmonas blastica. 4ATP synthase from E.coli and P.modestum have two 
copies of the b subunit and ATP synthase from chloroplasts, cyanobacteria and 
rhodobacteria have one copy of each b and b’. The b and b’ are homologous. (-) No subunit 
equivalence. From (Antoniel et al. 2014) 
Table 1 : Equivalence of subunits of ATP synthase from different sources1. 
 
  
21 Introduction 
Numerous atomic structures have been resolved : i) of the isolated  F1 part 
from bovine (Abrahams et al. 1996; van Raaij et al. 1996; Orriss et al. 1998; Braig et 
al. 2000; Menz et al. 2001; Kagawa et al. 2004; Bowler et al. 2007; Bason et al. 2011; 
Rees et al. 2012) and yeast mitochondria (Kabaleeswaran et al. 2006; Kabaleeswaran 
et al. 2009),; ii) of bovine F1 in complex with full-length or truncated subunits of the 
lateral stalk (Rees et al. 2009); and iii) of the bovine F1c8 (Watt et al. 2010) and yeast 
F1c10 subcomplexes (Stock et al. 1999; Dautant et al. 2010; Giraud et al. 2012). All 
these structures established that the three β-subunits adopt three different tertiary 
structures and are in three diverse nucleotide-bound states. According to the original 
paper published at the beginning of the Nineties (Abrahams et al. 1994) the first 
conformation, named βTP, hosts the binding site for ATP; the second, called βDP, 
binds with high affinity ADP and Pi; the third, βE, does not efficiently bind any 
nucleotide. This asymmetry supported the binding change mechanism theorized by 
Boyer (Boyer 1993), according to which the sequential interconversion between these 
different conformations, driven by the central stalk rotation, enables the catalysis. 
This is constituted by the γ, δ and ε subunits in chloroplasts and mitochondria and by 
the γ and ε subunits in bacteria. More recent findings established that βE is not likely 
to exist during catalysis and all the three catalytic sites bind nucleotides at any time 
(Menz et al. 2001; Rees et al. 2012) (Figure 1.4). Differently from β, the three α 
subunits adopt the same conformation, but are named according to their adjacent β. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Change of the states of three β subunits during 
hydrolysis or synthesis of one ATP. The rotation occurs in opposite 
directions during ATP synthesis and hydrolysis, resulting in different 
sequences and specific interconversion of catalytic sites .From (Yoshida et 
al. 2001). 
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1.2.3 Oligomycin sensitivity conferring protein (OSCP) 
Located on top of the catalytic F1 sector in the mitochondrial complex, OSCP 
makes stable contacts with both F1 and the peripheral stalk, ensuring the structural 
and functional coupling between FO and F1. Indeed, truncation mutants of N-
terminal and C-terminal OSCP showed an impaired coupling or failed to survive 
(Prescott et al. 1994).  
The physical location of OSCP has been defined in the crystal of a F1- 
peripheral stalk subcomplex from bovine (Rees et al. 2009). Its N-terminal domain 
(residues 1-113) contains 6 α-helices, of which helix 1 and 5 provide the binding site 
(i) for residues 6-17 of subunit αE (which contacts βE in α3β3 subcomplex), largely via 
hydrophobic interactions; (ii) for the  N-terminal β-barrel domains of especially the 
βDP-subunit. These interactions are capable of resisting the torque generated by the 
rotary motor of the enzyme. The structure of the C-terminal domain of OSCP consists 
of a β-hairpin, which precisely locates  along the α/β interface (Baker et al. 2012), 
followed by two α-helices, helix 7 and 8, which make extensive helix-helix 
interactions with  the C-terminal of subunit b and with the N-terminal α-helix of 
subunit F6 of the lateral stalk. The linker region between the N- and C- domains 
appears to be flexible, enabling a bending of the peripheral stalk towards the top of F1 
in the intact ATP synthase (Zhou et al. 2015). 
1.2.4 Rotational catalysis 
The peculiar structural organization of ATP synthase is the base of the 
catalytic mechanism of the enzyme, which is the smallest rotary motor existing in 
nature. Boyer originally suggested that Fo is a rotary motor driven by the proton 
flow, and that F1 is another rotary motor driven by ATP hydrolysis. The two motors 
have a common stalk (central stalk), but the genuine rotary directions of the two 
sectors are different. When the free energy liberated by the downward flow of 
protons is greater than the free energy of ATP hydrolysis, the Fo motor rotates the 
central stalk in the Fo’s genuine direction. The F1 motor is forcibly rotated in its 
reverse direction, resulting in ATP production in its catalytic sites. If the free energy 
of ATP hydrolysis is higher, the F1 motor gains control and rotates the stalk in its 
own direction. Protons are then pumped out by Fo against an uphill potential, 
resulting in membrane potential generation (Boyer 1993). 
It is now widely recognized that during ATP synthesis, the clockwise (viewed 
from the membrane) c-ring rotation in FO powered by the proton traslocation into 
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the mitochondrial matrix trough (half) channels located at the interface of a and c 
subunits drives the γ subunit rotation within the α3β3 F1 subcomplex (at about 100 
times per second) that takes each of the three catalytic sites through at least three 
major functional states denoted as βE, βDP and βTP, thereby synthesizing three ATP 
molecules from ADP and Pi during each 360° rotation.  When the enzyme works in 
the direction of ATP hydrolysis passing through the βE, βDP and βTP functional states, 
drives the counterclockwise rotation of the γ subunit and the c-ring, thereby causing 
proton traslocation into the intermembrane space.  
To reveal the dynamic features of F1 rotation, several single molecule 
rotational assays  (Oosawa & Hayashi 1986; Boyer 1993; Funatsu et al. 1995; Yasuda 
et al. 1998) have been developed since the method was first developed in 1997 (Boyer 
1993). In most assays, the α3β3 F1 subcomplex is immobilized onto a cover slip, and a 
rotation marker tag is fixed to the protruding part of the γ subunit allowing the 
visualization of its ATP-driven rotation. While a fluorescently labeled actin filament 
was used as the rotation marker in the pioneering studies, micron-sized plastic beads 
or gold colloids of 40-60 nm are frequently used at present. In some experiments, a 
magnetic bead was attached to the subunit γ , which was controlled by an external 
magnetic field to first force the backward (clockwise) rotation of F1, leading to ATP 
synthesis. When the magnetic field was switched off, the F1 molecule underwent 
anticlockwise rotation at a speed proportional to the amount of synthesized ATP 
(Rondelez et al. 2005; Nakanishi-Matsui et al. 2013). A further technical 
sophistication used a sub-millisecond resolution camera to detect the rotation of gold 
beads attached to the γ subunit of the α3β3γ subcomplex along with fluorescence 
changes of an ATP hydrolysable analog. This technique allowed to display in real 
time the binding and release of nucleotides at the three catalytic sites simultaneously 
with the γ rotation (Adachi et al. 2007). Single molecule technology studies have 
been applied also to the whole FoF1 complexes from Propionigenium modestum and 
Escherichia coli. Rotation was probed with probes attached to the c-ring in the 
immobilized F0F1 and, as expected, occurred in the opposite direction when c-ring 
rotation was driven by ATP or by proton-flow (Ueno et al. 2005). 
In accordance with its pseudo three fold symmetrical structure, F1 hydrolyzes 
threes ATP molecules per rotation. The γ subunit rotation is not continuous, but 
rather proceeds in 120° steps, each driven by hydrolysis of one ATP molecule (Yasuda 
et al. 1998; Rondelez et al. 2005). In the bacterial enzyme these consist of substeps, 
the first of 80° driven by ATP binding and the second of 40° driven by release of ADP 
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or Pi (Adachi et al. 2007), whose angular velocity is debated (Martin et al. 2014). 
These substeps differ from those of human F1, in which ATP binding to one β-
subunit occurs at 0°, Pi release from another β-subunit at 65° and ATP hydrolysis on 
the third β-subunit at 90°, demonstrating that chemomechanical coupling angles of 
the γ subunit are tuned during evolution (Suzuki et al. 2014).  
Rotary subunit movements within the whole bacterial H+-ATP synthase were 
also monitored in real time and with subnanometre resolution by a single-molecule 
FRET (fluorescence resonance energy transfer) approach, which uses a double-
labelled enzyme incorporated in liposomes driving either ATP hydrolysis or ATP 
synthesis (Diez et al. 2004; Ernst et al. 2012).  
Critical residues in the catalytic sites are βLys162 and βThr163 of the P-loop, 
βGlu188 and αArg373 (bovine numbering), which are highly conserved (Fig. 1.5). The 
hydrolysis of an ATP molecule bound to the βDP-subunit proceeds via the in-line 
nucleophilic attack of the γ-phosphate by a water molecule activated by residue  
βGlu188. It has been proposed that in the bovine enzyme the αR373 plays a critical 
role in this step by correctly positioning the γ-phosphate of the nucleotide (Rees et al. 
2012). The reaction advances via formation of a transition-state intermediate, as 
observed in the transition analog structure of bovine F1 (Menz et al. 2001), followed 
by scission of the terminal phosphate and release of products.  
In the bacterial enzyme the conserved arginine of  α subunit (αR376 – E. coli 
numbering) seems to be important for conformational communication among the 
three catalytic sites, (Futai et al. 2012), which entails the tremendous acceleration of 
ATP hydrolysis rates upon binding of ATP at lower affinity to the second and more so 
the third catalytic sites.  
It is important to notice that the catalytic process requires the presence of 
Mg2+, which contributes with γ subunit in determining the asymmetry of the catalytic 
sites necessary for the binding-change mechanism (Weber et al. 1996). Bovine F1 
crystal structures showed that Mg2+, interacts directly with βThr163, with ATP atoms 
βO2 and γO2, and through three water molecules with βArg189, βGlu192 and 
βAsp256 (Rees et al. 2012) (Figure 1.5).  
On the available evidence it appears that during catalysis, in the bovine 
enzyme at least, both phosphate and the magnesium ion are released before ADP 
(Rees et al. 2012). 
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Mg2+ can be replaced by other divalent cations including Ca2+, the ionic radius 
being the chief factor determining their ability to activate the ATPase activity (Selwyn 
1968). Intriguingly, Ca2+ ions, differently from other divalent cations with similar 
ionic radius, only support ATP hydrolysis, which is not coupled to proton 
translocation both in bacteria (Nathanson & Gromet-Elhanan 2000) and in 
mammals (Papageorgiou et al. 1998). In spite of this, CaATP was capable of 
supporting rotation of γ subunit attached to an actin filament in a similar way to 
MgATP, as demonstrated in a highly active hybrid F1-ATPase consisting of α /β 
subunits from Rhodospirillum rubrum and γ subunit from spinach chloroplasts 
(Tucker et al. 2004). Replacement of the equivalent βT163 (bovine numbering) with 
serine in ATP synthase from Rhodospirillum rubrum produced a mutant unable to 
catalyze the proton-decoupled Ca2+-dependent ATP hydrolysis while maintaining 
proton-coupled ATP synthesis as well as Mg2+- and Mn2+-dependent ATP hydrolysis 
(Nathanson & Gromet-Elhanan 2000). These observations suggest that Ca2+ 
mayinduce different conformational changes in the catalytic sites compared to Mg2+ 
(Bernardi et al. 2015).   
1.2.5 ATP Synthase assembly process  
The mitochondrial FoF1 complex is composed of both nuclear and 
mitochondrial gene products. In yeast the three Fo core proteins a, A6L and c, named 
Su6, Su8 and Su9 respectively, are encoded by mtDNA, while in mammals only 
subunits a and A6L are encoded by mitochondrial genome. This arrangement 
highlights the complexity of enzyme assembly, which requires accessory factors 
Figure 1.5: Localization of Mg ion in the catalytic sites of βDP 
and βE subunits in bovine ATP Synthase : Residues involved in 
the interaction with Mg2+ are depicted, distances are expressed in Å 
From (Rees et al. 2012). 
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whose definition is still under investigation (Wittig & Schägger, 2008). Altogether 9 
factors have been identified in yeast, but, until now, the role of only five of them has 
been defined. Three factors mediate the F1 formation (Atp11p, Atp12p and possibly 
Fmc1p) (Ackerman 2002; Lefebvre-Legendre et al. 2001) and two the Fo assembly 
(Atp10p and Atp22p) (Helfenbein et al. 2003; Rak et al. 2011). Recent findings in 
yeast have unveil that the coordinated expression of the ATP synthase genes depends 
on the cytosolic complex AME, which is made of two aminoacyl-t-RNA synthetases 
(cERS and cMRS) attached to the anchor protein Arcp1 (Frechin et al. 2014). In 
mammalian cells only two factors are known, which are orthologus to yeast F1 
assembly factors. 
The assembly process is best characterized in yeast, where recent in organello 
pulse-labeling and pulse-chase experiments have enabled to identify three different 
assembly intermediates and to demonstrate that the whole enzyme is formed by two 
separate pathways that converge to form the ATP synthase from their respective end-
products. One pathway leads to the formation of F1, which was already known to 
assemble as an independent unit (Tzagoloff et al. 1969), and of the Su9- ring. These 
two sub-complexes subsequently combine to constitute the F1/Su9-ring end-product. 
The other pathway leads to the formation of the Su6/Su8/stator sub-complex, which, 
in addition to Su6 and Su8, contains the chaperone Atp10p and additional still 
undefined proteins of the lateral stalk (Rak et al. 2011)  
A similar assembly strategy has been proposed for human ATP synthase.  
Indeed, when expression of the lateral stalk d-subunit was knocked-down, human 
cells accumulated two subcomplexes, one containing the F1-c-ring subcomplex and 
the other containing stator stalk components ("b-e-g" complex). F1-c-ring was also 
formed when expression of mtDNA-coded a-subunit and A6L was suppressed, 
suggesting that the central rotor  and the stator stalk are formed separately and they 
assemble later (Fujikawa et al. 2015).  
It has been proposed that this bifurcated process may recapitulate some of the 
evolutionary events that gave rise to this enzyme. The F1/Atp9p ring intermediate 
could be the product of an evolutionary event, which enabled a passive channel to be 
converted to an active ion transporter. The function of the ancestral protein from 
which the Atp6p/Atp8p/stator complex evolved is more difficult to envision. Its 
function may have been adapted to further modify the ATP-dependent ion pump into 
the present energy transforming machine (Rak et al. 2011). 
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1.2.6 Oligomers 
ATP synthase is commonly purified as a functional monomer but this seems 
not to be its physiological state in mitochondrial membranes. Electron microscopic 
analyses of Paramecium multimicronucleatum mitochondria first showed F1 
complexes arranged as double rows of particles that wind around tubular cristae of 
the inner mitochondrial membrane (Allen et al. 1989). Subsequent studies in yeast 
demonstrated that these supra-molecular structures are formed by dimers of ATP 
synthase associated in oligomers that play a special role in defining mitochondrial 
morphology, being involved in cristae formation (Paumard et al. 2002). Additional 
proposed roles of the ATP synthase oligomers are higher efficiency (Bisetto et al. 
2007; Strauss et al. 2008) and higher stability (Thomas et al. 2008a) 
The structural role of ATP synthase has been further demonstrated by recent 
electron cryotomagraphy studies showing that in different types of mitochondria 
(bovine heart, potato and three fungi) ATP synthase dimers and oligomers are 
present exclusively on tightly curved cristae edges, where they interact within the 
IMM through the Fo subunits (Figure 1.6A) (Davies et al. 2011; Davies et al. 2012). 
These studies also revealed a fixed angle of 86° between the monomers (Davies et al. 
2012), in contrast with previous single-particle electron microscopy images which 
indicated angles ranging from 40° (Couoh-Cardel et al. 2010; Minauro-Sanmiguel et 
al. 2005) to 70-90° (Dudkina et al. 2006; Thomas et al. 2008b). Based on this 
observation, the authors proposed that the shape of the FoF1 ATP synthase dimer was 
sufficient to deform the lipid bilayer and drive the self-assembly of the FoF1 ATP 
synthase dimers into rows (Davies et al. 2012). However, more recent studies based 
on single-particle cryo-EM map of detergent solubilised bovine FoF1 ATP synthase 
monomers (Baker et al. 2012) and on a combination of electron cryo-tomography, 
subtomogram averaging, and electron crystallographic image processing of intact 
bovine FoF1 ATP synthase in 2D membrane crystals (Jiko et al. 2015) proposed that 
the monomers alone can deform the lipid bilayer and that this membrane 
deformation is likely to be a prerequisite for the self-association of FoF1 ATP 
synthases into dimers and of dimers into rows. Interestingly, ATP synthase dimers 
have also been observed in chloroplasts of algae, where they appear to be more 
susceptible towards environmental effects, e.g. Pi concentration (Seelert & Dencher 
2011), but not in bacteria. 
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In yeast the structural properties of dimers have been characterized by genetic 
approaches and cross-linking analyses, which established preferential interactions 
within the IMM mainly through the Su6(a) (Wittig & Schägger 2008), Su4(b) 
(Spannagel et al. 1998), e (Everard-gigot et al. 2005) and g subunits (Bustos & 
Velours 2005) and also through subunit h(F6) and the yeast-specific subunit i 
(Fronzes et al. 2006). In keeping with its general occurrence, the involvement of 
subunit a (Wittig et al. 2010), e (Bisetto et al. 2008; Johann Habersetzer et al. 
2013)and g (Habersetzer et al. 2013a) in ATP synthase dimer/oligomer formation has 
been demonstrated also in mammals. Moreover, a stabilizing effect on mammalian 
ATP synthase dimers has been reported for the inhibitor protein IF1 (García et al. 
2006; Campanella et al. 2008; Bisetto et al. 2013)and the matrix metalloprotein 
Factor B, which interacts with e and g subunits of FO (Belogrudov 2009). In addition, 
a second interface (named the oligomerization interface) has been described in yeast; 
this interface was stabilized through e/e and g/g interactions allowing oligomer 
formation (Habersetzer et al. 2013b). However, the existence of an oligomerization 
interface has been criticized based on the above cited electron cryotomography data, 
which evidenced variable distance between dimers making direct protein contacts 
difficult (Davies et al. 2012).  
Both in yeast (Habersetzer et al. 2013b; Wittig & Schägger 2008) and 
mammals (Bisetto et al. 2013; Wittig et al. 2010; Habersetzer et al. 2013a) the 
stabilizing contribution of the different subunits seems to be additive and low 
amounts of ATP synthase dimers and oligomers have been detected by native PAGE 
Figure 1.6 Disposition of ATP Synthase oligomers in mitochondrial 
cristae. The ATP synthase forms dimers rows (yellow) at the cristae tips, whereas the 
proton pumps of the electron transfer chain (green) reside predominantly in the 
adjacent membrane regions. From (Davies et al. 2011). 
  
29 Introduction 
also in mutants lacking one or  more of the above mentioned subunits, such as ρ° 
cells depleted of a- and A6L-subunits (Wittig et al. 2010), and yeast (Paumard et al. 
2002) and human (Habersetzer et al. 2013a) cells totally or partially depleted of e- 
and g-subunits. Surprisingly, down-regulation of e- and g-subunits in HEK and HeLa 
cells not only affected ATP synthase dimerization/oligomerization, but also the 
OXPHOS activity and the mitochondrial network (Habersetzer et al. 2013a).  
1.2.7 ATP Synthase interactors 
Beside the formation of oligomers, ATP synthase activity is optimized by 
biochemical events, such as by reversible association of regulatory peptides and by 
post-translational modifications (PTMs). A high number of modifications has been 
identified in the various subunits of ATP synthase, including phosphorylation, 
acetylation, trimethylation, nitration, s-nitrosylation and tryptophan oxidation 
(Covian & Balaban 2012). However, in most cases it remains unknown what are the 
signalling pathways responsible for these PTMs, in which tissues or biological 
conditions these modifications occur, how they impact on the biochemical activity of 
the target protein and of the holo-enzyme, and how much of the target protein can be 
modified (Bernardi et al. 2015). 
The endogenous inhibitor protein IF1 is considered as a major determinant in 
the regulation of ATP synthase (Green & Grover 2000; Campanella et al. 2009). IF1 is 
evolutionarily conserved from yeast to human and reversibly binds to F1 with a 1:1 
stoichiometry fully inhibiting the enzyme activity.  
IF1 is encoded in the ATPIF1 gene and in humans three different isoforms of the 
protein due to alternative splicing of the IF1 mRNA primary transcript have been 
described (Sánchez-Cenizo et al. 2010). In yeast, along with IF1, two additional 
proteins, namely Stf1 and Stf2 (stabilizing factor 1 and 2) have been found, whose 
role is still debated (Venard et al. 2003).  
The levels of IF1- F1 interactions are governed by the factors promoting release 
and rebinding, i.e. membrane potential and MgATP (Lippe et al. 1988). In addition, 
IF1 binding is strongly favored by low pH. Indeed, in mammalian mitochondria low 
pH favours the formation of the inhibitory dimeric IF1, while the increase in pH 
provokes the formation of tetramers hence masking the N-terminal inhibitory region 
of IF1 (Cabezón et al. 2000). This regulation involves three key histidine and one 
glutamic acid ( H49, H55, H56 and E26 – bovine numbering) (Bason et al. 2011).  
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Consistently, treatment of bovine IF1 with the histidine reagent diethyl pyrocarbonate 
(DPC) prevented its binding to the inner membrane at acidic pH (Panchenko & 
Vinogradov 1985). In contrast, the yeast IF1, which lacks the above mentioned 
histidine, can be found as an inhibitory monomer at low pH and as a non-inhibitory 
dimer at high pH (Robinson et al. 2013).  
IF1 blocks the rotation of the enzyme nanomotor by inserting its N-terminal 
inhibitory domain between the C-terminal domains of the αDP and βDP subunits and 
the coiled-coil region of the γ subunit. The mechanism of IF1 inhibition is quite 
complex and fundamental insights have been recently obtained by point mutations 
and X-ray crystallography of bovine (Bason et al. 2011; Bason et al. 2014a) and yeast 
IF1 (Robinson et al. 2013). Interestingly, the pathway from the initial interaction of 
IF1 to F1 to the final inhibited IF1-F1 complex implies that the rotor of the enzyme 
turns through two 120° steps hydrolyzing two ATP molecules, which are trapped in 
bovine IF1 as Mg2+ -ADP complexes in both βDP and βTP subunits, while βE is empty 
(Bason et al. 2011; Bason et al. 2014). In spite of a similar structure, the final 
inhibited IF1-F1 complex of yeast still contains an ADP molecule (without Mg2+ and 
Pi) in the catalytic site of βE, indicating that IF1 has arrested the catalytic cycle at a 
slightly different point (Robinson et al. 2013). Interestingly, the novel inhibitor ζ 
subunit of the FOF1-ATPase of Paracoccus denitrificans similarly blocks the intrinsic 
rotation of the nanomotor (García-Trejo et al. 2016). 
At variance from IF1 binding, the mechanism of IF1 release from F1 in response 
to the formation of a membrane potential is less clear; it has been proposed that the 
reversal of the direction of γ rotation to drive ATP synthesis destabilizes IF1 binding, 
leading to its ejection (Bason et al. 2011; Bason et al. 2014).   
The activity of IF1 as an inhibitor of the ATP synthase is also regulated by 
PTMs. Indeed, phosphorylation of S39 in human IF1 by the action of a mitochondrial 
cAMP-dependent protein kinase A hampers its interaction with the ATP synthase, 
indicating that only the dephosphorylated IF1 interacts with the enzyme (García-
Bermúdez et al. 2015).  
IF1 is considered responsible for the beneficial (at least partial) inhibition of 
FoF1 during ischemia both in in vitro experimental models as well as in vivo (Rouslin 
& Broge 1996; Di Pancrazio et al. 2004; Green & Grover 2000; Campanella et al. 
2009). Unexpectedly, IF1-knockout mice grew without defects, but their behavior 
against stressful situations have not been tested (Nakamura et al. 2013).   
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New emerging roles of IF1 are related to metabolic reprogramming of cancer 
cells, where IF1 overexpression causes inhibition of oxidative phosphorylation, 
triggering mitochondrial hyperpolarization and ROS production, which is able to 
reprogram the nucleus of the cell to confer cell resistance against oxidative stress 
(Sánchez-Aragó et al. 2012). Consistently, recent findings indicate that a high 
expression level of IF1 is a bad predictor of survival and recurrence of the disease in 
liver, bladder, gastric and glioma cancer patients (Song et al. 2014; Yin et al. 2015; 
Wei et al. 2015; Wu et al. 2015). However, in breast and colon carcinomas the 
overexpression of IF1 predicts much better patient’s prognosis (Sánchez-Aragó et al. 
2013), indicating that IF1 overexpression affects carcinogenesis in a tissue specific 
manner.  
Recently it has been reported that ATP synthase binds another regulatory 
protein, which interacts with the OSCP subunit of the lateral stalk: Sirtuin3 
(Vassilopoulos et al. 2014; Wu et al. 2013). It is possible that Sirtuin3 acts as sensing 
protein whose loss of function may induce ATP Synthase dysfunction and might 
indirectly compromise mitochondrial respiratory function capacity by affecting the 
formation of mitochondrial supercomplexes and their electron transfer function 
(Vassilopoulos et al. 2014). Also p53 has been reported to interact with OSCP 
(Bergeaud et al. 2013), taking part in the assembly or stabilization of the mature FoF1 
complex. This finding suggests that the mitochondrial fraction of p53, although very 
low, may be an important regulator of mitochondrial physiology potentially exerting 
tumor suppression (Bergeaud et al. 2013). However, interaction domains between 
Sirtuin3and p53 with OSCP have been not yet determined.  
Another interactor that induces the enzyme inhibition is the Protein Kinase 
Cδ which binds to the d subunit of the FoF1 lateral stalk (Nguyen et al. 2010). Others 
interactors conversely improve the enzyme performance, such as S100A1, which 
interacts with the F1 moiety in a Ca2+-dependent manner in cardiomyocytes (Boerries 
et al. 2007; Kraus et al. 2010), and Bcl-XL that also binds to F1 and increases the 
aerobic ATP production in healthy neurons by decreasing the membrane leak 
conductance (Alavian et al. 2011). Indeed, neurons overexpressing Bcl-xL, have 
higher ATP levels with respect to the cells in which endogenous Bcl-xL is depleted or 
inhibited.  
A new, intriguing interactor is the CyPD, a peptidyl-prolyl cis-trans isomerase 
which binds to the OSCP subunit inhibiting both the hydrolytic and synthetic activity 
of ATP synthase (Giorgio et al. 2013;). CyPD is the unique mitochondrial isoform of 
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CyPs in mammals (Giorgio et al. 2010), it is involved in protein folding (Fischer et al. 
1989; Takahashi et al. 1989; Galat & Metcalfe 1995) and, most importantly, plays a 
crucial role in the regulation of the mitochondrial permeability transition pore (PTP), 
a conserved high-conductance channel located in the IMM (Bernardi et al. 2015).  
The identification of CyPD interaction with the OSCP subunit of ATP synthase was an 
essential step for the identification of the molecular nature of PTP. (For a further 
description see paragraph 1.4.1).  
1.3 Permeability transition pore 
The first description of permeability transition (PT) can be found in a 1976 
manuscript published in The Journal of Biological Chemistry by Douglas Hunter, 
Robert Haworth and James Southard where they concluded that Ca2+ addition to 
isolated cow heart mitochondria induced a “…nonspecific increase in the 
permeability of the inner membrane, resulting in entry of sucrose into the matrix 
space and the observed configurational transition (swelling) of mitochondria” 
(Hunter et al. 1976). Further, they showed that this process required the energized 
uptake of Ca2+ through a ruthenium red-sensitive mechanism now known to be the 
mitochondrial calcium uniporter (MCU), the genetic identity of which was recently 
defined (De Stefani et al. 2011; Baughman et al. 2011); and that the PT resulted in 
uncoupling of oxidative phosphorylation. The same group followed this discovery 
with numerous reports detailing the nature of the PT and its role in physiology that 
have largely held to date. The authors concluded in subsequent studies that the 
channel is gated in a Ca2+-specific manner and that its opening imparts permeability 
to solutes up to 1.5kDa in size (Hunter et al. 1976; Hunter & Haworth 1979). 
The PTP hypothesis, despite being described in mitochondria from different 
species, was not greeted with enthusiasm by the scientific community, because it was 
in contrast with the chemiosmotic theory, which had just been recognized with the 
award of the Nobel Prize to Peter Mitchell in 1978 (Mitchell 1979).  
An important turning point was the discovery that the PT can be desensitized 
by submicromolar concentrations of cyclosporine A (CsA). Fournier et al. first 
described the enhanced ability of CsA-treated mitochondria to accumulate high loads 
of Ca2+ (Fournier et al. 1987). CsA is well known to be a potent immunosuppressant 
able to inhibit calcineurin signaling after complex formation with CyPA (Clipstone & 
Crabtree 1992). Available evidence indicated that CsA affects the pore independently 
of calcineurin. Indeed, Pfeiffer’s group proposed that CsA bound a modulatory entity 
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specific to pore formation (Broekemeier & Pfeiffer 1989), which was then identified 
as the matrix CyPD, whose enzymatic activity is inhibited by CsA with a matching 
inhibition of the PTP (Connern & Halestrap 1992; Nicolli, Nicolli, et al. 1996; 
Woodfield et al. 1997; Griffiths & Halestrap 1991) 
These discoveries provided a protein regulator to the PTP (CyPD), and a drug 
(CsA) to test its occurrence in cells and living organisms. Through the use of CsA the 
occurrence of PTP opening in cell death (Crompton & Costi 1988) could be tested in a 
series of pioneering studies in hepatocytes subjected to oxidative stress (Broekemeier 
et al. 1992; Imberti et al. 1992) or anoxia (Pastorino et al. 1993), as well as in 
cardiomyocytes (Duchen et al. 1993) and isolated hearts (Griffiths & Halestrap 1995) 
exposed to ischemia followed by reperfusion. The realization that a whole spectrum 
of cell death modalities exists (Galluzzi et al. 2015) and that PTP is involved in several 
of them (Lemasters et al. 2002; Orrenius et al. 2015) resulted in a vastincrease of 
interest in the phenomenon of PT over the last 30 years, as testified by over 5,000 
publications on regulation of the PTP and its role in cell death (Bernardi et al. 2015). 
Another important point was the characterization of the biophysical properties 
of the PTP by using patch-clamping techniques. In the early 1990s Szabò and Zoratti 
found a large conductance channel located in the IMM referred to as the 
mitochondrial megachannel (MMC). This channel was inhibited by CsA and other 
PTP regulators (such as Mg2+ and ADP), therefore the authors hypothesized that the 
MMC and the PTP were expression of the same entity and were constituted by the 
same molecular components (Bernardi 1992; Szabó et al. 1992). The channel shows a 
maximum conductance in the range of 0.9 to 1.3 nS (Szabó & Zoratti 1991) and, in its 
fully open conformation, its apparent diameter is about 3 nm, thus able to allow 
diffusion of ions and of solutes with molecular masses up to 1.5 kDa . 
MMC presents different conductance states and in particular one of these has 
a conductance that is half of the maximum, suggesting that the channel has a binary 
structure . Electrophysiology has greatly contributed to our understanding of the PTP 
(Szabo & Zoratti 2014).  
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1.3.1 Regulation of the PTP 
The consequences of PTP opening depend on the open time of individual 
pores and on the number of open pores per mitochondrion at any given time. 
Measurements of the membrane potential resolved in individual mitochondria 
demonstrated transient and asynchronous cycles of depolarization-repolarization, 
which over time tended to become long-lasting (Hüser et al. 1998). When PTP 
opening is persistent, collapse of the proton gradient prevents ATP synthesis and 
ATP hydrolysis by the ATP synthase worsens ATP depletion. In mammalian 
mitochondria persistent PTP opening is also followed by equilibration of ionic 
gradients and solutes up to 1.5 kDa, which may cause swelling, cristae unfolding and 
eventually OMM rupture (Bernardi et al. 2015).  
Numerous studies demonstrated that the pore open–closed transitions are 
highly regulated by multiple effectors the main of which are discussed below (Figure 
1.7).  
 
 
 
 
 
 
 
 
 
Ca2+ ions. As already mentioned, matrix Ca2+ plays a key role in the 
induction of the PTP, but the mechanism is still undefined. The threshold Ca2+ load 
required for PTP opening (the Calcium Retention Capacity,CRC) varies with the 
experimental conditions, in particular the presence of Pi (see below). Matrix Mg2+ 
desensitizes the PTP, and the effect is synergistic with that of adenine nucleotides. 
The desensitizing effect is also seen with other divalent cations that are transported 
by the MCU, indicating that the Ca2+ binding site in the matrix can be competitively 
inhibited by other Me2+ ions, such as Mn2+ and Sr2+ (Bernardi et al. 1992; Szabó et al. 
1992). On the other hand, all these Me2+ ions, including Ca2+ itself, decrease the 
Figure 1.7 Matrix and membrane regulators of PT. 
From (Bernardi 1999). 
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probability of pore opening through an external binding site that does not require 
cation uptake (Bernardi et al. 1992). 
Matrix inorganic phosphate is the most puzzling PTP effector. In 
mammalian mitochondria Pi is a classical inducer of the PTP, in spite of the fact that 
increasing concentrations of Pi decrease matrix free [Ca2+] (Zoccarato & Nicholls 
1982). On the other hand, Pi can inhibit the PTP in CyPD null mouse liver 
mitochondria, suggesting that the inducing effects of Pi may depend, in part at least, 
on CyPD (Basso et al. 2008; Azzolin et al. 2010). This result is particulary intriguing 
because Pi is an inhibitor rather than an inducer of the PT in yeast (Jung et al. 1997; 
Yamada et al. 2009) and in Drosophila melanogaster¸ where the PTP cannot be 
desensitized by CsA (von Stockum et al. 2011). 
The PT is strictly modulated by matrix pH. The optimum matrix pH for PT 
occurrence is about 7.3, and both an increase and decrease lead to decreased 
probability of PTP opening (Figure 1.8). An acidic pH locks the pore in the closed 
conformation through reversible protonation of still-unidentified His residues that 
can be blocked by DPC, whilst the mechanism of inhibition by pH > 7.4 is still 
unknown (Nicolli et al. 1993; Petronilli et al. 1993). His126 of CyPA plays an 
important role both in ligand binding and in catalysis (Yu & Fesik 1994), but PTP 
modulation by matrix pH was not affected by genetic ablation of CyPD (i.e, in Ppif-/- 
mice) demonstrating that the PTP-regulatory His are located on the PTP (Basso et al. 
2005). It should be mentioned that in energized mitochondria an acidic matrix pH 
can promote rather than desensitize the PTP because it increases the rate of Pi 
uptake, worsening tissue damage in ischemic and postischemic acidosis (Kristian et 
al. 2001).  
 
 
 
 
 
 
 
 
Figure 1.8 Effect of pH on the PTP: 
CyPD null (close symbol) and wild-type 
(open symbol) mouse liver mitochondria 
were treated at different pH and the rate of 
permeabilization was evaluated after Ca2+ 
addition .From (Basso et al. 2005). 
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The PTP is voltage-dependent in the sense that that inside-negative ΔΨm 
tends to stabilize the PTP in the closed conformation while the open state is favored 
by depolarization (Bernardi et al. 1992), as confirmed at the single channel level 
(Zoratti & Szabó 1994). The existence of a voltage sensor that may comprise critical 
Arg residues has been proposed, as suggested by modulation of the PTP voltage 
dependence by Arg-selective reagents (Eriksson et al. 1998; Johans et al. 2005). This 
mechanism could contribute to explain the effects of membrane-perturbing agents 
on the PTP. In general, amphipathic anions, such as fatty acids produced by 
phospholipase A2 (PLA2) (e.g. arachidonic acid) mimic a depolarization and favor 
the PT. Instead, polycations such as spermine, amphipathic cations such as 
sphingosine and trifluoroperazine, and positively charged peptides mimic a 
hyperpolarization and inhibit pore opening (see (Bernardi et al. 2006; Rasola & 
Bernardi 2007)for review). Control by the proton electrochemical gradient provided 
a conceptual framework to reconcile the PTP with chemiosmosis (Bernardi 1999). 
The voltage-dependence in turn is modulated by redox events. Pore opening 
is strongly promoted by oxidation of pyridine nucleotides (NADH/NAD+ and 
NADPH/NADP+) (Costantini et al. 1996), and by a dithiol-disulfide interconversion 
at two distinct, matrix- and intermembrane space exposed sites. These can be 
discriminated by the use of proper oxidants and reductants. The membrane 
permeant dithiol reagent phenylarsine oxide (PhAsO) cross-links matrix-exposed 
internal cysteins (Cys), and this can be prevented by low concentrations of N-
ethylmaleimide (NEM) (Petronilli et al. 1994) or monobromobimane (Costantini et 
al. 1995). A second redox-sensitive site whose oxidation increases the probability of 
PTP opening is affected by the membrane-impermeant oxidant copper-o- 
phenantroline [Cu(OP)2]; oxidation of this site is inhibited by dithiotreitol and β-
mercaptoethanol but not by monobromobimane (Costantini et al. 1998). 
It appears likely that oxidation of critical PTP thiols mediates the inducing 
effects of peroxides and redox-cycling agents, which are indeed prevented by low 
concentrations (Ki about 5 M) of NEM and monobromobimane (Petronilli et al. 
1994).   
The PTP open probability increases with electron flux within complex I 
(Fontaine et al. 1998) and this finding led to the discovery that the PT is regulated by 
quinones: Ubiquinone 0 or decylubiquinone prevent pore opening and their 
inhibitory effects can be relieved by pore-inactive quinones (Walter et al. 2002). 
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Provided that Pi is present, also rotenone desensitizes the PTP. The potency of the 
drug has been correlated with the CyPD expression levels, the less CyPD 
mitochondria express, the more potent rotenone is in inhibiting the PTP (Li et al. 
2012). It appears likely that PTP modulation by complex I is mediated, in part at 
least, by production of ROS. Indeed, oxidation of succinate, which induces reverse 
electron flow at complex I, greatly favors ROS production and PTP opening, both 
events being prevented by rotenone (Li et al. 2012). 
The PTP is regulated by two inhibitors of the ANT: bongkrekate and 
atractylate. Both compounds inhibit the ANT yet have the same effect on pore 
opening, which is inhibited. This set of observations was one of the bases for the 
proposal that the PTP forms from the ANT (Woodfield et al. 1998), which was 
disproved later by genetic studies as discussed in the next paragraph. To explain the 
effects of these ANT inhibitors a modulation by the surface potential, which in turn 
may affect the PTP open-closed transition through the voltage sensor, has been 
proposed (Bernardi, 2015).  
The PT is primarily an IMM event, as it also occurs in mitoplasts, i.e. in 
mitochondria stripped of the OMM (Šileikytė et al. 2011), yet the OMM plays a role in 
pore modulation. Indeed, PTP induction by high concentrations (0.5-1.0 mM) of 
NEM and other substituted maleimides and by hematoporphyrin plus high light 
doses, a treatment that leads to the production of singlet oxygen (Petronilli et al. 
2009), requires an intact OMM (Šileikytė et al. 2014).  
1.3.2CyPD 
Cyclophilins (CyPs) can be identified in the genomes of mammals, plants, 
insects, fungi and bacteria; they all share a common domain of approximately 109 
amino acids, the CyP-like domain, which is endowed with peptidyl-prolyl cis–trans 
isomerase (PPIase) activity (Wang & Heitman 2005). In humans 16 CyPs isoforms 
have been found (Wang & Heitman 2005), with cytosolic CyPA representing the most 
abundant one and CyPD the unique mitochondrial CyP isoform.  
The evolutionary conservation of the PPIase activity among species suggested 
that this can be an important function of the CyPs. However, and somewhat 
surprisingly, Saccharomyces cerevisiae mutants lacking all 12 yeast CyPs were 
viable, and the phenotype of the dodecuplet mutant resulted from simple addition of 
the subtle phenotypes of each individual mutation (Dolinski et al. 1997). This striking 
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finding led the authors to propose that each CyP instead may regulate a restricted 
number of unique partner proteins (Dolinski et al. 1997). In keeping with this 
prediction, CyPs have been shown to be involved in a variety of pathophysiological 
processes including inflammation and vascular dysfunction (Jin et al. 2004; Kim et 
al. 2004; Kim et al. 2005; Arora et al. 2005), wound healing (Kong et al. 2007), 
innate immunity to HIV (Sokolskaja & Luban 2006), hepatitis C infection (Flisiak et 
al. 2007), host–parasite interactions (Bell et al. 2006) , tumor biology (Yao et al. 
2005), besides the PTP regulation.  
Cs (Cyclosporins) are cyclic undecapeptides known to bind CyPs and to inhibit 
their PPIase activity. CsA is the most studied (Borel et al. 1977); its ability to prevent 
the immune response has revolutionized medicine, allowing organ transplantion to 
become a standard therapeutic practice. As mentioned above, interaction of CsA with 
cytosolic CyPA generates a complex that acquires the ability to bind, and inhibit, the 
cytosolic, Ca2+-activated phosphatase calcineurin (Liu et al. 1991). As a consequence 
of calcineurin inhibition, its substrate phospho-NFAT is no longer dephosphorylated 
and therefore unable to translocate to the nucleus and trigger the IL-2-dependent 
activation of the immune response against the transplant (Clipstone & Crabtree 1992; 
Walsh et al. 1992). Work with mutants of human CyPA has allowed a clear 
separationof the PPIase activity of the protein from CsA binding and calcineurin 
inhibition (Zydowsky et al. 1992).  
As already mentioned, CyPD is the mitochondrial target for CsA and 
modulates the PTP by decreasing the Ca2+ load required for pore opening, an effect 
that is prevented in the presence of CsA (Crompton & Costi 1988; Connern & 
Halestrap 1992; Woodfield et al. 1997). This has been definitely proven by the crystal 
structure of human CyPD in complex with its inhibitor CsA obtained at 0.96 Å 
resolution (Kajitani et al. 2008) and by the genetic ablation of the Ppif gene (which 
encodes for CyPD) in the mouse (Baines et al. 2005; Basso et al. 2005; Nakagawa et 
al. 2005; Schinzel et al. 2005). CyPD-null mice showed no overt phenotype and no 
obvious changes in mitochondrial function. As expected, CyPD-null mitochondria 
were desensitized to Ca2+, as opening of the PTP required about twice the Ca2+ load 
necessary in wild-type mitochondria, and were insensitive to CsA. Other than for the 
requirement of higher Ca2+ loads, the PTP response to a variety of modulators was 
similar in mitochondria from wild-type and CyPD null mice, thereby demonstrating 
that CyPD has all the key aspects of a PTP modulator but is not an essential 
structural component of the PTP. Consistently, the electrophysiological features of 
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the PTP from CyPD-null mitochondria were indistinguishable from those of wild-
type individuals (De Marchi et al. 2006). Moreover, yeast and Drosophila PTPs are 
not modulated by CyP and are insensitive to CsA (Jung et al. 1997; von Stockum et al. 
2011).  
A major step in mechanistic understanding of the role of CyPD in PTP 
regulation has been the discovery that CyPD masks an inhibitory site for Pi (Figure 
1.9). In fact, in the absence of Pi, the sensitivity to Ca2+ is identical in wild type and 
CyPD-null mitochondria (Basso et al. 2008).  
 
 
 
 
 
 
 
 
 
 
1.3.3CyPD involvement in pathology 
The use of CyPD-null mice allowed to demonstrate that a wide variety of 
diseases, most notably ischemia-reperfusion injury of the heart and brain, muscular 
dystrophies and neurodegeneration,  have their basis in mitochondrial pathogenesis 
and misregulation of the PTP (Giorgio et al. 2010). Baines and colleagues (2005) 
have found that CyPD null mice are protected from ischaemia-reperfusion in vivo, 
whereas CyPD overexpressing mice show mitochondrial swelling and spontaneous 
cell death. Consistently, mitochondria isolated from the livers, hearts and brains of 
Ppif-/- mice (Ppif encodes CyPD) are resistant to mitochondrial swelling and 
permeability transition in vitro. Moreover, primary hepatocytes and fibroblasts 
isolated from these mice are largely protected from Ca2+ overload and oxidative 
stress-induced cell death, but not from staurosporine- or TNFα- mediated cell death, 
or death induced by Bax. Consistent with these data, CyPD overexpression in B50 
neuronal cells promoted PTP and necrotic cell death, although it inhibited apoptotic 
Figure 1.9. Modulation of the PTP by CyPD and Pi. The 
CyPD-bound form of the PTP shows a higher probability of 
opening; addition of CsA displays CyPD and unmasks an 
inhibitory Pi (Giorgio et al. 2010). 
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cell death (Li et al. 2004).  
Ppif-/- mice also display a striking resistance to the development of axonopathy 
in a model of autoimmune encephalomyelitis (Forte et al. 2007), and to disease 
progression after crossing with the superoxide dismutase 1 mice (Martin et al. 2009; 
Parone et al. 2013), suggesting that CyPD-dependent mechanism may be critical in 
the neurodegenerative aspects of de-myelinating and motor neuron diseases. Genetic 
ablation of CyPD rescues mitochondrial defects enhancing β-cell survival in diabetes 
(Fujimoto et al. 2010), preventing muscle apoptosis in collagen VI myopathic mice 
(Palma et al. 2009) and improving learning, memory and synaptic function in a 
mouse model of Alzheimer disease, where it also alleviated reduction of long-term 
potentiation mediated by the amyloid β peptide (Du et al. 2008).  
1.3.4Molecular nature of the PTP 
A set of observations, based primarily on biochemistry and electrophysiology 
studies, led to a model where the PTP would be a multiprotein complex spanning 
both mitochondrial membranes and comprising the ANT and the Pi carrier (PiC) of 
the IMM, matrix CyPD, as well as the voltage-dependent anion channel (VDAC), the 
translocator protein (TSPO, also known as peripheral benzodiazepine receptor), 
hexokinase (HK) and Bcl-2 proteins of the OMM (Zamzami & Kroemer 2001).  
However, this model did not stand the test of genetics as a CsA-sensitive PT 
could be easily detected in the absence of ANT (Kokoszka et al. 2004), VDAC 
(Krauskopf et al.2006; Baines et al. 2007) as well as of TSPO (Šileikytė et al. 2014). 
1.3.4.1ANT 
The ANT is the most abundant IMM protein and catalyzes the exchange of 
ATP for ADP. In most mammals four isoforms are present, showing differential 
tissue distribution.  
The hypothesis that ANT could be a structural component of the PTP was 
initially suggested by the effects of bongkrekic acid and atractylate on PT (Hunter & 
Haworth 1979; Schultheiss & Klingenberg 1984), as described above. Further 
investigations found that ANT reconstituted into liposomes exhibits high-
conductance channel activity that is stimulated by Ca2+ and insensitive to CsA, like 
the MMC; unike the MMC, however, currents could only be inhibited by ADP and 
bongkrekate together, while ADP alone had a marginal effect (Brustovetsky & 
Klingenberg 1996). Moreover, binding of the ANT to a CyPD affinity matrix has been 
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reported and the authors proposed that the effects of both CsA and ADP on the PTP 
could be due to ANT interaction with CyPD. However, the relevance of CyPD-ANT  
interaction to PTP regulation remains unclear because CyPD bound equally well the 
ANT purified from rat liver or yeast (Woodfield et al. 1998) in spite of the fact that in 
yeast mitochondria the PT is not regulated by CyP or inhibited by CsA, (Jung et al. 
1997).  
A decisive proof against this theory was the generation of mice lacking Ant1 
and Ant2  by the Wallace and Coworkers, who demonstrated that mitochondria 
isolated from double-null hepatocytes still exhibited PT induced by Ca2+, sensitive to 
CsA and favoured by diamide and H2O2. These data clearly indicated that the ANT is 
not essential for PTP formation and is not the site of action of these oxidants, or the 
relevant partner for CyPD binding (Kokoszka et al. 2004); of note, mice (and all 
rodents) lack a gene for ANT3 and the fact that PTP from ANT1/ANT2-null 
mitochondria was resistant to atractylate and ADP excludes a compensatory 
(mis)targeting of ANT4 in liver (Bernardi, 2015).  
1.3.4.2PiC  
The PiC (SLC25A3 gene) is the primary transporter of inorganic phosphate 
(Pi) into the mitochondrial matrix by proton cotransport (or in exchange for hydroxyl 
ions) and in mammals is encoded by a single gene. PiC has been proposed to be 
either an effector of the PTP or, possibly, a structural component in cooperation with 
the ANT (Halestrap 2009). This hypothesis was mainly based on the observation that 
the CsA-sensitive binding of CyPD to the PiC and its modification by SH-reagents 
correlated with PTP opening and inhibition (Leung et al. 2008).  
Genetic tests demonstrated that mitochondria where PiC expression was 
reduced by 60% showed no alteration in PTP function (Gutiérrez-Aguilar et al. 2014) 
and that in mitochondria with over 90% reduction in PiC levels the PTP could still 
form, and displayed marginally reduced sensitivity to activators (Kwong et al. 2014). 
Moreover, patch-clamp experiments with the reconstituted, functionally active PiC 
revealed conductance properties different that those of the MMC (Herick et al. 1997). 
These data indicate that PiC, like the ANT, cannot constitute a key structural element 
of the PTP. 
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1.3.4.3 Spastic paraplegia 7   
A recent paper (Shanmughapriya et al. 2015) proposed thatthe spastic 
paraplegia 7 protein (SPG7 or paraplegin) is an essential component of the PTP. 
SPG7 is an AAA-type protease involved in the processing and quality control of a 
variety of mitochondrial proteins that forms oligomeric (normally hexameric) ring-
shaped complexes (Casari et al. 1998). The candidacy of SPG7 emerged from an 
initial screening in which 128 possibly relevant genes were knocked down by 
appropriate shRNAs and the effects on the mitochondrial PT was evaluated. 
However, it should be noted that the selected genes also included some of the 
candidates ruled out by genetic tests, such as ANT2 and VDAC1. Moreover, no 
electrophysiological  data have been provided, while these latter may be particularly 
relevant, because SPG7 has not yet been reported to form permanent pores . 
1.3.4.4 VDAC 
VDAC is a major OMM protein which functions as a general diffusion pore for 
small hydrophilic molecules; in mammals, distinct genes encode three variants of the 
protein, VDAC1, 2 and 3 (Raghavan et al. 2012). Various observations from different 
groups suggested that VDAC1 could be an essential component of the PTP. Purified 
VDAC1 incorporated into planar phospholipid bilayers forms channels with a pore 
diameter of 2.5-3.0 nm, whose electrophysiologial properties were similar to those of 
the PTP (Szabó et al. 1993; Szabó & Zoratti 1993). Moreover the VDAC channel 
properties were modulated by NADH (Zizi et al. 1994), Ca2+ (Gincel et al. 2001), 
glutamate (Gincel & Shoshan-Barmatz 2004) and hexokinase (Pastorino et al. 2002), 
all factors that also regulate the PTP. However, as for ANT, studies based on genetic 
ablations questioned this conclusion. Indeed mitochondria lacking all three VDAC 
isoforms compared to wild-type mitochondria showed the same properties in terms 
of pore opening (Baines et al. 2007) 
1.3.4.5 TSPO 
The translocator protein of 18 kDa, TSPO, , is a hydrophobic protein localized 
to the OMM with a cytoplasmic domain containing a cholesterol recognition region 
(Li et al. 2001). In several steroidogenic cell types it has been found that TSPO 
ligands stimulate steroid synthesis and promote translocation of cholesterol from the 
OMM to the IMM (Krueger & Papadopoulos 1992; Gavish et al. 1999). Consistently, 
TSPO was initially identified as the peripheral benzodiazepine receptor, which was 
presumed to have a key role in the hormonally induced entry of cholesterol into 
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steroidogenic cells (Besman et al. 1989). However, the ubiquitous expression of 
TSPO suggested that it could serve more general functions. Moreover, its role in 
cholesterol metabolism has been questioned in conditional Tspo-/-  mice (Morohaku 
et al. 2014); consequently, the precise function of TSPO remainsto be established.  
It was suggested that TSPO takes part to PTP formation due to its interaction 
with VDAC and ANT (McEnery et al. 1992). In addition, experiments with 
compounds specifically targeting TSPO suggested that its ligands influenced the 
opening of the PTP, such as the benzodiazepine Ro5-4864,the isoquinoline 
carboxamide PK-11195, and protoporphyrin IX, which are inducers of the PTP 
(Kinnally et al. 1993; Pastorino et al. 1994; Šileikytė et al. 2014). However, it has been 
recently found that the PTP properties are identical in TSPO null and wild type 
mitochondria, demonstrating that TSPO plays no role in the regulation or structure 
of the PTP (Šileikytė et al. 2014).  Consistent with this conclusion, hearts lacking 
TSPO are as sensitive to ischemia-reperfusion injury as hearts from wild-type mice 
(Šileikytė et al. 2014), in contrast to mice missing CyPD (Baines et al. 2005). These 
results indicate that OMM regulation of PTP activity occurs though a mechanism that 
does not require TSPO and call into question a number of studies implicating TSPO 
in  pathological processes mediated by the PTP (Bernardi et al. 2015). 
1.3.5Alternative models for PTP formation 
In 2002 a model was proposed where the PTP would originate from misfolded 
membrane proteins (He & Lemasters 2002), similarly to an earlier suggestion that 
the PT is due to oxidative damage of membrane proteins rather than a consequence 
of the opening of a pre-formed pore (Kowaltowski et al. 2001). This misfolding by 
oxidative stress and other perturbations would expose hydrophilic clusters enclosing 
aqueous channels that allow diffusion of low molecular weight solutes. Alterations of 
thiol groups, particularly cross-linking, may be critical for the initial misfolding of 
membrane proteins leading to clustering. Similarly, exogenous amphipathic peptides 
would also assemble into pore-forming clusters. After the initial formation of protein 
clusters, He and Lemasters propose that one or more chaperone-like proteins (such 
as CyPD) bind to the clusters to block pore conductance. Increased Ca2+ causes CyPD 
to perturb the protein cluster/chaperone complex causing the opening of a CsA-
sensitive PTP. When the number of these protein clusters exceeds available 
chaperones opening of “unregulated” pores would occur, which would no longer be 
sensitive to CsA. 
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The model accounts for both CsA-sensitive and -insensitive pores, as well as 
for the lack of selectivity of the permeability pathway. On the other hand, it doesn’t 
account for the regulatory role of membrane potential and matrix pH, whose effects 
are difficult to explain by heterogeneous misfolded proteins (Bernardi et al. 2006). 
1.4 FoF1 ATP Synthase and the PTP 
Recently our group has demonstrated that purified FoF1 ATP synthase dimers 
from bovine heart, (Giorgio et al. 2013), yeast (Carraro et al. 2014) and Drosophila 
melanogaster (von Stockum et al. 2015) form channels possessing many properties 
of the PTP after treatment with oxidants in the presence of Ca2+.  
Two sets of critical observations greatly contributed to these findings. The first 
was that CyPD binds to the OSCP subunit of the mammalian complex, resulting in 
partial enzyme inhibition; CsA displaces CyPD from OSCP resulting in enzyme 
reactivation (Giorgio et al. 2009). The second was that ATP synthase dimers, but not 
monomers, generate Ca2+-dependent currents with features indistinguishable from 
those of the MMC, the electrophysiological equivalent of the PTP (Giorgio et al. 
2013).  
While these findings leave little doubt that the PTP forms from the ATP 
synthase, the mechanism of pore formation remains an open question. Our working 
hypothesis is that channel forms from dimers of ATP synthase after replacement of 
Mg2+ with Ca2+ at the F1 catalytic sites, which induces specific conformational 
changes leading to the uncoupling of ATP hydrolysis from H+ transport 
(Papageorgiou et al. 1998). Once the conformational change has occurred, 
permeation would take place at the interface between dimers. The ATP synthase 
would then return to its basal coupled state when the catalytic site is reoccupied by 
Mg2+, consistent with the full reversibility of the PT. 
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1.4.1 CyPD interaction with mammalian FoF1 ATP Synthase 
Initially, CyPD interaction with bovine heart ATP synthase has been 
demonstrated by blue native electrophoresis of mitochondrial proteins after low-
detergent extraction, which is widely used for the identification of protein-protein 
interactions (Wittig et al. 2006), and immunoprecipitation of ATP synthase (Giorgio 
et al. 2009). Furthermore, cross-linking with the membrane-permeant cleavable 
bifunctional reagent dimethyl 3,3-dithiobis-propionimidate, which reacts with the 
primary amines of two interacting proteins at an average distance of about 8 Å 
(Green et al. 2001), evidenced that CyPD forms a cross-linked complex with the 
subunits OSCP, b, and d subunits in an apparent ratio of 1:1:1:1 (Giorgio et al. 2009), 
supporting the interaction of CyPD with the extrinsic part of the ATP synthase 
peripheral stalk.  
Binding of CyPD to the enzyme complex is favored by Pi and competed by CsA. 
Importantly, CyPD binding has major functional consequences, with a decrease of 
both ATP synthetic and ATP hydrolytic activity that can be reversed by CsA-
dependent CyPD displacement (Giorgio et al. 2009). Consistently, the stimulatory 
effect of CsA was lost in Ppif−/− mitochondria, indicating that it is mediated by CyPD, 
while assembly of the ATP synthase was unaffected by CyPD ablation (Giorgio et al. 
2009), demonstrating that CyPD is not involved in the enzyme assembly process. 
By immunoprecipitation of each of the lateral stalk subunits b,d and OSCP 
individually it was later established that OSCP is the direct interactor of CyPD 
(Figure 1.10) (Giorgio et al. 2013). Moreover, decreased expression of OSCP after 
treatment with specific siRNAs in human HQB17 cells led to a parallel decrease of 
CyPD binding to F-ATP synthase, and, most importantly, to a matching decrease of 
the threshold matrix Ca2+ required for PTP opening, suggesting that ablation of OSCP 
or CyPD binding to OSCP would induce equivalent effects causing increased 
probability of PTP opening.  In this scenario OSCP would be a “negative” modulator 
influencing the probability of replacing Mg2+ with Ca2+ in the F1 catalytic sites, while 
CyPD would be a “positive” effector, which does increase the apparent Ca2+ affinity of 
the PTP.  
CyPD interaction with the OSCP subunit can be displaced by Bz-423. In 
addition, Bz-423 has a PTP-sensiting effect, in a striking analogy with CyPD, 
suggesting that their binding site may coincide. Bz-423 was originally characterized 
as an apoptosis-inducing agent acting through mitochondria (Blatt et al. 2002). 
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OSCP was identified as its target through the unbiased screening of a human phage 
display library (Johnson et al. 2005) and by NMR studies, which established that Bz-
423 binds to a region comprising the helices 3 and 4 and induces conformational 
changes able to perturb the OSCP- F1 interface resulting in enzyme inhibition (Stelzer 
et al. 2010).     
 
 
 
 
 
 
 
 
 
Consistently, helices 3 and 4 of OSCP form a low surface potential region and 
may therefore be a putative binding site of the basic CyPD on OSCP, whose 
interactions are mostly electrostatic in nature, being disrupted by increased ionic 
strength. However, the same study identified a second region of low surface potential 
located at OSCP residues His112, Glu115 comprised in helix 6, and Val116, Glu128 
and Glu133 of the linker region (Figure 1.11) (Giorgio et al. 2013). 
 
 
 
 
 
 
 
 
 
OSCP b d
CyPD
OSCP
d
b
Figure 1.10 CyPD interaction whit OSCP. 
Immunoprecipitates of bovine heart mitochondria whit 
OSCP, b and d subunits are shown. From (Giorgio et al. 
2013). 
 
Figure 1.11 Surface potential and isopotential curves of 
CyPD and OSCP. A) Electrostatic isopotential curves on CyPd 
are displayed in blue (positive) and red (negative). B) Side chain 
atoms with the lowest average surface potential on OSCP. The two 
main regions of lowest surface potential are indicated. 
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1.4.2  ATP Synthase dimers form the PTP 
The demonstration that in mammalian mitochondria Bz-423 induces the PTP, 
and that its binding site may coincide with that of CyPD on OSCP paved the way to 
the demonstration that ATP synthase can form channels with the features of the PTP-
MMC.   
To test this hypothesis digitonin mitochondrial extracts were separated 
through blue native electrophoresis (Wittig & Schägger 2009). ATP Synthase dimers 
and monomers were eluted and inserted into planar lipid membrane for subsequent 
electrophysiological characterization. Dimers and monomers were subjected to 
Western blot analysis, which excluded the presence of VDAC and ANT. Purified 
dimers, but not monomers, formed channels activated by Ca2+, Bz-423 and oxidative 
stress with a unit conductance of about 500 pS. This is a value close to that of a “half-
MMC” channel (De Marchi et al. 2008), suggesting that the maximum-size PTP may 
be formed by ATP synthase tetramers (Bernardi et al. 2015). The channels were 
inhibited by Mg2+/ADP and by the ATP synthase inhibitor -imino ATP (a non 
hydrolyzable ATP analog). Consistent with the lack of CyPD and ANT in the 
preparations, channels were insensitive to CsA, bongkrekic acid and atractyloside 
(Giorgio et al. 2013). The channel-forming property was also found in preparations 
from Saccharomyces cerevisiae, which displayed Ca2+-dependent currents of about 
300 pS (Carraro et al. 2014) and Drosophila melanogaster, where the conductance 
was 53 pS, in keeping with earlier results on solute permeation (von Stockum et al. 
2015). Importantly, yeast mutants lacking the ATP synthase e and g subunits 
involved in dimer formation, turned out to be resistant to Ca2+-dependent PTP 
opening, supporting the dimer model (Carraro et al. 2014).  
Channel formation by ATP synthase has been confirmed in human cells 
(Alavian et al. 2014) and is supported by a study where the c subunit was 
downregulated by siRNA in HeLa cells, which resulted in PTP inactivation (Bonora et 
al. 2013). These studies proposed that the F0 c-ring is a core component of the pore, 
an idea that was originally suggested by the observations that the PT could be 
induced by a phosphorylated peptide derived from the c subunit and by subunit c 
itself (Azarashvili et al. 2002; Azarashvili et al. 2014). Alavian et al. have observed 
that upon reconstitution into an artificial bilayer assemblies of tagged c subunits 
formed large Ca2+-dependent pores with peak conductance up to 1.5-2 nS resembling 
the PTP, whose opening was blocked by addition of the F1 β subunit, but not by 
subunits ,// , which interact with the Fo c-ring in the native enzyme. The authors 
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suggested that the PTP channel forms within the c-ring itself after Ca2+-dependent 
extrusion of F1. However, if PTP opening depends on F1 release, their data show that 
F1 itself cannot reintegrate within FO through subunits //, each event of pore 
opening would denature the corresponding ATP synthase, while the PTP is fully 
reversible in mitoplasts (Szabò et al. 1992), intact mitochondria (Petronilli et al. 
1994) as well as in reconstituted dimers of ATP synthase (Giorgio et al. 2013). 
Moreover, in the protocols of Alavian et al. channel openings strictly required CyPD, 
while neither the yeast nor the Drosophila PTPs are regulated by CyPs. Another 
critical point of this model is that both in mammals and in Drosophila the c-ring is 
composed by 8 subunits (Watt et al. 2010), making quite difficult to see how c-rings 
of the same size can form 500 pS channels in mammals and 53 pS channels in 
Drosophila. The lack of correlation between conductance of the channel and 
composition of the c-ring is also supported by measurements in yeast, where the c-
ring has 10 subunits and the conductance is 300 pS (Carraro et al. 2014). In 
summary, the ensemble of these findings is not consistent with the idea that the PTP 
channel forms within the ring of c subunit. Furthermore, when present in “excess”, c 
subunit forms hydrophobic aggregates with no increase of membrane permeability, 
as recently observed after silencing of the  subunit in HEK293 cells, which blocked 
the biogenesis of ATP synthase with accumulation of subunit c (Havlíčková et al. 
2010). Mitochondria in these cells were more coupled, which is unexpected if the c-
ring can form high-conductance membrane channels. 
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AIM 
PTP formation from ATP Synthase poses the challenging opportunity to 
determine the molecular mechanisms through which the enzyme complex  shifts 
from an energy-conserving into an energy-dissipating device based on the structural 
and functional properties of ATP synthase.  
pH plays a relevant role in the PTP modulation. The probability of PTP 
opening has an optimum at neutral matrix pH, while the pore is blocked at acidic 
matrix pH values. Inhibition  is due to reversible protonation of histidyl residue(s) 
because diethylpyrocarbonate (DPC), a histidine-modifying reagent, prevents PTP 
inhibition by H+ through carbethoxylation of histidyl residues. In addition, low pH 
promotes release of the PTP-modulator CyPD from the IMM through reversible 
protonation of histidyl residues still blocked by DPC.   
The goal of the present work is to identify the mechanism(s) through pH 
affects the PTP. As CyPD interacts with the OSCP subunit of ATP synthase, the 
possibility that the histdine critical for pH modulation of PTP are located within 
OSCP will be evaluated. Moreover, the involvement of the histidine(s) responsible of 
the pH-dependent binding of the endogenous inhibitor IF1 will be considered. 
Finally, the pH influence on the structural stability of the ATP synthase dimers will 
be assessed.  
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2.1 Isolation of bovine heart mitochondria 
Bovine heart mitochondria were prepared following two procedures, as 
described below.  
2.1.1 Isolation of heavy bovine heart mitochondria (HBHM) 
Heavy bovine heart mitochondria were prepared from fresh hearts (Löw & 
Vallin 1963) obtained from the abattoir and packed in ice. All the following steps 
were run at 4°C. The meat was diced and fat and connective tissue were removed. 
Then the diced meat was suspended in buffer A (0.25M sucrose, 10mM Tris/HCl, pH 
7.8) in a volume ratio of 1:3 and the pH decrease due to lactic acid release was 
neutralized by the addition of 2M Tris. Buffer A was removed by filtration through 
muslin clothes, the minced meat was re-suspended in buffer B (0.25M sucrose, 
10mM Tris/HCl, 2mM EDTA and 1mM Tris/succinic acid, pH 7.8) and then 
homogenised in a Waring blender (Waring Products Division, New Hartford CT, U. 
S. A.) for 30sec. Cell debris was removed by low speed centrifugation at 1,000xg for 
10min. The supernatant was filtered twice through muslin clothes and the 
mitochondria, now in suspension, were collected by high-speed centrifugation at 
19.000xg for 20min. The pellets from each portion were re-suspended, combined 
and homogenised in a Potter homogeniser. After a final high-speed centrifugation 
step (39.000xg for 15min), the supernatant was decanted and the pellets stored at -
80°C.  
2.1.2Isolation of functional mouse liver (MLM) and bovine heart 
mitochondria (BHM) 
To obtain small quantities of well coupled mitochondria, the method of 
(Costantini et al. 1995) was used. All steps were run at 4°C. Wild type or Ppif-/- mouse 
livers were removed and placed in a glass beaker containing ice-cold buffer C (0.25 M 
sucrose, 10 mM Trs/HCl, 0.1 mM EGTA pH 7.4), cut into small pieces with scissors.  
rinsed with ice-cold buffer C (to remove as much blood as possible) and passed through a 
pre-chilled Potter homogenizer. In the case of bovine heart, the ventricular tissue was 
freed from fat and connective tissue before being cut into small pieces with scissors.  
rinsed with ice-cold buffer C (to remove as much blood as possible) and passed through a 
pre-chilled Potter homogenizer. The homogenate was centrifuged at 700xg for 10 
minutes (4°C) to remove unbroken cells and nuclei. The supernatant containing 
mitochondria and other organelles was centrifuged at 7.000xg for 10 minutes at the 
same temperature. The mitochondrial pellet was carefully suspended in ice-cold buffer C 
  
54 Matherials and Methods 
and spun at 9.000xg for 5 minutes at 4°C. The mitochondrial pellet was suspended in 
buffer C to give a protein concentration of about 60-80 mg/ml and immediately used. 
2.2 Preparation of submitochondrial particles from HBHM 
Ultrasonic disintegration of mitochondria produces inverted 
submitochondrial particles, in which the substrate binding sites for both the ATP 
synthase and the respiratory chain are on the outside. Different types of 
submitochodrial particles can be prepared depending on the medium used during the 
ultrasonic disintegration. 
2.2.1 MgATP submitochondrial particles (MgATP-SMP)  
In this type of membrane preparation the interaction between the F1 and the 
Fo domains is well coupled (Löw & Vallin 1963). HBHM stored at -80°C were thawed 
under cold tap water and suspended at 15 mg/ml with buffer A. MgCl2 and ATP were 
added to reach a final concentration of 15mM and 1mM respectively. Aliquots of 3ml 
were exposed to sonic oscillation for four 30 sec cycles separated by 30 sec intervals 
in a Labsonic oscillator. The entire treated batch was centrifuged at 19.000xg for 20 
min at 4°C , followed by a second centrifugation of the supernatant for 30m at 
100.000xg. The pellet was suspended in a small amount of 0,25M Sucrose, 10mM 
Tris/HCl, pH 7.3 and the protein content was determined according to the Lowry 
method. Typically, the yield of particles was 17-22% of the mitochondrial protein 
(Löw & Vallin 1963). 
2.2.2 EDTA submitochondrial particles (EDTA-SMP)  
In this type of membrane preparation the interaction between the F1 and the 
Fo domains is specifically altered, moreover the IF1 content is reduced (Rouslin et al. 
1995). Thawed HBHM were suspended in 0.25M sucrose to give a protein 
concentration of 20mg/ml. EDTA was added at the suspension to obtain a final 
concentration of 2mM, and the pH was adjusted to about 8.5-8.8 values with NaOH. 
Then the suspension was exposed to ultrasonic energy, as described above, and 
diluted 1:1 with 0.25 M sucrose. The sample was centrifuged at 19.000xg for 20 min 
at 4°C and the supernatant centrifuged again at 100,000xg for 30min. The final 
pellet was supended in 0.25M sucrose, 10mM Tris/HCl, pH 7.3 and the protein 
content estimated according to the Lowry method. 
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2.3  IF1 extraction 
For IF1 extraction, MgATP-SMP were used as source materials. These 
particles were suspended in 0.25M Sucrose, 10mM Tris and 2 mM EDTA pH at a 
protein concentration of 20mg/ml and heated in a glass tube for 4 min at 75°C with 
occasional shaking. The denatured proteins were removed by centrifugation at 
100.000xg for 10 min at 20°C. The supernatant was removed carefully, its volume 
measured and added with 125 mg per ml of ammonium sulfate and 5,5 ml per ml of 
ice-cold anhydrous ethanol. The suspension was mixed for 2 min and centrifuged at 
100.000xg for 10 min at 20°C. The pellet (mainly containing IF1) was suspended in 
2ml of 10mM Tris pH 7.4 and concentrated through the Vivaspin®Centrifugal 
concentrator for 20min at 8.000xg. The resulting supernatant was quantified by the 
Lowry method. 
2.4  Protein estimation 
The Lowry method (Lowry. et al., 1951) is particularly suitable for membrane 
protein estimation thanks to the presence of a detergent. The method consists of two 
steps: 
1. The starting interaction between the proteins and cuprous ions in a basic 
solution; 
2. The reduction of phosphotungstic and phosphomolybdic acid to blue 
tungstate and blue molybdate by the complex Cu-proteins and by tryptophan and 
tyrosine residues present in the proteins.  
The reaction is followed spectrophotometrically at 750nm. Aliquots of 
mitochondria or submitochondrial particles were suspended in 0.2 ml of 10% (w/v) 
sodium deoxycolate (Na-DOC) solution in 0.01N NaOH and shaken. Then, 1 ml of 
reagent A (50 parts of 2% (w/v) Na2CO3 in 0.1N NaOH and 1 part of 0.5% (w/v) 
CuSO4 4H2O in 1% (w/v) of Na-K tartrate) were added. After an incubation of 10min 
at 25°C, 50 μl of reactive B (1:1 Folin-Ciocalteau and H2O) were added and the 
samples were shaken. The following incubation was carried on for 30min at room 
temperature and then the absorbance at 750nm was measured. 2-64 μg of bovine 
serum albumin (BSA) was used to establish standard calibration curves for each 
assay. 
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2.5  Measurement of ATP hydrolysis 
The ATP hydrolysis rate was determined using an ATP regenerating system as 
shown in the scheme (Rosing et al. 1975). 
 
 
 
When the mitochondrial samples are added to the assay buffer, the decrease 
of absorbance due to NADH oxidation is directly proportional to the amount of 
hydrolysed ATP. As ATP is continuously regenerated, the rate of ATP hydrolysis 
remains constant over time.   
The assay buffer consists of 30mM sucrose, 50mM Tris/HCl pH 7.4, 50mM 
KCl, 2mM EGTA, 4mM MgCl2 and 2mM phospho-enol pyruvate (PEP), 2mM 
ATP/Tris pH 7.4, 0.3mM NADH; 4U/ml pyruvate kinase (PK) plus 3U/ml lactate 
dehydrogenase (LDH) (Das & Harris 1990). The assay was carried out at 37°C adding 
appropriate aliquots of MLM or BHM or MgATP-SMP or EDTA-SMP (treated as 
specified below) to a final volume of 1ml using a plastic cuvette. In the case of 
samples containing mitochondria 10 μM alamethicin was also added. The decrease in 
absorbance of NADH at 340nm was measured over a period of 5 min. An extinction 
coefficient (ε) of 6220 M-1 cm-1 was used to calculate the specific activity.  
2.5.1 Pre-treatments of mitochondria or submitochondrial particles 
Freshly prepared MLM or MgATP-SMP were suspended at 1 mg/ml in a 
medium containing 0.25M Sucrose, 10mM MOPS, 5mM Succinate, 20 μM EGTA pH 
7.4 with KOH (assay buffer) in the absence or presence of 10mM KH2PO4 (Pi) and 
incubated with or without 200-400 μM DPC or 100-200 μM NBD-Cl (in the dark) for 
15 minutes at room temperature. Samples incubated with Pi were treated with 1,6 μM 
CsA  for 15 min at room temperature before addition of DPC or NBD-Cl, while 
samples treated with 200 μM DPC in the absence of Pi were subsequently incubated 
with 1mM hydroxylamine for 20 min at room temperature. 
EDTA-SMP were suspended at 0.25 mg/ml in a medium containing 50mM 
Sucrose, 10mM KCl, 1mM MgATP, 10mM MOPS at pH 6 and incubated for 10min at 
37°C with 1 μg of IF1 pre-treated with or without DPC, as described by Vinogradov 
(Panchenko & Vinogradov 1985). Before incubation with the EDTA-SMP the isolated 
  
57 Matherials and Methods 
IF1 was diluted to 0.045 μg/μl with 50mM Sucrose, 10mM KCl, 10mM MOPS at pH 6 
and incubated in the absence or presence of 1 mM DPC for 10 min at room 
temperature. 
2.6 Immunoprecipitation of FoF1 ATP Synthase after 
mitochondria treatment with or without DPC and 
incubation at low/neutral pH  
Immunoprecipitation has been performed by using a commercial 
immunocapture kit, i.e. the anti-ATP Synthase monoclonal Ab covalently linked to 
protein G-Agarose beads (ATP Synthase immunocapture kit from Abcam). 
To test the effects of pH on CyPD-ATP synthase interaction, 0.6 mg of freshly 
prepared BHM (2.1.2) were suspended at 3 mg/ml in a buffer containing 0.25M 
sucrose, 10mM MOPS, 10 mM Pi, 5mM succinate, 20μM EGTA,pH 7.4 (MOPS 
buffer) or in 0.25 M sucrose, 10mM sodium acetate, 10 mM Pi, 20μM EGTA, pH 7.4 
(acetate buffer) and treated with or without 200 μM DPC for 15 minutes at room 
temperature. Five millimolar of MOPS pH 6 or pH 7.4 was added to the samples 
suspended in MOPS buffer to adjust the pH value at 6.5 or 7.4, respectively.Ten 
millimolar of sodium acetate (pH 4.5) was added to the samples suspended in acetate 
buffer to adjust the pH at 5.  
After centrifugation for 15 minutes at 20.000xg at 4°C the mitochondrial 
pellets were suspended at 12 mg/ml in MOPS buffer (containing 10mM of imidazole 
to quench the DPC reaction), added with 1% (w/v) digitonin and centrifuged 
100.000xg for 25 minutes at 4°C. Supernatants were then incubated overnight under 
wheel rotation at 4°C in the presence of anti-ATP Synthase monoclonal Ab in a ratio 
of 20 μl/mg of protein. After gentle centrifugation, the beads were washed twice in a 
buffer containing 0,05% (w/v) dodecyl maltoside (DDM) in PBS (8.1mM Na2HPO4, 
1.9mM KH2PO4, 137mM NaCl, 2.7mM KCl pH 7.4). The elution was performed in 
SDS-PAGE loading buffer (20mM Tris/HCl, pH 6.8, 4% (w/v) SDS, 2% (v/v) β-
mercaptoethanol, 20% (v/v) glycerol and 0.01% (w/v) bromophenol blue). The 
collected fractions were heated at 98°C for 5 min and subjected to 15% SDS-PAGE 
followed by Western blotting against CyPD and β subunit of ATP Synthase. 
For the mass spectrometry analyses the immunoprecipitation protocol 
includes these modifications: mitochondria were incubated in MOPS buffer without 
Pi (pH 7.4) and treated with 1 mM DPC. The samples were eluted in a buffer 
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containing 2% (v/v) TCEP instead of β-mercaptoethanol and the 15% SDS-PAGE was 
followed by Coomassie staining. 
To evaluate the effect of DPC on the IF1 binding to ATP Synthase, freshly 
prepared BHM were suspended in MOPS buffer pH 7.4 or acetate buffer pH 7.4, 
treated with DPC and adjusted to pH 7.4 or 6 as described above. After 
immunoprecipitation with anti-ATP Synthase monoclonal Ab and 15% SDS-PAGE 
the samples were probed for the presence of IF1 and β subunit of ATP Synthase by 
Western blotting. 
2.7 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
(Laemmli U.K., 1970) was used to analyze all IP samples using 10x10x0,1cm gels. The 
15% acrylamide concentration in the separating gel was chosen according to the 
molecular size of the proteins to be separated and a ratio of 37.5:1 (w/w) between 
acrylamide and N,N’-methylenebisacrylamide was maintained. This mixture was 
solubilized in 0.25M glycine, 0.025M Tris/HCl, pH 8.8 and 0.1% (w/v) SDS. The 
stacking gel was prepared using 4% (v/v) acrylamide in stacking buffer (0.125M 
Tris/HCl, pH 6.8, 0.1% (w/v) SDS). 0.1% ammonium persulfate and 0.0015% (v/v) 
TEMED were added to start gel polymerization. Electrophoresis was performed with 
a limiting voltage of 250V and a current of 15mA until the dye front reached at the 
bottom of the gel. The electrophoresis system was cooled using an internal fan to 
circulate water. 
Protein molecular weights were estimated by running standard proteins of 
known molecular weights in separated lanes (Bio-Rad). 
Gels were stained with Colloidal Blue staining Kit (Invitrogen). This kit allows 
detection of <10ng of protein and it is mass spectrometry compatible. Proteins were 
visible within 3h and background was eliminated with water. Alternatively, gels were 
subjected to Western blotting.  
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2.8 Blue native Gel electrophoresis (BN-PAGE) 
Blue native-polyacrylamide gel electrophoresis (BN-PAGE) is a powerful 
electrophoresis method for isolation and characterization of large multi-protein 
complexes in their native state (Wittig et al. 2006). BN-PAGE employs Coomassie 
blue G-250 dyes to introduce charge shifts on proteins and  in the absence of 
denaturing detergents allows first dimension separation according to the size and 
shape of the complex. 
Freshly prepared EDTA-SMP were supended at 3mg/ml in MOPS buffer at 
pH 7.4 or 6.5 or in 0.25 M sucrose, 20mM sodium acetate, 20μM EGTA, pH 5.0 for 
20 min at room temperature. Then the samples were centrifuged at 100.000xg for 30 
min at 4°C and the pellets suspended at 10 mg/ml in 50mM NaCl, 30mM Tris and 
5mM amminocaproic acid (pH 7.4). Digitonin was added at 1 mg of detergent/mg 
protein and the suspensions were immediately centrifuged at 100.000xg for 25 min 
at 4°C. 14µl of each supernatant were mixed with 1µl of sample buffer (5% 
Coomassie-Brilliant-blue G-250 in 1M amminocaproic acid) and loaded onto a 3-12% 
gradient gel (Invitrogen). 
The electrophoresis was performed at 4ºC. For the first step of 
electrophoresis, cathode buffer containing Coomassie-Brilliant blue G-250 was used 
and the voltage was set for 30min at 150V and then shifted to 250V. When the blue 
front had migrated to two thirds of the separation distance, the cathode buffer was 
replaced by a cathode buffer without Coomassie-Brilliant blue G-250. Cathode 
buffers were prepared according to the manufactore’s protocol (Invitrogen) At the 
end the gels were stained or incubated in a specific solution to measure the ATPase 
activity of ATP Synthase. Bands corresponding to monomeric and dimeric form of 
ATP synthase were cut out and loaded onto a SDS-gel. 
2.8.1 In-gel ATPase activity staning  
Because no denaturants are present in native PAGE, subunit interactions 
within a multimeric protein are generally retained and many proteins have been 
shown to be enzymatically active. After migration in BN-PAGE the ATP Synthase 
complex was identified by in-gel staining of the ATPase activity using the qualitative 
method of (Zerbetto et al. 1997). The activity was measured by plunging the gel into a 
solution containing 35mM Tris, 270mM glycine, 14mM Mg SO4, 0.2% (w/v) 
Pb(NO3)2, 8mM ATP ( pH 7.4) at 37°C. ATP Synthase appears as a white band due to 
the Pb3(PO4)2 precipitation. 
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2.9 Western blot analysis 
Proteins separated via SDS-PAGE were transferred to a 0.2μm pore size 
nitrocellulose membrane (Bio-Rad) using a semi-dry blotting apparatus (Amersham 
Biosciences TE 22 Tank Transfer Unit) 
The transfer was performed at 2.5 mA/cm2 for 1 h in a transfer buffer 
comprising 25mM Tris, 192mM glycine, 20% (v/v) methanol. After staining with 
ATX Ponceau S red staining solution (Fluka Analytical) to check transfer efficiency, 
the nitrocellulose sheet was saturated with 3% (w/v) non-fat dry milk in PBS buffer 
plus 0.1% Tween 20 for 1 h at room temperature and then incubated overnight with 
the following antibodies:  
 
 Anti β subunit (Abcam)         1:1000 in PBS-0.1% Tween20  
 Anti CyPD (Calbiochem)       1:1000 in PBS-0.1% Tween20 
 Anti IF1 (Abcam)                     1:1000 in PBS-0.1% Tween20 
 
Blots were then rinsed three times with PBS buffer plus Tween 20 and 
incubated for 1.30 h with peroxidase coupled to anti-mouse-IgG (1/5000) at room 
temperature. The membrane was washed again three time in PBS buffer plus 0.1% 
Tween 20 and developed with SuperSignal West Dura Extended Duration Substrat 
(Thermo Scientific) according to the manufacturer's protocol.  
2.9.1Densitometric analysis 
High resolution images of the films were acquired using the instrument SF 
Launcher and processed using the program ImageQuant TL.  
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2.10  Mass spectrometry analyses 
Mass spectrometry approach was applied to detect the DPC modification of 
apomyoglobin, used as model protein, and of the ATP synthase OSCP subunit. Mass 
spectrometry analyses were done in collaboration with Dr. Barbara Spolaore, CRIBI 
Biotechnology Centre, University of Padova.  
Horse heart apomyoglobin (ApoMb) was prepared by removal of the heme 
group from myoglobin (Ascoli et al. 1981). ApoMb was suspended at 1 mg/ml in 
MOPS buffer pH 7.4, treated with or without  5-fold molar excess of DPC for 10 min 
at 37°C. The DPC reaction was quenched with 10mM of imidazole (Zhou & Vachet 
2012) and each suspension was divided in two parts: one part was incubated 4 hours 
at 37°C and the other overnight at 4°C. From all samples one aliquot of 50 µg was 
used to determine the percentage DPC modification by reversed phase HPLC (RP-
HPLC) followed by ESI-MS (detailed procedures in paragraph 2.11.1.1 and 2.11.1.2) 
From the samples incubated 4 h at 37°C , other two aliquots of 50µg each were 
obtained. One aliquot was immediately digested with 5ng/µl of trypsin (Promega, 
modified sequencing grade) for 3h at 37°C and subjected to RP-HPLC and ESI-MS. 
Another aliquot was instead suspended in SDS-PAGE loading buffer (20mM 
Tris/HCl, pH 6.8, 4% (w/v) SDS, 2% (v/v) TCEP, 20% (v/v) glycerol and 0.01% (w/v) 
bromophenol blue), heated at 98°C for 5 min and loaded into 15% SDS-PAGE. After 
the gel staining with Colloidal Blue staining kit (Invitrogen), the ApoMb band was 
excided, processed for in gel-digestion and analysed by ESI-MS (detailed procedures 
in paragraph 2.11.1.3 and 2.11.1.2, respectively) . 
2.10.1 Reversed phase HPLC (RP-HPLC) 
RP-HPLC consists of a non-polar stationary phase and an aqueous, 
moderately polar, mobile phase, in a high pressure system. The RP-HPLC analysis 
was performed with a liquid chromatograph instrument at high pressure, purchased 
from Agilent Technologies, model 1100 (Waldbronn, Germany). The column used 
was a Jupiter C4 (Phenomenex, Torrance, CA, USA), whose dimensions are 4.6 x 150 
mm with a diameter particles of 5 m. Chromatographic separations were performed 
at flow rate of 0.8 mL/min by a linear water/acetonitrile gradient from 5% 
acetonitrile containing 0.1% of trifluoroacetic acid (TFA) to 60% acetonitrile 
containing 0.085% of trifluoroacetic acid (TFA) in 30 minutes. The effluent was 
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monitored by recording the absorbance at 226 nm. The collected fractions were 
analysed by ESI-MS. 
2.10.2ESI-MS 
Mass determinations were obtained with an electrospray ionization (ESI) 
mass spectrometer Q-Tof Micro from Micromass (Manchester,UK). The 
measurements were conducted at a capillary voltage 3kV and a cone and extractor 
voltages of 30 and 1 V, respectively (positive ion mode). Instrument control, data 
acquisition and processing were achieved with Masslynx 4.0 software (Micromass). 
 
2.10.2.1 In-gel digestion of proteins 
Enzymatic digestion of proteins in gel requires the following steps 
(Shevchenko et al. 1996): 
 Washing of gel pieces 
The protein bands were cut into roughly 1mm3 cubes and transferred to a 
clean tube. The gel pieces were washed with water (5 times gel volume) for 15 
minutes. Water was then substituted with the same volume of 50% 
acetonitrile. After two washings of 15 minutes each, the gel pieces were shrunk 
with neat acetonitrile. When the bands became white and sticky, acetonitrile 
was removed.  
 
 Reduction and alkylation 
The gel particles were swelled in 10mM dithiothreitol, 0.1 M NH4HCO3 (pH 
8.2) and incubated for 45 minute at 56°C. After cooling at room temperature, 
the liquid was replaced quickly with roughly the same volume of 
iodoacetamide solution (55mM iodoacetamide in 0.1 M NH4HCO3). The tubes 
were incubated for 30 minutes in the dark at room temperature before 
removal of the  iodoacetamide solution. 
 
 Washing of gel pieces 
The gel pieces were washed again with water and acetonitrile to remove 
completely the Coomassie staining.  
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 Tryptic digestion 
The gel particles were rehydrate on ice in 50mM NH4HCO3 and 5 ng/µl of 
trypsin (Promega, modified sequencing grade) was added. After 45 minutes 
the remaining supernatant was removed, replaced with 50mM NH4HCO3 
without trypsin and incubated overnight at 37°C.  
 
 Extraction of peptides from gel 
The tubes containing the gel pieces were centrifuged at 6.000xg for 3 minutes 
at room temperature and the supernatants with the peptides transferred to 
clean tubes. To extract more peptides from the gel, 0.1%(v/v) of formic acid 
was added for 15 minutes, followed by the addition of the same volume of neat 
acetonitrile and incubation was continued for 15 minutes. The tubes with the 
gel pieces were centrifuged at 6.000xg for 3 minutes and the supernatants 
recovered. This step was repeated two folds. Then the samples were dried 
using a Speed-Vac system (Savant).  
Protein digests were redissolved in 0,1% of formic acid and analysed by ESI-
MS. 
2.10.3MS analyses of OSCP  
After immunoprecipitation of ATP Synthase from BHM (as described in 2.6), 
the samples were loaded into 15% SDS-PAGE and the OSCP band was excised, 
processed for in-gel digestion (as described in 2.11.1.3) and analysed by LC-MS/MS. 
2.10.3.1 LC-MS/MS 
Liquid chromatography (LC) coupled to tandem mass spectrometry (MS/MS) 
was used to increase the sensitivity of the analysis on the tryptic peptide of OSCP 
containing the unique histidine (95−113: LTNTPAVISAFSTMMSVHR).Protein 
digests suspended in 0,1% (v/v) formic acid, 3 % acetonitrile were analysed by LC-
MS/MS with a 6520 Q-TOF mass spectrometer (Agilent Technologies)coupled online 
with a 1200 series HPLC system through a Chip Cube Interface (Agilent 
Technologies). Samples were loaded onto a Polaris-HR-Chip 3C18 (enrichment 
column of 360 nl; separating column 75 µm×150 mm; Polaris C18 180 Å, 3 µm; 
Agilent Technologies). Peptides were separated with a gradient from 5 to 50% of 
solvent B over 15 min and from 50% to 65% B in 3 min at a flow rate of 0.27 µl/min 
(solvent A: H20 with 0,1% formic acid; solvent B: acetonitrile with 0.1% formic acid). 
LC-MS/MS analyses were performed in a data dependent mode for protein 
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identification and in a targeted mode to acquire MS/MS spectra of the native and 
modified peptide 95−113 of OSCP. Raw data files were converted into Mascot Generic 
Format (MGF) files with MassHunter Qualitative Analysis Software (Agilent 
Technologies) for MASCOT search and manually analyzed using the same software.  
MS/MS data were searched using the MASCOT search engine (version 2.3.01, 
Matrix Science) against the Mammalia sequences of the Swiss-Prot database (release 
2013_04). The following parameters were used in the MASCOT search: Trypsin 
specificity; maximum number of missed cleavages:2; fixed modification: 
carbamidomethyl (Cys); variable modifications: oxidation (M), deamidated (NQ); 
peptide mass tolerance: ± 10 ppm; fragment mass tolerance: ± 0.05 Da; protein 
mass: unrestricted; mass values: monoisotopic. 
2.11 Cell culture 
All the experiments were carried out using HEK293T cell line (Human 
Hembrionic Kidney). Through the CRISP/Cas9 system the genomic codons 
specifying His at position 112 of OSCP subunit were replaced by alternate codons 
directing the specific replacement of His at this position with Gln. This genome 
modification of HEK293T was done in the laboratory of Prof. Micheal Forte, Vollum 
Institute, Oregon Health and Sciences University. 
HEK293T cells were grown in a culture medium composed of DMEM 
(GIBCO) supplemented with 10% Foetal Bovine Serum (GIBCO), 100 U/ml penicillin 
and 100µg/ml streptomycin (Invitrogen). Cells were grown in T-75 250 ml Falcon 
flasks and incubated at 37°C in a 5% CO2 humidified incubator. Once the cells have 
reached 70-80% confluency, they were split and plated again on T-75 flasks. Cells 
were first washed with PBS, followed by trypsinization at 37°C, 5% CO2 using 0.05% 
Trypsin-EDTA in Phenol red (GIBCO). To stop the action of trypsin, DMEM was 
added and then the cells were centrifuged at 1.200xg for 5 min, resuspended in about 
9 ml of DMEM, counted and re-plated at 3∙106 cells for flask. 
2.12 Oxygen consumption rate (OCR) 
Oxygen consumption rate was measured using XF24 Extracellular Flux 
Analyzer (Seahorse Bioscience). This instrument measures in real time the 
extracellular flux changes of oxygen and protons in the medium immediately above 
adherent cells cultured in a microplate. Seahorse medium was used  (DMEM-Sigma 
D5030- added with 25 mM glucose, 1 mM sodium pyruvate and 2 mM glutamine). 
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Cells that had been grown in flasks were trypsinized and counted, and then 
about 40,000 wild type cells per well and 50,000 OSCP His112Gln cells per well were 
seeded on appropriate 24-well plates (coated with 0.01% Poly-L-Lysine (Sigma)), 
each with 28mm2 surface and containing about 900µl of DMEM. Cells were 
incubated at 37°C in a 5% CO2 humidified incubator for 24 hours. Different cell 
concentration was used to reach the same confluent monolayer. Each XF24-
microplate was coupled to a disposable sensor cartridge, embedded with 24 pairs of 
probes for measuring oxygen concentration and pH. Assay were initiated by 
replacing the growth medium with 670 µl of Seahorse medium prewarmed at 37°C. 
Cells were incubated at 37°C for 30 min to allow temperature and pH equilibration. A 
titration with FCCP was performed for wild type and OSCP His112Gln cells in order 
to determine the optimal FCCP concentration (i.e., the concentration that stimulates 
respiration maximally), which was found to be 1µM for both cell types. After an OCR 
baseline was established, 70µl of each solution containing oligomycin, FCCP, 
rotenone and antimycin A were sequentially added to each well to reach a final 
concentration of 1µg/ml oligomycin, 0.1µM FCCP, 1µM  rotenone and antimycin A.  
2.13 Calcium retention capacity (test) 
The Calcium retention capacity (CRC) is one of the most sensitive assay to 
assess the propensity of the PTP to opening (Fontaine et al. 1998). The test measures 
the amount of Ca2+ that mitochondria can accumulate and retain before the 
precipitous release that marks PTP opening. Extramitochondrial Ca2+ fluxes were 
measured fluorimetrically using Calcium Green-5N (excitation-emission λ: 505-535 
nm), a low affinity membrane-impermeant probe which increases its fluorescence 
upon Ca2+ binding. 
The cells were cultured for 48 hours to reach 70-80% confluency, then 
harvested by trypsinization and suspended in KCl buffer (130mM KCl, 10mM 
MOPS/Tris, 1mM phosphoric acid-Tris, 0.1 mM EGTA/Tris, pH 7.4). Cells were 
centrifugated at 1.200xg for 5 min, the pellet was resuspended in KCl buffer ( EGTA 
was increased to 1 mM) to give a concentration of 2 ∙107 cells per ml and treated with 
100µM digitonin (Sigma) for 10 min on ice to permeabilize the plasma membrane. 
Excess of digitonin was eliminated by washing cells twice in KCl buffer and the cells 
were suspended to 10∙107 cells per ml in CRC buffer (250mM sucrose, 10Mm 
MOPS/Tris, 10µM EGTA/Tris, 1mM phosphoric acid, 5mM glutamate and 2.5 mM 
malate, pH 7.4.). Then the cells were dispensed 1∙106 cells/well  to a 96-well black 
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assay plate (Falcon 353376) containing 0,2ml of CRC buffer supplemented with 
0.5µM Calcium Green-5N in each well. The assay was done also in the presence of 
2µM CsA. A train of 5 µM Ca2+ pulses was added at 4 minutes intervals and the 
fluorescence intensity was read on Fluoroskan Ascent FL (Thermo Scientific) plate 
reader.   
2.14 Mitochondrial swelling  
Changes in mitochondrial volume of permeabilized cells were followed in a 96 
well clear assay plate (Falcon 353072) at a final volume of 0.2 ml. First, the cells were 
cultured and permeabilized in KCl buffer (deprived of 1mM phosphoric acid-Tris) as 
described above. Then cells were suspended in KSCN buffer (0.1M KSCN, 5mM 
MOPS/KOH, 10 µM EGTA/KOH) at pH 7.4 or KSCN buffer at pH 6.5 and dispensed 
1∙106 cells/well. Absorbance was first read for about 3 min at λ 540 nm to get the 
basal line using a Multi-Skan EX (Thermo Scientific) plate reader. Then 0,1 mM Ca2+ 
was added to induce mitochondrial swelling and the absorbace changes were 
followed for 30 min. Ca2+ -dependent pore induction by DPC was assessed in KSCN 
buffer at pH 6.5. The test wells contained 0.5 mM DPC and the experiment was 
started as described before. 
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3.1 Modulation of the FoF1 ATP synthase by pH: role of 
His112 protonation of OSCP  
As already mentioned, our group demonstrated that in mammalian 
mitochondria (i) CyPD interacts with the OSCP subunit of ATP synthase, resulting in 
partial enzyme inhibition; (ii) CyPD binding requires high Pi concentrations, while 
the CyPD inhibitor CsA displaces CyPD from OSCP, resulting in enzyme reactivation; 
(iii) CyPD-OSCP contacts are mostly electrostatic in nature, because they are disrupted 
by increased ionic strength and (iv) ATP synthase dimers generate Ca2+-dependent 
currents with features indistinguishable from those of the PTP, suggesting that the 
PTP forms from a Ca2+-dependent conformational change of FOF1 dimers (Giorgio et 
al. 2013). These findings imply that many modulators of the PTP may act on the ATP 
synthase.  
The most potent inhibitors of the PTP are H+ ions; indeed, the pore is potently 
inhibited at acidic matrix pH values via reversible protonation of still undefined 
histidine(s) that can be prevented by the histidine modifying reagent DPC (Nicolli et 
al. 1993). As PTP modulation by matrix pH was not affected by genetic ablation of 
CyPD (i.e, in Ppif-/- mice), the involvement of histidyl residues located on the PTP 
was postulated (Basso et al. 2005). In addition, low pH promotes release of  CyPD 
from the IMM through reversible protonation of histidyl residues, which is also 
blocked by DPC (Nicolli, Basso, et al. 1996).  
Based on these observations, the hypothesis has been advanced that the same 
histidine(s) located on ATP synthase may be responsible for both the pH effects on 
PTP/ATP synthase opening and for CyPD (un)binding to PTP/ATP synthase. To test 
this working hypothesis in the first part of this doctoral work experiments have been 
performed to: (i) define the pH profile of the ATP synthase-CyPD interaction and 
evaluate the involvement of histidine residue(s) by DPC treatment of bovine heart 
mitochondria; (ii) identify the ATP synthase histidine(s) modified by DPC using mass 
spectrometry; (iii) evaluate the effect of DPC on the enzymatic activity of ATP 
synthase. As the results obtained suggested that reversible protonation of the unique 
histidine of OSCP (His112 in bovine mitochondria) may play a critical role in 
modulation of the CyPD-ATP synthase interaction, its role in ATP synthase/PTP 
switch has further been addressed by mutagenesis, as described in the second part of 
this thesis.  
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3.1.1 Effects of pH and of the histidine modifying reagent DPC on the 
interaction between CyPD and FoF1 ATP Synthase in bovine heart 
mitochondria 
To assess the pH profile of the CyPD-ATP synthase interaction freshly 
prepared respiring mitochondria from bovine heart were added with millimolar Pi 
concentrations, in order to favour CyPD binding to ATP synthase (Giorgio et al. 
2009; Giorgio et al. 2013), and incubated  with or without 200 µM DPC at pH 7.4, as 
in previous experiments (Nicolli et al. 1993). DPC reaction was quenched by adding 
an excess of imidazole (Mendoza & Vachet 2008) and mitochondria were treated 
with buffers of different pH (7.4, 6.5 and 5.0). After centrifugation, the mitochondrial 
pellets were suspended at pH 7.4, added with digitonin and incubated with anti-ATP 
synthase monoclonal Abs covalently linked to protein G-Agarose beads to 
immunoprecipitate the complex (immunocapture kit from Mitosciences). The IPs 
were subjected to 15% SDS-PAGE and immunoblotted with monoclonal antibody 
against CyPD and F1 β subunit. The parallel detection of CyPD and F1 β subunit 
allowed to express CyPD content as the CyPD/F1 ratio and to follow its variations 
under the different experimental conditions (Figure 3.1). 
The results clearly indicate that acidic treatment of mitochondria causes CyPD 
release from ATP synthase, although the exact matrix pH value induced by the 
different buffers has not been determined. DPC did not affect CyPD binding at 
neutral/slightly acidic pH, while at low pH it prevented CyPD release. As DPC as such 
does not affect matrix pH, its effect can be traced to carbethoxylation of histidyl 
residues (Nicolli et al. 1993). This behavior perfectly matches the effect of DPC on 
CyPD-PTP interaction (Nicolli et al. 1996), demonstrating that, consistent with PTP 
formation by ATP synthase, CyPD binding to ATP synthase, which is mostly 
electrostatic in nature (Giorgio et al. 2013), is also modulated through protonation of 
one or more histidine(s). Considering that the OSCP subunit of the lateral stalk is the 
binding partner of CyPD on ATP synthase (Giorgio et al. 2013), the involvement of 
OSCP histidyl residue(s) has been evaluated by assessing whether they were modified 
by DPC treatment of mitochondria. 
  
  
71 Results and Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of OSCP sequence showed that OSCP has only one histidine, His 112 
(bovine numbering), which is conserved among species (Figure 3.2A). This histidine 
appeared an interesting candidate for the pH modulation of the CyPD-ATP synthase 
interaction for several regions: (i) it is exposed to the matrix, as depicted in Figure 
3.2B, potentially allowing its modification by DPC, which is known to react only with 
surface-accessible hystidyl nitrogen atoms (Hnízda et al. 2008); (ii) it is located in 
one of the lowest (i.e. most negative) surface potential regions (Figure 3.2C), that has 
been recognized as a putative CyPD binding regions due to the complementary 
electrostatic properties (Giorgio et al. 2013); (iii) it is located in the linker region 
between the N- and C-terminal domains of OSCP (Rees et al. 2009), which appears 
to be flexible, enabling bending of the peripheral stalk towards the top of F1 in the 
intact ATP synthase (Zhou A et al. 2015); (iv) it has a low pKa of 5.7, which is a 
property of histidine(s) involved in conformational changes induced by their 
protonation (Edgcomb & Murphy 2002). pKa value has been obtained by pre-
processing the structure of bovine OSCP (PDB code 2WSS, chain S) using the 
Figure 3.1 The histidine reagent diethylpyrocarbonate (DPC) 
prevents the release of CyPD from ATP synthase induced by 
acidic pH. Bovine heart mitochondria, were incubated at the indicated 
pH in the absence or presence of DPC, and ATP synthase was 
immunoprecipitated with an anti-ATP Synthase Ab followed by 15% SDS-
PAGE. β subunit and CyPD content were detected by Western blotting. 
Each immunodetected band was analyzed by densitometry and the ratio 
between the peak area of CyPD and that of the corresponding  subunit 
was measured and expressed relative to the ratio obtained at pH 7.4 in the 
absence of DPC, which was taken as 100%. Values are average ± S.E. of 
three independent experiments .**P<0.01, n.s.= not significant (Student t 
test). 
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program PDB2PQR (Dolinsky et al. 2007) and the CHARMM set of radii and 
charges. The resulting pqr file was used as input to the program Bluues (Fogolari et 
al. 2012) to compute all titratable residues pKa. The results were compared with 
those obtained with the program PROPKA (Olsson et al. 2011), which essentially 
identical results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 OSCP structure analysis. A) Sequence alignement of OSCP from different 
species. OSCP sequences were retrieved from Swiss-Prot database and the alignement 
performed with Clustal O (McWilliam et al. 2013). Numbering includes signal peptide. 
Conserved residues are highlighted in red and the unique conserved histidine is marked with 
an asterisk, which corresponds to position 112 of the bovine protein. B) View of the His112 of 
OSCP and the top of F1 domain based on the bovine crystal structure 2WSS (PDB entry). C) 
His 112 is located in one (highlighted by a red circle) of the two lowest potential regions on 
OSCP, which represent the putative binding regions of CyPD. The color code for the potential 
is: saturated red -8.0 kJ/(mol q), saturated blue 8.0 kJ/(mol q). F1 structure is shown in 
transparency. Surface potential is computed as previously described (Fogolari F. et al. 2012; 
Giorgio V. et al. 2013; Antoniel M. et al. 2014) 
 
A 
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* 
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3.1.2Mass spectrometry analysis of the DPC-modified OSCP subunit 
of FoF1 ATP Synthase  
It is well established that DPC labeling is very useful for studying protein 
structure and protein-protein interactions (Dage et al. 1998; Tsubaki et al. 2000; Qin 
et al. 2003). Due to DPC’s molecular size, proteins are typically only labelled at 
amino acids that are exposed to the solvent on the protein surface (Hnízda et al. 
2008). In particular, the reaction between DPC and histidine is accompanied by the 
formation of an ethoxyformyl group bound to the nitrogen atom of imidazole leading 
to a mass increase of 72 Da (Figure 3.3), so that the sites modified by DPC can be 
readily identified with high sensitivity by mass spectrometry (MS) because their 
signals are not diluted across many products (Foti et al. 1991; Zhou & Vachet 2012). 
 
 
 
 
 
 
 
 
Although very useful, the main limitation of using DPC is the relative 
instability of histidyl ethoxyformylation, which is particularly relevant at acidic and 
alkaline pH values (Melchior & Fahrney 1970). Moreover, thiol groups could capture 
a carbethoxy group from a modified histidine during SDS-PAGE (Zhou & Vachet 
2012). Therefore, to set up the conditions of sample preparation for MS analysis of 
DPC-modified OSCP, a model protein, apomyoglobin (ApoMb), was used to check 
the stability of the DPC-modified histidines over time. 
ApoMb, which  contains 11 histidyl residues, is an extremely well-
characterized protein commonly used in MS standardization (Zhou & Vachet 2012) 
and. The purified protein was treated with 5-fold molar excess of DPC for 10 minutes 
at 37 °C, the reaction was quenched with 10 mM imidazole and the sample was 
analysed by HPLC-MS after 4 hours incubation at 37°C, a time frame that does not 
Figure 3.3 Modification of histidine by DPC and formation of 
carbethoxyhistidine (Cet-His) .From (Hnizda et al.2008). 
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result in significantchanges in DPC-dependent histidine modification (Zhou & Vachet 
2012). As expected, only His64 and His93 were modified, and the percentage 
modification was of about 30% as determined after overnight (O/N) incubation at 
4°C, as well as after 4 hours incubation at 37°C followed by in solution tryptic 
digestion or in gel tryptic digestion. In this latter condition, Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) was used as a thiol-free reducing 
agent during SDS-PAGE (Table 2). These results demonstrated that DPC 
modification remained rather stable under all the tested conditions, making this 
approach for MS analysis of DPC-modified OSCP.   
 
 
 
 
 
 
 
 
 
Mitochondria were then incubated in the absence or presence of DPC, as in 
Figure 3.1 and the ATP synthase immunoprecitates were subjected to 15% SDS-PAGE 
and stained with Coomassie Colloidal Blue. The bands at the molecular mass 
expected of the OSCP subunit were excised and processed by in-gel trypsin digestion. 
The resulting peptide mixtures were analysed by LC-MS/MS and MS/MS data were 
checked using the MASCOT search engine (Matrix Science Ltd, London, UK) against 
the Mammalian sequences of the Swiss-Prot database. The results showed a very 
high sequence coverage, confirming that the bands extracted from the gels 
correspond to OSCP subunit of bovine heart ATP synthase (Table 3). 
Visual inspection of the ESI-MS spectrum acquired in the LC-MS/MS analysis 
of the OSCP tryptic peptide 95-113 (which contains His112) showed a mass shift of 72 
Da compared  to the sample not treated with DPC,  consistent with His112 
Residue 4 h 37° C 
4 h 37° C 
Tryptic 
digestion 
4 h 37° C 
In-gel 
digestion 
O/N 4° C 
His64 23,9 27,7 25,3 31 
His93 29 31 28 34,2 
a Modification percentages were calculated as ratio between peak intensity of 
carbethoxyhistidine and total histidine.  
Table 2. Comparison of DPC modification percentagesa of ApoMb under different 
conditions 
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aLC-MS/MS data were acquired on the tryptic digest of the SDS-PAGE band corresponding 
to the theoretical molecular mass of OSCP separated from the ATP synthase IPs. LC-MS/MS 
analyses were performed on a 6520 Q-TOF mass spectrometer (Agilent Technologies)  and 
the data were analysed by the MASCOT software against the Mammalia sequences of the 
Swiss-Prot database (release 2013_04). The following parameters were used in the MASCOT 
search: Trypsin specificity; maximum number of missed cleavages: 2; fixed modification: 
carbamidomethyl (Cys); variable modifications: oxidation (M), deamidated (NQ); peptide 
mass tolerance: ± 10 ppm; fragment mass tolerance: ± 0.05 Da; protein mass: unrestricted; 
mass values: monoisotopic; bSequence coverage calculated on the mature  protein; c Peptides 
sequenced with a significant score (p<0.05).  
 
modification by DPC (Figure 3.4). Further analysis of the ESI-MS/MS spectra of the  
95-113 peptides revealed that all the y ions in the DPC-modified peptide exhibit a 
mass shift of 72 Da, confirming the carbethoxylation of the unique His112 of OSCP 
(Figure 3.5). Of note, y ions derive from fragmentation of the CO-NH bonds, which 
are the most common cleavage sites along the amino acid backbone, and retain the 
charge on the C-terminal fragments (Roepstorrf et al. 1984; Johnson et al. 1989). 
 
 
 
 
 
  
Protein 
UniProtKB 
AC. 
Mass 
(Da) 
Protein 
score 
Sequence 
cov. (%)
b 
Peptide 
sequences 
ATP synthase 
subunit O, 
mitochondrial 
OS=Bos 
taurus 
P13621 23419 505 72.1 14(6c) 
Table 3. Results of the MASCOT search for the OSCP band.
a
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95−113, [M+3H]
3+
 
Calc. mass: 2062.034 Da 
Exp. mass: 2062.0504 Da 
 
95−113
1DPC
, [M+3H]
3+
 
Calc. Mass: 2134.0551 Da 
Exp. Mass: 2134.0713 Da 
 
Tryptic peptide 95−113: LTNTPAVISAFSTMMSVHR 
 
 
A. RT 16.8 min 
 
A. RT 16.8 min 
B. RT 17.3 min 
 
B. RT 17.3 min 
Figure 3.4. ESI-MS spectra acquired in the LC-MS/MS analysis of the tryptic digest of OSCP derivatised 
with DPC. The m/z region of the spectra in which the +3 molecular ions of peptide 95−113 (A, RT 16.8 min) and 95−113
1DPC 
(B, RT 17.3 min)
 
were detected are shown.  
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Figure 3.5.Region 170-280 m/z of the MS/MS mass spectra of peptide 95–113 of OSCP and OSCP modified at level of His112 
with DPC. Fragments of the series b and y that were identified in the MS/MS spectra are indicated on the sequence of the peptides. His112 is 
indicated in bold as H and H
1DPC 
 for the modified peptide. In the MS/MS spectra, ions assigned to fragments of the series y and b are indicated. 
All y ions show, in the modified peptide, a mass shift of +72 Da which is consistent with carbethoxylation of the unique His112. 
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3.2 Effect of DPC on the ATP hydrolytic activity of FoF1 ATP 
synthase  
As already mentioned, CyPD binding to OSCP has major functional 
consequences, with a decrease of the ATP hydrolytic activity catalysed by ATP 
synthase that can be reversed by CsA-dependent CyPD displacement. Consistently, 
the ATPase activity of CyPD null mice mitochondria was 50% higher than that of wild 
type mitochondria, and CsA had no effect on the rate of ATP hydrolysis (Giorgio et al. 
2009). As DPC treatment of mitochondria caused the modification of the unique 
histidyl residue of OSCP possibly involved in the CyPD binding, the effect of DPC on 
the enzyme activity was evaluated under conditions that affect CyPD binding to ATP 
synthase.   
Assay of ATP hydrolysis was performed in Mg2+-ATP submitochondrial 
particles from bovine heart (MgATP-SMP), wherebound CyPD can be displaced by 
CsA (Nicolli, Basso, et al. 1996). This membrane preparation, where the F1 catalytic 
moiety of ATP synthase is exposed to the solvent, is particularly useful inkinetic 
assays where putative enzyme modulators are tested. Briefly, MgATP-SMP were 
suspended in a medium containing 10 mM Pi (Pi), to favor CyPD binding, or without 
Pi (w/o Pi), treated with 200 µM or 400 µM DPC and the oligomycin-sensitive ATP 
hydrolysis rate was determined in the presence of an ATP-regenerating system 
(Harris & Bashford 1987). As shown in figure 3.6A, DPC inhibits the hydrolytic 
activity of ATP synthase in a dose-dependent manner, reaching a maximum value of 
about 30%, that is consistent with the inhibition value obtained with other inhibitors 
that target OSCP, such as Bz-423 (Johnson et al. 2005; Giorgio et al. 2013). However, 
DPC affected the ATPase activity only in the absence of Pi, while in the presence of Pi 
ATP synthase was protected from DPC inhibition. Moreover, DPC inhibition was 
reverted by hydroxylamine, strongly suggesting that its effect can be specifically 
traced to carbethoxylation of histidyl residues, which is readily reversed in the 
presence of nucleophiles, rather than to reaction with tyrosyl or sulfhydryl groups 
Nicolli et al. 1993 (Mendoza & Vachet 2008) (Figure 3.6B). 
We also tested the effect of DPC in the presence of Pi and CsA, which displaces 
CyPD from ATP synthase even in the presence of Pi. Interestingly, under these 
conditions DPC inhibited the ATP hydrolytic activity, strongly suggesting that the 
“protective” effect of Pi on DPC inhibition is due to CyPD binding to OSCP rather 
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than to a direct effect of Pi on ATP Synthase (Figure 3.7A). Consistently, CsA was 
ineffective against inhibition of MgATP-SMP by 4-chloro-7-nitrobenzofurazan (NBD-
Cl) (Perez et al. 1986), which reacts specifically with Tyr-311 of βE subunit (Orriss et 
al. 1998) and is protected by the binding of Pi to the F1 catalytic sites (Figure 3.7B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Figure 3.6. Effect of Pi and hydroxylamine on DPC-dependent ATP synthase 
inhibition. A) MgATP-SMP were incubated with the indicated concentrations of DPC in the 
presence (Pi) or absence (w/o) of 10 mM Pi and the rate of oligomycin-sensitive ATP hydrolysis 
at 37 °C was measured. B) MgATP-SMP were treated with 200 µM DPC in the absence of Pi, 
followed by their incubation with 1 mM hydroxylamine before the measurement of the ATP  
hydrolytic activity. Data are average ± S.E. of 4 independent experiments. 
 
 
Figure 3.7. Effect of Pi and CsA on ATP Synthase inhibition by DPC and NBD-Cl. 
MgATP-SMP were incubated with the indicated concentrations of DPC (A) or NBD-Cl (B) in 
the absence of Pi (w/o Pi), in the presence of 10 mM Pi (Pi) or in the presence of  10 mM Pi and 
1.6 µM CsA (Pi+CsA). The rate of oligomycin-sensitive ATP hydrolysis at 37 °C was measured. 
Data are average ± S.E. of 4 independent experiments. 
 
A B 
  
80 Results and Discussion 
To further test the involvement of CyPD in the protection against DPC inhibition, 
mitochondria from CyPD null mice were treated with DPC in the presence or absence of 
Pi. As expected, ablation of CyPD abolished the protective role of Pi against DPC 
inhibition (Figure 3.8A). Conversely, in the same mitochondria Pi protection against 
NBD-Cl was totally ineffective (Figure 3.8B). 
 
 
 
 
 
 
 
 
 
 
 
 
In summary, the ensemble of these findings suggest that the partial inhibition of ATPase 
activity by DPC may be a consequence of carbethoxylation of the OSCP His112, which is 
not accessible to the solvent when CyPD is bound to ATP synthase. Indeed, DPC 
inhibited the ATPase activity exclusively in the presence of CsA (which releases CyPD 
from OSCP) or in mitochondria from Ppif-/- mice (where CyPD has been genetically 
ablated). Consistent with this model, DPC does not influence CyPD binding at neutral 
pH, because His112 is not exposed. Conversely, lowering pH (i) favors CyPD release due 
to protonation of His112 and (ii) at the same time, it allows DPC reaction with His112, 
allowing  CyPD (re)binding. These data therefore strongly support the hypothesis that 
OSCP His112 is part of the binding site of CyPD on the protein. This region also 
comprises Glu115, Glu128 and Glu133, which confer a low potential surface (Giorgio et al. 
2013).  
 
B 
 
B 
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Figure 3.8. Effect of Pi and CsA on ATP Synthase inhibition by DPC and NBD-Cl in 
CyPD-null mitochondria. Freshly prepared liver mitochondria from Ppif-/-mice were 
incubated in the presence (Pi) or absence (w/o Pi) of xx mM Pi and treated with the indicated 
concentrations of DPC (A) or NBD-Cl (B). After incubation with 10 µM alamethicin ATP 
Synthase hydrolytic activity was measured. Reported values are average± S.E. of 3 independent 
experiments. 
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As already mentioned, bioinformatic analyses suggested a secondputative binding 
region of CyPD on OSCP located at residues Glu48, Asp71, Glu76, Phe78 (bovine 
numbering). This region overlaps with helices 3 and 4, the binding site of the PTP 
inducer Bz-423 (Giorgio et al. 2013). When the effect of Bz-423 on the association of 
CyPD was tested, both in mouse and bovine ATP synthase a concentration-dependent 
displacement was observed that is indeed consistent with competition for a common 
binding site (Giorgio et al. 2013). On the other hand, an NMR study established that Bz-
423 binding to OSCP helices 3 and 4 induces conformational changes at helices 1,5 
and 6 perturbing the OSCP-F1 interface and resulting in enzyme inhibition (Stelzer et 
al. 2010). As His112 is very close to helix 6 (Rees et al. 2009), it may be speculated 
that Bz-423 competition with CyPD is not directly due to a common binding site on 
helices 3 and 4, but rather to Bz-423-dependent conformational rearrangements of the 
domain comprising His112. 
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3.3 Effects of pH on the PTP in OSCP His 112 mutants 
The results presented so far suggest (i) that protonationof the His 112 of OSCP 
favours CyPD release from ATP Synthase (which would lead to PTP inhibition by acidic 
pH), and (ii) that DPC-dependent His112 carbethoxylation prevents CyPD release (which 
would allow PTP opening in spite of the acidic pH). In order to investigate whether a 
mechanistic relationship exists between CyPD binding to ATP synthase and propensity of 
the PTP to open OSCP His112 was been replaced with a residue that is not subjected to 
reversible protonation. 
By applying the CRISPR/Cas9 technology  a OSCP H112Q variant was introduced 
in the genome of HEK cells by the laboratory of Prof. Micheal Forte, Vollum Institute, 
Oregon Health and Sciences University. This amino acid substitution was chosen based 
onusing the PAM120 database, built by comparing evolutionarily close sequences that 
are highly similar (Wilbur 1985).The His  Gln mutation was found to be very frequent 
and should be the most conservative because it removes the charge and the pH 
equilibrium, but maintains hydrogen-bonding capability. Another frequent mutation was 
His  Tyr but this was not preferred for the possible occurrence of tyrosine 
phosphorylation events 
To assess whether ATP Synthase activity was affected by the mutation  we 
assessed oxygen consumption rate (OCR) with the sensitive Seahorse technology (Wu et 
al. 2007). In a typical experiment, basal respiration largely reflects mitochondrial oxygen 
consumption linked to ATP synthesis, as shown by its inhibition with oligomycin. 
Addition of the protonophore FCCP then allows to determine the maximal respiratory 
rate, and the subsequent addition of rotenone (selective inhibitor of respiratory complex 
I) and antimycin A (inhibitor of complex III) allows to define the small fraction of 
residual non mitochondrial respiration  
Wild type cells (WT) and cells carrying the OSCP His112Gln mutation (H>Q cells) 
displayed exactly the same respiratory pattern (Figure 3.9), indicating that respiratory 
function and mitochondrial ATP production are unaffected by the mutation,  consistent 
with its conservative nature of the mutation and to the location of His112 in the flexible 
linker region between the N- and C-terminal domains of OSCP. This is at variance with 
the yeast OSCP Gly  Asn mutation at position 166, which is located in the structured C-
terminal domain that contacts with F6 and b of the lateral stalk, so that the mutation 
causes impaired coupling of ATP synthase complexes, which were more susceptible to 
dissociation of F1 from Fo (Boyle et al. 2000).  
  
83 Results and Discussion 
 
 
 
 
 
 
 
 
 
 
 
The ability of WT and mutated cells to undergo PT was evaluated with the 
sensitive CRC test. Briefly, digitonin permeabilized cells were suspended in sucrose assay 
buffer that also contains Calcium Green-5N, a probe that increases its fluorescence 
emission upon calcium binding, and subjected to a train of Ca2+ pulses. PTP opening is 
marked by a process of precipitous Ca2+ release. 
H>Q cells readily took up a train of Ca2+ pulses in a process that was sensitive to 
CsA. The Ca2+ load required to trigger PTP opening was indistinguishable from that of 
wild type cells (Figure 3.10A and B), meaning that, at neutral pH, PTP function is 
maintained in the cells carrying the OSCP His112Gln mutation. 
 
 
 
 
 
 
 
Figure 3.9 Activity of FoF1 ATP Synthase in wild type HEK 
cells and in HEK cells carrying the OSCP His112Gln 
mutation (H>Q). ATP Synthase activity was measured by the 
Seahorse technique as detailed in Materials and Methods. Where 
indicated (arrows) oligomycin (O), FCCP (F), rotenone (R), and 
antimycin A (A) were added. The traces are representative of 3 
experiments. 
 
Figure 3.9 Activity of FoF1 ATP Synthase in wild type HEK 
cells and in HEK cells carrying the OSCPHis112Gln 
mutation (H>Q). ATP Synthase activity was measured by the 
Seahorse technique as detailed in Materials and Methods. Where 
indicated (arrows) oligomycin (O), FCCP (F), rotenone (R), and 
antimycin A (A) were added. The traces are representative of 3 
experiments. 
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To assess the pH sensitivity of the PT, permeabilized cells were suspended in 
KSCN buffers in the absence of respiratory substrates at different pH, in order to 
achieve constant values of matrix pH, as in (Nicolli et al. 1993). Under these 
conditions diffusion of the lipophilic SCN- anion within mitochondria provides the 
driving force for electrophoretic Ca2+ accumulation (Selwyn et al. 1970). Ca2+ influx 
collapses SCN- diffusion potential and prevents development of a large membrane 
potential that would counteract the increase of PTP opening (Bernardi et al. 1992; 
Petronilli et al. 1993). Since the permeability for SCN- and Ca2+ is higher than that for 
H+, it is possible to achieve Ca2+-dependent PTP opening in absence of respiration 
and of net H+ movements (Nicolli et al, 1993) and the PT can be measured as the rate 
of swelling (decrease in absorbance at 540nm). 
As expected, in wild type cells PTP opened at pH 7.4, while at pH 6.5 there is a 
strong inhibitory effect of matrix H+ on its opening (Figure 3.11 A). Conversely, in 
H>Q cells Ca2+ addition induces mitochondrial swelling at both neutral and acidic 
pH (Figure 3.11 B), indicating that the PTP of these cells is insensitive to inhibition at 
acidic pH.  
DPC was expectedly effective in allowing PTP opening at acidic pH in wild 
type cells (Figure 3.12A), as originally observed in isolated mitochondria (Nicolli et 
al. 1993). On the other hand in H>Q cells DPC had no effect both at neutral and 
acidic pH.  Therefore, these experiments conclusively show that His112 of OSCP 
A 
 
A 
B 
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Figure 3.10 Ca2+ sensitivity of the PT in wild type HEK cells (A) and in HEK 
cells carrying the OSCPHis112Gln mutation (H>Q) (B). The PTP function is 
assessed through CRC assay in the absence and presence of CsA (see Materials and 
Methods). The traces are representative of 4 experiments. 
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mediates the inhibitory effect of acidic pH on the PTP (Bernardi et al. 1992; Nicolli et 
al., 1993) and that it is the target of DPC (Figure 3.12B). Further experiments are in 
progress in HEK cells carrying the OSCP His112Tyr mutation, which is also very 
frequent. Indeed, OSCPTyr112 is not susceptible to protonation at low pH, because 
its pKa is much higher than OSCPHis112. 
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Figure 3.11 pH-dependent modulation of PTP opening in wild type HEK 
cells (A) and in HEK cells carrying the OSCP His112Gln mutation (H>Q) 
(B). Permeabilized cells were suspended in KSCN buffers at pH 7.4 or pH 6.5 and the 
PTP opening was measured as the rate of swelling (decrease in absorbance at 540nm), 
as outlined in Materials and Methods. Traces are representative of 3 experiments. 
 
 
 
Figure 3.11 pH-dependent modulation of PTP opening in wild type HEK 
cells (A) and in HEK cells carrying the OSCPHis112Gln mutation (H>Q) (B). 
Permeabilized cells were suspended in KSCN buffers at pH 7.4 or pH 6.5 and the PTP 
opening was measured as the rate of swelling (decrease in absorbance at 540nm), as 
outlined in Materials and Methods. Traces are representative of 3 experiments. 
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In summary, these results point at His112 of OSCP as the critical residue of 
the FoF1 ATP synthase responsible for the sensitivity of the PTP to acidic matrix pH. 
OSCP makes contacts with both F1 and the peripheral stalk and the linker region 
comprising His112 appears involved in the bending of the entire peripheral stalk 
towards the top of F1 in the intact ATP synthase (Zhou et al. 2015). It is tempting to 
speculate that His112 protonation may cause conformational changes within OSCP 
that affect accessibility of the Me2+ binding sites in β subunits and/or the state of the 
lateral stalk, blocking switch of ATP synthase switch to the PTP. OSCP His112 also 
appears critical for pH modulation of CyPD binding, at least in mammalian cells. 
Evaluation of the pH and DPC sensitivity of the CyPD binding to ATP synthase in 
mutated HEK cells, which is in progress, will help shed further light on the 
fascinating problem of modulation of the PTP by H+.  
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Figure 3.12. Effect of DPC on the PTP opening in wild type HEK cells (A) 
and in HEK cells carrying the OSCP His112Gln mutation (H>Q) (B). 
Permeabilized cells were suspended in KSCN buffers at pH 6.5 and the PTP opening 
was measured as the rate of swelling (decrease in absorbance at 540nm), as in Figure 
3.11. Traces are representative of 3 experiments. 
 
 
 
 
Figure 3.12. Effect of DPC on the PTP opening in wild type HEK cells (A) 
and in HEK cells carrying the OSCPHis112Gln mutation (H>Q) (B).At low H 
is mediated by His protonation. Per eabilized cells were suspe ded in KSCN buffers at 
pH 6.5 and the PTP opening was measured as the rate of swelling (decrease in 
absorbance at 540nm), as in Figure 3.11. Traces are representative of 3 experiments. 
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3.4 Assessment of the interaction between inhibitor protein  
(IF1) and FoF1 ATP Synthase  
Inhibition of the at acidic pH may also suggest involvement of the inhibitor 
protein IF1, whose binding to F1 is favored by low pH with formation of the inhibitory 
dimeric form of IF1 (Cabezon et al. 2000). Indeed, in the inhibited IF1-F1 complex two 
Mg2+-ADP molecules are trapped in the catalytic sites of both βDP and βTP subunits 
(Bason et al. 2011; Bason et al. 2014b), which may affect the hypothetical replacement of 
Mg2+ with Ca2+ at the F1 catalytic sites that we postulate to be required for the switch of 
ATP synthase to PTP. On the other hand, the inhibited IF1-F1 complex does not contain 
Pi, which is a PTP inhibitor at low concentration, suggesting that IF1 binding might mask 
an inhibitory site favoring rather than preventing PTP opening. 
Interestingly, in the 1980s it had been reported that DPC treatment of isolated IF1 
blocks its inhibitory activity towards submitochondrial particles deprived of endogenous 
IF1 (Panchenko & Vinogradov 1985). Consistently, it was later established that IF1 from 
mammalian mitochondria harbours a conserved histidine residue (His49), which 
requires a change in protonation to disassemble inactive IF1 tetramers in two dimers 
allowing inhibition of ATPase activity by each dimer (Cabezón et al. 2003).  
These observations might suggest that the effect of DPC on the PTP formation at 
low pH is, in part at least, related to the DPC modification of IF1 impairing its inability to 
bind ATP synthase. We assessed whether DPC prevents the increased IF1 binding to ATP 
synthase at acid pH in submitochodrial particles deprived of endogenous IF1 and in 
whole mitochondria from bovine heart. Isolated IF1 was treated with DPC and its ability 
to inhibit the ATP synthase activity tested as in (Panchenko & Vinogradov 1985).  Whole 
mitochondria were treated with DPC prior to acidification and then subjected to ATP 
synthase immunoprecipitation to evaluate the amount of bound IF1 by Western Blot 
against IF1 and β subunit. As expected, DPC treatment of isolated IF1 impaired its ability 
to inhibit ATP hydrolysis in submitochondrial particles (Figure 3.13A). Moreover, in 
whole mitochondria the amount of IF1 bound to ATP synthase (expressed as IF1/β ratio), 
which is regulated by several factors (Lippe et al. 1988), increased at low pH in the 
absence but not in the presence of DPC (Figure 3.13B and C). 
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These results appear promising but do not yet allow firm conclusions to be made. 
Although IF1 silencing/overexpression could, at least in principle, establish if this factor 
has a role in PTP formation or modulation, conflicting results have been reported, 
demonstrating that modulation of the IF1 expression differentially affects metabolism in 
normal (Bisetto et al. 2013) and tumor (Campanella et al. 2008) cells (Sánchez-Aragó et 
al. 2012). Single mutation of IF1 at histidine residues appears a more promising approach 
to check if it is involved in the pH sensitivity of the PTP.  
As already mentioned, in our hands only the dimeric form of ATP synthase is able to 
generate currents in electrophysiology experiments. The inhibition of PTP formation at 
low pH might be due to a structural instability of the dimers and the consequent 
dissociation into monomers. To test this hypothesis the stability of the dimers at different 
pH has been evaluated by blue native-PAGE assessing the ratio between the dimeric and 
Figure 3.13. Effect of DPC on IF1 binding to ATP Synthase  
(A) Purified bovine heart IF1, incubated in the absence or presence of DPC, were added 
to the EDTA-SMP suspended at pH 6.5 before measuring their ATP hydrolysis activity 
as described in Methods. B) Freshly prepared bovine heart mitochondria were 
suspended at pH 7.4 or 6.0 and treated or not with DPC; ATP synthase was 
immunoprecipitated and the amount of IF1 and β subunit was detected by 
Immunoblot.  C) Each immunodetected band was analyzed by densitometry and the 
ratio between the peak area of IF1 and that of the corresponding β subunit was 
measured and expressed relative to the ratio obtained at pH 7.4 in the absence of DPC, 
which was taken as 100%. Data are mean of 3 experiment ± SEM.**P <0.01, n.s.=not 
significant (Student t test). 
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monomeric form both by Coomassie Blue and activity staining (Bisetto et al. 2007). 
Submitochondrial particles (EDTA-SMP) were suspended in buffers at different pH 
values, extracted using digitonin and subjected to blue native-PAGE. The 
dimer/monomer ratio revealed by Coomassie staining did not change, demonstrating 
that dimer stability is not affected by low pH (Figure 3.15A). Intriguingly, treatment at 
low pH selectively caused inhibition of the in-gel ATPase activity of the dimers, 
suggesting the occurrence of inhibitory binding to ATP synthase of IF1 associated to the 
IMM (Figure 3.15B).  
IF1 content of both monomers and dimers was then evaluated by excising the bands from 
the native gel, followed by 2D SDS-PAGE and Western Blot analysis. As shown in Figure 
3.15 C IF1 content of monomers did not change in function of pH, while IF1 seems to 
prefer the dimeric form of ATP synthase as binding partner at low pH. Therefore, 
decreased ATPase activity at low pH matches increased levels of bound IF1 suggesting 
that it is not due to instability of the dimers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14. Blue native-PAGE of EDTA-SMP subjected to different pH-
treatments.EDTA-SMP were suspended in buffers at the different pH and subjected 
to blue native PAGE stained by Coomassie staining (A) or in-gel ATPase activity (B). 
The bands of the ATP Synthase dimers (Vd) and monomers (Vm) were excised, their 
subunits were separated by 15% SDS-PAGE and the amount of IF1 was revealed by 
Western blotting (C). The patterns are representative of 4 experiments. 
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The results presented in this Thesis document the critical role of the unique 
OSCP histidine (His112) in the modulation of the CyPD-ATP Synthase interactions, 
strongly indicating that the region comprising His112 is the binding site of CyPD. 
Moreover, replacement of OSCP His112 with a Gln residue in HEK cells 
demonstrated that His112 mediates PTP inhibition by H+, indicating that OSCP 
His112 is responsible for both pH modulation of PTP and CyPD binding to ATP 
synthase.  
Treatment of bovine heart mitochondria with the histidine modifier reagent 
DPC (i) partially reduced IF1 binding at acidic pH, which is consistent with a critical 
role of IF1 histidyl residues for the inhibitory activity on the ATP synthase and (ii) 
prevented the release of CyPD from ATP synthase induced by acidic pH. While the 
first effect is probably not relevant to PTP modulation, the second effect led us to 
unravel the mechanism of PTP inhibition by acidic pH. This latter  effect of DPC was 
reversed by hydroxylamine, indicating that it can be traced to carbethoxylation of 
histidyl residue(s). Consistently, both electrospray ionization mass spectrometry 
(ESI-MS) and mass tandem (LC-MS/MS) analyses confirmed the carbethoxylation of 
OSCP His112, which mediates partial inhibition of ATP synthaseonly when CyPD is 
not bound to the complex.  Indeed, DPC inhibited ATPase activity only in 
mitochondria from CyPD null mice or in submitochondrial particles treated with 
CsA, i.e. a condition that promotes CyPD release from OSCP.  In permeabilized HEK 
cells carrying the His112Gln mutation Ca2+ induced PTP opening both at neutral and 
acidic pH. This is at striking variance from wild-type HEK cells were Ca2+ does not 
induce PTP opening at acidic pH. These data demonstrate that protonation of OSCP 
His112 is responsible for PTP inhibition by H+, and provide  compelling evidence that 
ATP synthase and PTP are the same molecular entity. 
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Abstract: The oligomycin-sensitivity conferring protein (OSCP) of the mitochondrial FOF1 
ATP synthase has long been recognized to be essential for the coupling of proton transport 
to ATP synthesis. Located on top of the catalytic F1 sector, it makes stable contacts with 
both F1 and the peripheral stalk, ensuring the structural and functional coupling between FO 
and F1, which is disrupted by the antibiotic, oligomycin. Recent data have established that 
OSCP is the binding target of cyclophilin (CyP) D, a well-characterized inducer of the 
mitochondrial permeability transition pore (PTP), whose opening can precipitate cell death. 
CyPD binding affects ATP synthase activity, and most importantly, it decreases the 
threshold matrix Ca2+ required for PTP opening, in striking analogy with benzodiazepine 
423, an apoptosis-inducing agent that also binds OSCP. These findings are consistent with 
the demonstration that dimers of ATP synthase generate Ca2+-dependent currents with 
features indistinguishable from those of the PTP and suggest that ATP synthase is directly 
involved in PTP formation, although the underlying mechanism remains to be established. 
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In this scenario, OSCP appears to play a fundamental role, sensing the signal(s) that 
switches the enzyme of life in a channel able to precipitate cell death. 
Keywords: mitochondria; oligomycin-sensitivity conferring protein (OSCP);  
cyclophilin D (CyPD); FOF1 ATP synthase dimer; permeability transition pore (PTP) 
 
1. Introduction 
Mitochondria are cytoplasmic double-membrane-delimited organelles of variable size, with a 
diameter between 0.5 and 5 μm, which are organized in a dynamic network [1] and are responsible of 
the aerobic production of ATP by the oxidative phosphorylation system (OXPHOS). In addition, 
mitochondria participate in intermediary metabolism and are involved in the early stages of cell death, 
where the Ca2+-dependent permeability transition pore (PTP) plays a key role [2]. OXPHOS catalyzes 
the oxidation of fuel molecules and the concomitant synthesis of ATP via five complexes located in 
the inner mitochondrial membrane (IMM), which is highly folded into cristae. Briefly, Complexes I, 
III and IV of the respiratory chain catalyze a sequential series of redox reactions, resulting in the 
reduction of oxygen to water; at the same time, they pump protons across the IMM into the 
intermembrane space (IMS), generating a proton electrochemical gradient that provides the driving 
force for the synthesis of ATP from ADP and inorganic phosphate (Pi) within Complex V (or FOF1 
ATP synthase). 
Intriguingly, recent data suggest that Complex V has a second function, as it is able to generate 
Ca2+-dependent currents with features indistinguishable from those of the PTP, as assessed after 
isolation in the form of dimers, which represent its physiological state in the IMM [3]. The enzyme of 
life appears therefore to be directly involved in PTP formation to stimulate cell death [4]. The OSCP 
(oligomycin-sensitivity conferring protein) subunit of ATP synthase appears to play a unique role, 
being the site of interaction of cyclophilin (CyP) D, a matrix protein that favors PTP opening, as will 
be discussed below. CyPD is also the downstream effector of kinase signaling pathways, which target 
the PTP, such as hexokinase II and the Akt-ERK-GSK3 axis, whose dysregulation is a hallmark of 
several neoplastic cell models [5]. Post-translational modifications (PTMs) of OSCP have also been 
reported [6–8], but their functional implications are still to be defined. These observations suggest that 
CyPD-OSCP interaction mediates a survival or death signal modulating the PTP closure/opening, 
although the underlying mechanism remains to be establish. 
The IMM also contains many transporters or carriers that translocate nucleotides, inorganic ions 
and metabolites, including phosphate, thereby determining the compartmentalization of the metabolic 
functions of mitochondria. The mitochondrial proteome ranges between about 800 (yeast) and  
1500 (human) different proteins [9], with relevant differences between organs [10]. Although the 
majority of mitochondrial proteins is encoded in the nucleus and post-translationally imported into the 
organelle by a complex protein-import machinery [11], some subunits of the OXPHOS (13 in humans) 
are encoded by the mitochondrial genome (mtDNA), which is present in several copies per organelle 
and is exclusively maternally inherited. 
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Defects in mitochondrial DNA (mtDNA) have been associated with mitochondrial diseases, which 
encompass a wide variety of degenerative diseases and may also play a role in aging and cancer [12]. 
Complex V deficiency due to mutations in the mtDNA-encoded subunits a and A6L is a very rare 
OXPHOS deficiency. Phenotypic variations in disease severity depend mainly on the fraction of 
mutated mtDNA percent (i.e., the level of heteroplasmy), as observed in Maternally inherited Leigh 
syndrome (MILS) and neuropathy, ataxia and retinis pigmentosa (NARP) syndrome, caused by subunit 
a (MT-ATP6) mutations. Mitochondrial diseases due to genetic defects in the nuclear genes affecting 
one structural subunit, one assembly and one ancillary factor have also been described [13]. Deficiency 
in ATP synthesis appears to be the main pathogenic factor, although other mechanisms are involved, 
such as the generation of reactive oxygen species (ROS) [14–16]. On the other hand, the novel 
function of ATP synthase in PTP formation makes this picture much more complex, considering the 
role played by PTP and by its dysregulation in a variety of diseases characterized by altered cell death, 
which include ischemia-reperfusion injury of the heart and brain, muscular dystrophies, 
neurodegeneration and cancer [5,17]. 
2. ATP Synthase Structure 
The mitochondrial ATP synthase is a 600-kDa multisubunit complex. Its molecular structure and 
catalytic mechanism were understood by the seminal work of the Nobel Laureates, Mitchell, Boyer 
and Walker [18–20], which revealed its complexity and the functional steps driving the synthesis of 
ATP. In addition to the IMM, ATP synthase is present in the thylakoid membrane of chloroplasts, and 
in the plasma membrane of bacteria and mammalian cells, although with opposite orientation [21,22]. 
It is well conserved, considering its structural complexity and the early divergence of bacteria, plants 
and animals [23]. Proton translocation and synthesis of ATP from ADP and Pi are coupled by a unique 
mechanism: subunit rotation. The electrochemical energy contained in the proton gradient is converted 
into mechanical energy in the form of subunit rotation and back into chemical energy as ATP [24–27]. 
The enzyme is also able to work in the direction of ATP hydrolysis, sustaining the formation of the 
proton gradient, when there is a loss of membrane potential. In both directions, Mg2+ is essential for 
catalysis, and it can be replaced by other divalent cations, such as Mn2+ and Co2+. Intriguingly, Ca2+ 
ions, which induce PTP formation, only sustain ATP hydrolysis by F1, which is not coupled to proton 
translocation both in bacteria [28] and in mammals [29]. 
Traditionally, ATP synthase is divided into two subcomplexes, the membrane-embedded FO 
subcomplex, through which the protons flow, and the soluble F1 subcomplex. The latter is always 
composed of three copies of each of subunits α and β (which carry the nucleotide binding sites) and 
one each of subunits γ, δ and ε (which constitute the central stalk of the complex). Subunit γ rotation 
within α3β3 takes each of the three β subunits through the conformations, βDP, βTP and βE, thereby 
synthesizing three Mg2+-ATP molecules during each 360° rotation [30]. 
The inhibitor protein, IF1, binds to F1, at a α/β interface, under energy deficiency [31,32], i.e., at low 
pH and membrane potential, when the enzyme hydrolyzes rather than synthesizes ATP. Therefore, IF1, 
which is evolutionarily conserved from yeast to mammals, is considered responsible for the beneficial 
(at least partial) inhibition of FOF1 during ischemia both in in vitro experimental models, as well as  
in vivo [33], as also demonstrated by our group in anaesthetized open-chest goat heart [34]. 
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Unexpectedly, IF1-knockout mice grew without defects, but their behavior against stressful situations 
have not been tested [35]. 
In the simplest form of the enzyme, such as that of bacteria, like Escherichia coli, FO consists of 
three different subunits, a, b and c, with stoichiometry ab2c9–12 [23]. Subunits a and c form the proton 
channel, while subunit b links the proton channel to F1. The animal mitochondrial FO sector has a more 
complicated structure, since ten subunits have been identified, a, b, c, F6, d, e, A6L, f, g and  
OSCP [36]. The a, b and c subunits share great similarity with the bacterial subunits, except for subunit 
c stoichiometry which comprises only eight copies, thus reducing the bioenergetic cost of ATP  
synthesis [37], whereas the remaining subunits are unique to the mitochondrial complex (Table 1). The 
membrane-embedded part of FO comprising subunits e, f, g and A6L is connected to F1 by a complex 
peripheral stalk, composed by one copy each of subunit b, d, F6 and OSCP, which is important to 
prevent the co-rotation of α and β subunits with γ and, therefore, the loss of enzyme efficiency. OSCP 
is a 213-amino acid protein (including the 23 amino acid mitochondrial leader sequence) located on the 
top of F1 [38], which is analogous to E. coli δ-subunit and is highly conserved among mammals [39]. 
Besides these subunits, in beef, rat and man, two hydrophobic proteins, namely a 6.8-kDa proteolipid 
(called MLQ) [40,41], and α1 acid glycoprotein/diabetes-associated protein in insulin-sensitive tissue 
(called AGP/DAPIT) [42], are associated with the FO. All together, the mitochondrial membrane 
domain is constituted by approximately 30 trans-membrane α-helices [43] (Figure 1). 
Table 1. Equivalence of subunits of ATP synthase from different sources 1. 
Mitochondria E. coli,  
P. modestum and A. woodii 
Chloroplast, cyanobacteria 2 
and rhodobacteria 3 Bovine Yeast 
α α α α 
β β β β 
γ γ γ γ 
δ δ ε ε 
ε ε - - 
OSCP OSCP δ δ 
b 4 or b B 4 b and b' (I and II) 
A6L 8 - - 
F6 h - - 
a 6 or a a a (IV) 
c 9 or c c c (III) 
d d - - 
e e - - 
f f - - 
g g - - 
- i/j - - 
- k - - 
MLQ - - - 
AGP/DAPIT - - - 
1 Subunit equivalence is based on sequence homology; 2 Synechococcus; 3 Rhodospirillum rubrum and 
Rhodopseudomonas blastica; 4 ATP synthase from E. coli and P. modestum have two copies of the b subunit 
and ATP synthase from chloroplasts, cyanobacteria and rhodobacteria have one copy of each b and b'. The b 
and b' are homologous; -, no subunit equivalence. 
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Figure 1. Schematic representation of FOF1 ATP synthase as a monomer. 
 
ATP synthase is commonly isolated as a functional monomer, but this is not the physiological state 
in yeast, mammalian and plant mitochondria [44,45]. Biochemical and electron microscopy studies 
demonstrated that within the IMM, the enzyme is organized in dimers associated with forming long 
rows of oligomers located at the cristae ridges to maintain a high local curvature [3] and normal cristae 
morphology [46,47]. Dimers interact within the IMM through the FO subunits [48] with the peripheral 
stalks turned away from each other [38]. The proposed roles of the ATP synthase oligomers are higher 
efficiency and higher stability [3,49]. Consistently, in aged mitochondria of Podospora anserina, the 
disappearance of the typical IMM architecture and impairment of ATP synthesis were concomitant  
to ATP synthase dimer dissociation and formation of IMM vesicles [50]. Intriguingly, electron 
tomography evidenced the binding of a bell-shaped protein, possibly CyPD, between the FO-FO of 
dimers at the bases of the peripheral stalks in early-vesicular mitochondria followed by its dissociation 
from monomers in aged mitochondria. These observation prompted the authors to propose a role of 
CyPD in promoting dimer dissociation. We found that CyPD interacts with OSCP in the ATP synthase 
dimers promoting PTP formation [2,4], as will be discussed below. If CyPD binding between the two 
FO will be confirmed by further investigation, the existence of distinct CyPD binding sites on ATP 
synthase dimers may be proposed. 
The structural properties of dimers were initially characterized in yeast, where genetic approaches, 
cross-linking analyses and electron microscopy images established preferential interactions within  
the IMM, mainly through the Su6 [51], Su4 [52], e [53] and g subunits [54], which formed Su6/Su6, 
Su4/Su4 and e/g interactions, and also through the yeast-specific FO subunits, h and i [55]. In keeping 
with its general occurrence, the involvement of subunits a [56], e [57] and g [44] in ATP synthase 
dimerization has been demonstrated also in mammals. In addition, a second interface (named the 
oligomerization interface) has been described in yeast; this interface was stabilized through e/e and g/g 
interactions allowing oligomer formation [45]. However, the existence of an oligomerization interface 
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has been criticized based on electron cryotomography data of mitochondria from different sources, 
including bovine heart, which evidenced variable distance between dimers, making direct protein 
contacts difficult [3]. Moreover, electron cryotomography showed that dimers of all species display 
fixed angles between two F1-F1 with an angle >70° [3], in contrast with previous single-particle 
electron microscopy images, which indicated angles ranging from 40° [58,59] to 70°–90° [48,60].  
It has been proposed that the 40° dimers form upon the inhibitory binding of IF1 [3], which was 
contained in considerable amounts in isolated dimers [58]. However, although IF1 was not essential for 
ATP synthase dimerization both in yeast [61] and mammals [62], we found that in cardiomyoblasts 
undergoing cardiac differentiation, IF1 binding promoted dimer/oligomer stabilization, possibly 
through a non-inhibitory interaction, which remains to be clarified. In fact, in differentiated cells, an 
increased IF1 binding occurred in parallel with an increase of ATP synthesis, as already reported in 
human HeLa cells [63] overexpressing IF1, as well as of ATP hydrolysis [64]. Intriguingly, a  
pH-independent interaction of IF1 with OSCP has been described [65], whose functional implication 
remains to be established. A stabilizing effect on bovine ATP synthase dimers has been also reported 
for the matrix metalloprotein, called factor B, which interacts with the e and g subunits of FO [66]. 
3. OSCP: Location and Structure 
It has long been established that OSCP is essential for conferring sensitivity to the inhibition of 
ATP synthase by the antibiotic, oligomycin [67], although oligomycin does not bind OSCP. Sensitivity 
to oligomycin can be defined in two contexts. The first relates to the “coupling” of the enzyme assayed 
as the oligomycin-sensitive ATP hydrolytic (ATPase) activity. It is a measure of the structural integrity 
of the enzyme, since detachment of F1 from FO leads to a decrease in oligomycin-sensitive ATPase  
activity [68–72]. Under these conditions, ATP hydrolysis by F1 still takes place, but ATP hydrolysis is 
no longer coupled to proton translocation, and the sensitivity to oligomycin is lost, demonstrating that 
oligomycin inhibits proton transport in FO, thus affecting the Vmax of ATP hydrolysis, only when FO is 
correctly bound to F1, i.e., in the coupled enzyme [70]. In this context, depletion/reconstitution studies 
in isolated membranes demonstrated that OSCP is absolutely necessary in coupling proton 
translocation to ATP synthesis [71]. In keeping with this key function of the subunit, yeast OSCP 
knockouts failed to survive under normal growth conditions [73]. 
The second context relates to the ability of the assembled ATP synthase complex to bind 
oligomycin. In yeast, the oligomycin resistance phenotype is conferred by mutations in one of the two 
mitochondrially encoded subunits, a (Su6) and c (Su9), indicating that the oligomycin-binding site 
encompasses the C-terminal region of Su6 and the transmembrane domains of Su9 [74]. This is 
consistent with the role of these subunits in proton translocation through FO, which requires the 
concerted action of both. 
Boyle and Colleagues have examined the effect of a single residue change at a conserved glycine 
(Position 166) of yeast OSCP [75]. A G166N mutant allowed enzyme assembly into functional 
complexes and was able to grow on ethanol, albeit with a slower generation time. Mutant cells 
demonstrated a relative insensitivity to oligomycin during State 3 respiration, as well as a passive leak 
of protons across the IMM. Moreover, ATP synthase complexes containing the G166N mutation were 
found to be unstable, being more susceptible to dissociation than complexes containing native OSCP. 
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These properties suggested that altered protein-protein interactions between OSCP and the α3β3 
hexamer partially uncoupled the enzyme. Interestingly, binding of 17β-estradiol to OSCP promoted an 
intrinsically uncoupled state of ATP synthase, while the enzyme was actually catalyzing the ATP 
synthesis in rat liver mitochondria [76]. Fluorescence resonance energy transfer (FRET) measurements 
have documented the stress developing between F1 and OSCP during ATP hydrolysis, which appears 
to match its role as part of the peripheral stalk [77]. 
Intriguingly, OSCP binds isolated F1 in bovine, but not yeast, mitochondria [70,78] Moreover,  
in organello pulse-labeling and pulse-chase experiments run in yeast seem to indicate that OSCP 
binding is the last step in the assembly of FOF1 and that it occurs independently of the two pathways 
that converge to form the whole ATP synthase from the F1/Su9-ring and Su6/Su8/peripheral stalk 
subcomplexes [79]. Consistent with these data, reducing OSCP levels in human cells did not alter the 
expression of other FOF1 subunits, as well as of the respiratory chain complexes [4,78]. Interestingly, 
in a model of Leigh syndrome obtained in a conditional knockout mouse heart for the mtDNA 
regulator, Lrpprc (leucine-rich pentatricopeptide repeat containing protein), the appearance has been 
recently observed of ATP synthase subcomplexes lacking OSCP and A6L. These subcomplexes 
contained a high amount of IF1, which blocked the ATP hydrolysis at physiological pH, counteracting 
the overall impairment of ATP production [16]. 
Rees and Colleagues [80] established the physical location of OSCP in the peripheral stalk by 
analyzing the crystal of a F1-peripheral stalk subcomplex and demonstrated that the subunit sits on top 
of the F1 domain (see Figure 1), in agreement with earlier experiments [81]. Its N-terminal domain 
(Residues 1–113) contains six α-helices and shows a similar fold to that of the N-terminal fragment of 
recombinant OSCP analyzed by NMR [82]. Helices 1 and 5 provide the binding site: (i) for  
Residues 6–17 of subunit αE (which contacts βE in α3β3 subcomplex), largely via hydrophobic 
interactions and two possible charge-charge interactions through R15 and E91; and (ii) for E7 and R94 
of subunits α and OSCP, respectively [80]. These interactions are similar to those determined with 
isolated OSCP and synthetic peptides from the N-terminals of mitochondrial and bacterial α  
subunits [81,83]. There is another region of interaction involving Residues 1–14 of the OSCP with the 
F1 N-terminal β-barrel domains of the βDP-subunit [80]. 
The structure of the C-terminal domain of OSCP, which is unstructured in the isolated protein [82], 
consists of a β-hairpin, which precisely locates along the α/β interface [38], followed by two α-helices, 
H7 and H8 [80]. H8 of the OSCP forms a three-helix bundle with the N-terminal α-helix of F6 and a 
segment of subunit b. The C-terminal of subunit b also packs against helix H7 of the OSCP, resulting 
in an extensive interface between OSCP and subunits b and F6. 
4. Post Translational Modifications of OSCP Subunit 
Information on post-translational modifications (PTM) of ATP synthase subunits has increased with 
the development of new techniques, such as PTM-specific mass spectrometry (MS)-based methods, 
selective dyes (ProQ Diamond) and specific antibodies. The association of several of these PTMs  
with specific biological processes, i.e., PDGF-mediated phosphorylation of the δ subunit [84,85], or  
diseases (such as type 2 diabetes [86]) has been found. The challenge is now to find direct  
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functional implications for these PTMs. The OSCP subunit has been reported to be glycosylated [7], 
phosphorylated [6,87–90] and acetylated [8,91] (Table 2). 
Table 2. Post-translational modifications of OSCP. 
Modification Method Residue Organism/Tissue Reference 
Acetylation 
MS 1 
K60, K70, K159, K162, 
K172, K176, K192 
Mouse/Liver [91] 
K Ab  Human 143B osteosarcoma cells [8] 
Phosphorylation 
ProQ  Pig/Heart [6] 
PhosTag  Pig/Heart [87] 
32P  Pig/Heart [90] 
MS T145 Pig/Heart [89] 
MS S155 Human/Muscle [88] 
Glycosylation Leptin resin  Bovine/Heart [7] 
Ubiquitination Ub Ab  Human colon cancer cells [92] 
1 Abbreviations: MS, mass spectrometry; K Ab, anti-lysine antibody; Ub Ab, anti-ubiquitin antibody.  
Although the glycosylation of secreted, membrane and nucleocytosolic proteins has been well 
studied, information on the glycosylation of mitochondrial proteins is limited [93,94]. Recently, 
different authors have proposed that several proteins with mitochondrial function or with 
mitochondrial-annotation and, thus, putative mitochondrial function may be glycosylated [95–98]. 
Berninsone and Burnham-Marusich [7] identified glycosylated isoforms of OSCP and the d subunit 
in bovine heart mitochondria by using a leptin resin. The same authors also detected a glycosylated 
isoform of the ATP synthase α subunit in bovine heart tissue, in a primate cell line (COS-7) and in the 
Caenorhabditis elegans primary embryonic cell line [99]. These results indicate that glycosylated 
isoforms of proteins with established mitochondrial function exist and may be more common than 
previously appreciated. Computational prediction of OSCP (P13621 sequence) glycosylation sites 
revealed two O-glycosylation sites, one of which is near to Helix 6, contacting αE [80] (NetOGlyc 4.0 
algorithm [100]), thus suggesting an involvement in the modulation of enzyme activity. Interestingly, 
in rat cardiac myocytes, an increase of O-glycosylation of Complex I, III and IV is associated with 
impaired respiratory activity [96]. Taken together, these findings open questions about where in the 
cell and, consequently, by which glycosyltransferases these proteins, including OSCP, become 
glycosylated and the nature of glycosylation (the attachment site and structure of glycans). 
Phosphorylation of OSCP was reported for the first time by Hopper et al. [6], who analyzed the 
phosphoproteome of the mitochondrial matrix in porcine heart, using the phosphorylation targeted dye, 
ProQ Diamond, in conjunction with 2D gel and mass spectrometry. A phosphorylated form of OSCP 
has been later found also in porcine heart by the Balaban group, who extensively studied mitochondrial 
phosphoproteome with PhosTag and 32P labeling (for a review of ATP synthase phosphorylation,  
see [89]). In particular, the OSCP residues, Ser155 and Thr145, have been found phosphorylated in 
human skeletal muscle and pig heart, respectively [88,101]. Their location near the αE subunit suggests 
that phosphorylation may participate in the regulation of motor function, but no evidence has been yet 
reported. Nevertheless, and in spite of these advances, kinases and phosphatases involved in ATP 
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synthase phosphorylation are still poorly defined, and further work will be needed to understand the 
consequences of phosphorylation on enzyme activity. 
The first extensive proteomic study of mitochondrial protein acetylation was performed in mouse 
liver mitochondria [91] and revealed that more than 20% of mitochondrial proteins contain acetylated 
lysine residues, including OSCP and the other peripheral stalk subunits, the F1 α, β, γ subunits and the 
FO g and A6L subunits, for which the acetylated sites have been identified. More recently, acetylation 
of α and OSCP subunits was confirmed by Wei et al. [8], who discovered that Sirtuin3, which belongs 
to a large family of NAD+-dependent protein deacetylases, interacts with OSCP and activates the 
enzyme through deacetylation of α and OSCP subunits. Such a finding is consistent with the ability  
of acetylation to neutralize the positive charge of lysine residues, as well as to increase the 
hydrophobicity and size of the lysine side chains, causing potential alterations of the protein propensity 
to interact with other proteins. Thus, the acetylation of OSCP can induce a conformational change of 
the protein itself or prevent complex formation with other proteins. The relevance of acetylation was 
confirmed by the observation that potentially every major metabolic enzyme is acetylated, both inside 
and outside the mitochondria [102,103]. 
Interestingly, selective immunoprecipitation of OSCP from mitochondrial lysates revealed that 
OSCP is ubiquitinated in colon cancer cells (human COLO 205 cell line) together with high levels of 
the expression of Hsp90 [92]. OSCP ubiquitination was not observed in an MS analysis of mouse 
heart, where, instead the α, β, γ and b subunits were found to be ubiquitinated [104], suggesting a 
specific role of OSCP ubiquitination in cancer cells. 
In summary, several PTMs have been identified in the OSCP subunit, especially phosphorylation 
and acetylation, for which specific sites have been found (Table 2). However, for most of them, the 
functional consequences are still unknown, as well as the enzymes involved in these modifications. 
5. OSCP Interactors: CyPD and PTP Formation 
ATP synthase activity is regulated by the reversible association of a variety of regulatory peptides, 
including CyPD. Beside the already mentioned IF1, an inhibitory interaction with protein kinase Cδ at 
subunit d of the lateral stalk has been described, whose disruption attenuated the injury resulting from 
prolonged oxygen deprivation in neonatal cardiac myocytes [105]. Conversely, the Ca2+-dependent 
association of S100A1 with F1 improved the enzyme performance in cardiomyocytes [106]. Binding of 
Bcl-XL to the β subunit and binding of Factor B to the membrane-embedded part of FO increased  
the aerobic ATP production by blocking a proton leak in healthy neurons [107] and in animal 
mitochondria [66,108], respectively. In addition, three new interactors have been described that 
selectively bind OSCP, i.e., the already mentioned Sirtuin3, CyPD and, possibly, p53 [109]. 
Sirtuins control a variety of cellular function via their NAD+-dependent deacetylase activity [110]. 
Sirtuin3 is the best characterized sirtuin in mitochondria and has emerged as a major regulator of 
mitochondrial metabolism and energy homeostasis through mitochondrial protein deacetylation [111]. 
As already mentioned, Wei and co-workers discovered that endogenous Sirt3 interacts with OSCP and 
mediates the deacetylation of the α and OSCP subunits. Interestingly, these authors found that ATPase 
acetylation and Sirtuin3 expression are altered in human cells harboring a pathogenic mtDNA mutation 
(the 4977 bp deletion), as well as under increased ROS production in human cells [8]. 
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p53 is a transcription factor rapidly activated in response to multiple stresses regulating hundreds of 
genes implicated in cell cycle, senescence, apoptosis, metabolism and DNA repair [112]. For a human 
cell model expressing mitochondrially-targeted p53 (with a vector in which the sequence encoding a 
mitochondrial import leader was fused to the 5' end of wild-type p53), a transcription-independent 
activity of p53 able to increase oxygen consumption and to decrease ROS production in the absence of 
acute stress has been recently reported. By immunoprecipitation and mass spectrometry, the authors 
demonstrated that p53 interacts with OSCP, taking part in the assembly or stabilization of the mature 
FOF1 complex, thus suggesting that the mitochondrial fraction of p53, although very low, may be an 
important regulator of mitochondrial physiology, potentially exerting tumor suppression [109]. 
However, interaction domains between p53 and Sirt3 with OSCP have been not yet been determined. 
CyPD belongs to a ubiquitous protein family with peptidyl-prolyl cis-trans isomerase (PPIase) 
activity, which is inhibited by cyclosporin (Cs) A [113]. CyPs share a common domain of 
approximately 109 amino acids, the CyP-like domain [17,114]. In spite of this, CyPs do not play a 
general role in protein folding, and the existence of tissue- and organelle-specific isoforms with the 
proper targeting and/or retention sequence(s) suggests that each CyP regulates a restricted number of 
unique partner proteins [114,115]. 
CyPD is the unique mitochondrial isoform of CyPs in mammals and is involved in the regulation of 
the PTP, but is not a structural pore component. PTP is a conserved high-conductance channel  
located in the inner mitochondrial membrane (IMM) that allows the diffusion of solutes up to about  
1500 Da [116]. PTP openings of a short duration lead to transient IMM depolarization [117] and may 
be caused by physiological stimuli [118]; while long-lasting openings cause permanent depolarization, 
loss of ionic homeostasis, depletion of matrix pyridine nucleotides, resulting in respiratory inhibition, 
and the generation of reactive oxygen species (ROS). Moreover, the matrix swelling occurs as a 
consequence of its high oncotic pressure, and the outer mitochondrial membrane (OMM) may disrupt 
with the release of pro-apoptotic intermembrane proteins, including cytochrome c. Thus, long-lasting 
PTP opening may represent a point of no return in cell commitment to death, which can occur either 
through apoptosis (if enough ATP is present to sustain caspase activity) or through necrosis  
(when ATP is depleted) [5]. 
The role of CyPD as a PTP inducer was suggested by the demonstration that addition of CsA to 
isolated mitochondria desensitizes the PTP, in that pore opening requires about twice the Ca2+ load 
necessary to open the pore in the absence of CsA [119]. Genetic ablation of the Ppif gene (which 
encodes for CyPD in the mouse) has confirmed that CyPD is the mitochondrial receptor for CsA, and 
it is responsible for the modulation of the PTP, both in vitro and in vivo [120–123]. The crystal 
structure of human CypD in complex with CsA demonstrated that it is composed of eight β-strands, 
two α-helices and one 310 helix [124]. 
A major step in the mechanistic understanding of the role of CyPD in PTP regulation has been the 
discovery that CyPD masks an inhibitory site for Pi, which is the actual PTP desensitizing agent [125]. 
Furthermore, PTP modulation by CyPD is affected by CyPD phosphorylation [5], acetylation [126] 
and nitrosylation [127]. Not surprisingly, several regulatory interactions of CyPD have been reported 
in the literature, including Hsp90 and its related molecule, TRAP-1 [128], Bcl-2 [129], ERK-2/GSK-3 [5] 
and possibly p53 [130], which also seems to bind OSCP [109]. 
Int. J. Mol. Sci. 2014, 15 7523 
 
 
The identification of CyPD interaction with the OSCP subunit of ATP synthase was an essential 
step for the identification of the PTP, whose molecular nature was still a matter of conjectures [2]. The 
previous model still postulated that PTP is formed by a supramolecular complex, including the  
voltage-dependent anion channel (VDAC) of the OMM, as well as the adenine nucleotide translocator 
(ANT) and the phosphate carrier (PiC) located in the IMM, but genetic testing has excluded this 
possibility for all of these proteins [2]. 
We observed that in mammals, CyPD binds the ATP synthase peripheral stalk in an apparent ratio 
of 1:1:1:1 with the OSCP, b and d subunits; that this interaction is favored by Pi, which exerts multiple 
effects on PTP [125], as well as on ATP synthase [131]; and that the interaction is competed by CsA 
concentrations known to displace CyPD from the IMM [132]. Importantly, CyPD preferentially binds 
to the ATP synthase dimers, causing a decrease of specific activity that can be reversed by CsA [133]. 
Consistent with a regulatory interaction, the stimulatory effect of CsA was lost in Ppif−/− 
mitochondria, indicating that it was mediated by CyPD, while the assembly of the ATP synthase was 
unaffected by CyPD ablation [133]. 
CyPD interaction with OSCP (which appears to be mostly electrostatic in nature) was confirmed by 
immunoprecipitation of OSCP from mitochondria [4]. When ATP synthase was immunoprecipitated 
from mitochondria with decreased OSCP levels, decreased levels of CyPD were detected, as well. A 
study of surface potentials and isopotential curves of CyPD and OSCP in the ATP synthase complex 
identified putative binding regions of CyPD on OSCP at the region overlapping with Helices 3 and 4, 
which represent the lowest (i.e., most negative) average surface potential regions, as shown in  
Figure 2, where OSCP in the context of ATP synthase is depicted. These helices are also the binding 
site of benzodiazepine (Bz)-423, a well-characterized inhibitor of ATP synthase (Figure 2) [78]. 
Treatment of mitochondria with Bz-423 induced CyPD displacement from ATP synthase, suggesting 
competition for a common binding site. Such localization is therefore consistent with the CyPD 
inhibitory activity of ATP synthase and may allow CyPD binding to all classes of dimers, including 
those displaying small angles between two F1, which have the peripheral stalks in contact, mutually 
hiding their subunits, except OSCP. These latter dimers probably form upon IF1 binding [3,58], i.e., 
when ATP synthase hydrolyses ATP generating high Pi, which, in turn, is necessary for CyPD  
binding [133]. Further work is needed to define the amino acids involved in these interactions. 
Consistent with the involvement of ATP synthase in PTP formation, mitochondria treated with  
Bz-423 or expressing decreased levels of OSCP also decreased the threshold Ca2+ required for PTP 
opening, revealing a striking analogy between the effects of Bz-423 and OSCP on PTP and ATP 
synthase. Direct evidence that PTP forms from ATP synthase was obtained by electrophysiology, 
which demonstrated that the addition of Bz-423 in the presence of Ca2+ to ATP synthase dimers 
isolated and incorporated in azolectin bilayers triggered Ca2+-dependent currents with features 
indistinguishable from those of the PTP [134], which were inhibited by Mg2+-ADP and by AMP-PNP 
(γ-imino ATP), a nonhydrolyzable ATP analog. Taken together, these findings prompted us to 
hypothesize that Ca2+, which is able to sustain only uncoupled ATP hydrolysis [29], replaces Mg2+ and 
induces conformational changes in FO, which could then mediate PTP formation from ATP synthase 
dimers. OSCP may thus act as a negative modulator of PTP affecting Ca2+ accessibility, except when it 
binds CyPD or Bz-423, which favor PTP formation. 
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Beyond CyPD and Ca2+, many other effectors regulate the open-closed transitions of PTP, including 
Mg2+, Mn2+, nucleotides and low pH (which favor its closure); and low membrane potential, high Pi, 
and ROS (which favor its opening) [118,135]. ROS may induce the PTP, but also form as a 
consequence of PTP opening, in a feed-forward loop that may stabilize the pore in the open 
conformation. The FOF1 ATP synthase potentially accommodates all these PTP pathophysiological 
effectors, since divalent cations, nucleotides and Pi bind to the catalytic sites of F1, and the membrane 
potential and pH regulate the catalytic activity, as well as IF1 binding; however, the underlying 
conformational changes responsible for PTP formation are still far from being characterized. 
Interestingly, OSCP contains one conserved histidine residue (His 112 in the bovine enzyme) 
exposed to the matrix and located in one of the lowest surface potential regions (Figure 2), which 
could be involved in the regulation of PTP by pH and ROS. In fact, previous studies highlighted  
an essential role of matrix-exposed histidine residue(s) in PTP regulation; histidine protonation at low 
pH indeed induced CyPD release and PTP closure [132,136]. Moreover, in vitro experiments 
demonstrated that oxidation of critical histidine residue(s) located on the PTP matrix side by singlet 
oxygen photogenerated in situ favored the PTP closed conformation by causing a secondary drop of 
reactivity to the cross-linking of pore-activating cysteine residues [137]. OSCP also contains a unique 
cysteine (Cys 118 in bovine mitochondria) conserved in mammals, whose function in ATP synthase 
catalysis is unclear [69]. We suspect that this residue may be involved in PTP activation by forming a 
dithiol cross-linking with a cysteine of another matrix protein, possibly only when His 112 is not 
oxidized. On the other hand, ATP synthase from various organisms is susceptible to different ROS 
species produced in in vitro experiments [138–140], as well as to oxidative/nitrative stress associated 
with central nervous system (CNS) disorders [141,142], caloric restriction [143] and aging [144,145]. 
We showed that isolated F1 from bovine heart ATP synthase is selectively inactivated by hydrogen 
peroxide through redox-active iron-protein adducts, probably generating highly reactive oxygen 
species [139]. More recently, an exclusive target of singlet oxygen and hydrogen peroxide has been 
identified in a highly conserved methionine-cysteine cluster of the chloroplast γ subunit that is 
essential for the enzyme coupling and whose oxidation appeared to be directly involved in the loss of 
enzyme activity [146]. Due to its conservation, it is tempting to hypothesize that also this cluster may 
be a candidate for ROS-mediated PTP modulation. Other selective ATP synthase targets of ROS may 
be three of the five Trp residues of the d subunit identified in human heart mitochondria [147]  
and a single Trp of the α subunit identified in Podospora anserina and possibly involved in protein 
quality control [148]. Their oxidation may occur as a consequence of PTP formation. Moreover, in 
Podospora anserina, an age-related post-translational modification of OSCP has been identified  
by 2D-PAGE and matrix-assisted laser desorption/ionization-Time-of-Flight mass spectrometry 
(MALDI-TOF MS) whose nature is still to be clarified [144]. 
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Figure 2. Surface potential regions on OSCP. The two lowest potential regions on OSCP 
are highlighted by a yellow circle. The average surface atom potential is displayed on the 
left; the cartoon structure is shown on the right with positively (blue) and negatively (red) 
charged side chains. The color code for the potential is: saturated red, −8.0 kJ/(mol·q); 
saturated blue, 8.0 kJ/(mol·q). The F1 structure is shown as transparent. The yellow circle 
in the upper panel is located at OSCP residues E48, D71, E76 and F78. The latter region, 
discussed in the text, encompasses Helices 3 and 4. For the sake of completeness, the 
yellow circle in the lower panel is located at the other lowest potential region located at 
OSCP residues H112, E115, V116, E128 and E133. The surface potential is computed as 
previously described [4,149]. 
 
6. Concluding Remarks 
Through its contacts with the F1 α3β3 hexamer and the peripheral stalk, OSCP not only ensures the 
structural and functional coupling between FO and F1, which is necessary for ATP synthesis, but also 
modulates the enzyme complex and is the target of inhibitors and interactors, including CyPD. CyPD 
affects ATP synthase activity and, most importantly, decreases the threshold matrix Ca2+ required for 
PTP opening. This finding, together with the electrophysiological demonstration that ATP synthase 
dimers give rise to Ca2+-dependent currents with features indistinguishable from those of the PTP, 
indicate that ATP synthase is directly involved in PTP formation and that OSCP plays a fundamental 
role in this process, acting as a sensor for signal(s) that switch the enzyme of life in a channel able to 
induce cell death. CyPD and OSCP are the targets of signaling pathways (such as phosphorylation and 
acetylation) and of common interactors (such as Hsp90). Many open questions remain, in particular:  
(i) How does CyPD interaction with OSCP change the apparent affinity of the ATP synthase for Ca2+, 
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triggering a conformational change that leads to PTP formation? (ii) Where is (are) the Ca2+ binding 
site(s)? (iii) Is the redox sensitivity of the transition of the ATP synthase to PTP formation mediated by 
a dithiol-disulfide interconversion, and where are the relevant cysteines located? (iv) Is the  
pH-dependent inhibition of the PTP due to IF1 binding, which is pH-dependent? These and many other 
questions can now be addressed with the powerful methods of genetics, and we have little doubt that 
the future has a lot in store toward our molecular understanding of the permeability transition. 
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Here we deﬁne the molecular nature of the mitochondrial
permeability transition pore (PTP), a key effector of cell death.
The PTP is regulated by matrix cyclophilin D (CyPD), which also
binds the lateral stalk of the FOF1 ATP synthase.We show that CyPD
binds the oligomycin sensitivity-conferring protein subunit of the
enzyme at the same site as the ATP synthase inhibitor benzodiaz-
epine 423 (Bz-423), that Bz-423 sensitizes the PTP to Ca2+ like CyPD
itself, and that decreasing oligomycin sensitivity-conferring protein
expression by RNAi increases the sensitivity of the PTP to Ca2+.
Puriﬁed dimers of the ATP synthase, which did not contain volt-
age-dependent anion channel or adenine nucleotide translocator,
were reconstituted into lipid bilayers. In the presence of Ca2+, ad-
dition of Bz-423 triggered opening of a channel with currents that
were typical of the mitochondrial megachannel, which is the PTP
electrophysiological equivalent. Channel openings were inhibited
by the ATP synthase inhibitor AMP-PNP (γ-imino ATP, a nonhydrolyz-
able ATP analog) and Mg2+/ADP. These results indicate that the PTP
forms from dimers of the ATP synthase.
The permeability transition (PT) deﬁnes an increased perme-ability of the inner mitochondrial membrane to ions and
solutes triggered by matrix Ca2+ in the presence of speciﬁc
inducers, the most classical being Pi and thiol oxidants (1). The
sensitivity to Ca2+ is decreased by several compounds, including
Mg2+, adenine nucleotides, and cyclosporin A (CsA) (2). In vitro
at least, the PT is accompanied by swelling of mitochondria,
which has long been known to prevent ATP synthesis (3). The
idea that swelling could be mediated by a Ca2+-regulated pore
was advanced in the 1970s (4, 5), and its basic regulatory features
were deﬁned in a series of seminal studies in 1979 (6–8). The PT
is mediated by opening of a high-conductance channel, the PT
pore (PTP), which was identiﬁed by patch-clamping of the inner
membrane and called mitochondrial megachannel (MMC) (9–
12). Opening of the PTP is causally involved in cell death asso-
ciated with many diseases, including heart ischemia (13), and
its role is particularly well-documented in muscular dystrophy
caused by defects of collagen VI (14). The molecular nature of
the channel(s) involved remains a mystery. The long-standing
idea that the PTP forms at contact sites of the inner and outer
membranes through voltage-dependent anion channel (VDAC)
and the adenine nucleotide translocator (ANT) (15) proved in-
correct, because VDAC- and ANT-null mitochondria still dis-
play a CsA-sensitive PT (16–18).
A well-characterized protein regulator of the PTP is cyclo-
philin D (CyPD), which in the mouse is encoded by the Ppif
gene. CyPD sensitizes the PTP to Ca2+, as deduced from
experiments in mitochondria from Ppif−/− mice where the PT
required higher loads of matrix Ca2+ (19–22), a behavior that is
perfectly matched by the MMC (23). CyPD binds the FOF1 ATP
synthase (complex V), the rotary enzyme that synthesizes the
vast majority of ATP in respiring cells (24). This complex is
formed by the catalytic F1, the membrane-bound proton-trans-
locating FO, and a lateral stalk linking F1 and FO. CyPD binds
the lateral stalk, which acts as a stator to counter the tendency of
the α3β3-subcomplex of the F1-catalytic domain to rotate with the
rotor containing the F1 subunits-γ, -δ, and -e and a ring of FO
subunits c (25). CyPD binding requires Pi and results in partial
inhibition of ATP synthase activity, whereas CsA displaces CyPD,
resulting in enzyme reactivation (24). Despite the striking analogy
with PTP regulation, whether these interactions are relevant for
the PT remains unknown. Here, we show that dimers of the FOF1
ATP synthase incorporated into lipid bilayers form Ca2+-activated
channels with the key features of the MMC-PTP (10–12).
Results
CyPD Binds Oligomycin Sensitivity-Conferring Protein Subunit of ATP
Synthase. We identiﬁed potential binding site(s) of CyPD to the
FOF1 ATP synthase in the b, d, and oligomycin sensitivity-con-
ferring protein (OSCP) subunits of the lateral stalk (24). To
more precisely deﬁne the speciﬁc partner(s) of CyPD within this
complex, we devised conditions optimizing its binding to the
ATP synthase, while separating the subunits of the peripheral
stalk. The ﬁrst condition was met by using 10 mM Pi and low
ionic strength (24); the second condition was met by adding a low
concentration of SDS to the Triton X-100–based extraction
buffer and using a polyclonal antibody against a peptide mapping
near the C terminus of OSCP, which disrupts the interaction
of the OSCP C-terminal domain with the N-terminal portion of
subunit b (25). This strategy allowed the immunoprecipitation
of individual OSCP, b, and d subunits, because no other stalk
protein was detected in the speciﬁc immunoblots (Fig. 1A).
CyPD was found exclusively in the immunoprecipitation with
OSCP antibody, suggesting that OSCP is the direct interactor of
CyPD in the ATPase complex (Fig. 1A). We next used OSCP-
speciﬁc siRNAs in HQB17 cells (26), where we studied the ex-
pression of selected ATP synthase subunits in total extracts of
mitochondria. We found the expected decrease of OSCP, but not
of F1 α- and β- subunits or CyPD (Fig. 1B, Left). When the ATP
synthase was immunoprecipitated from mitochondria with de-
creased levels of OSCP, decreased levels of CyPD were detected
as well, which precisely matched the decreased association of
OSCP to the enzyme complex (Fig. 1B, Right). It should be noted
that cells with stably reduced OSCP levels do not display de-
creased levels of α-, β-, and d subunits or alterations of mito-
chondrial membrane potential or mitochondrial ultrastructure,
indicating that assembly and function of ATP synthase are not
compromised (27).
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CyPD–OSCP interactions were mostly electrostatic in nature,
because they could be disrupted by increased ionic strength (Fig.
S1A). A study of surface potentials and isopotential curves of
CyPD and OSCP in the ATP synthase complex (Fig. S1 B and C)
identiﬁed putative binding regions of CyPD on OSCP at the
residues indicated in Fig. S1C. This region overlaps with helices 3
and 4, the binding site of benzodiazepine 423 (Bz-423), a well-
characterized inhibitor of the FOF1 ATP synthase that readily
permeates mitochondria (27, 28). We, therefore, tested the ef-
fect of Bz-423 on the association of CyPD to mouse and bovine
complex V at 10 mM Pi, and we found a concentration-
dependent displacement that is consistent with competition for
a common binding site (Fig. 1C). This set of experiments
documents that OSCP is the partner of CyPD on the lateral
stalk, that no CyPD binding occurs in the absence of OSCP, and
that the binding site covers the same region where Bz-423 binds
the OSCP subunit.
Bz-423 Induces the PTP. To test whether the interaction of Bz-423
with OSCP is also relevant for PTP modulation, we studied the
Ca2+ retention capacity (CRC) of mitochondria allowing the
deﬁnition of the threshold matrix Ca2+ load required to trigger
pore opening. Bz-423 decreased the CRC of mitochondria at
1 mM Pi but not 5 mM Pi (Fig. 2A). In the presence of CsA (Fig.
2B), which displaces CyPD from OSCP (24), or in CyPD-null
mitochondria (Fig. 2C), the PTP-sensitizing effect of Bz-423 was
observed at 5 mM Pi as well. This behavior matched the in-
hibitory proﬁle of Bz-423 on ATP hydrolysis, which required
higher concentrations of Bz-423 only in CyPD-competent
mitochondria at high Pi concentrations (Fig. S2). Inhibition of
ATP synthase with resveratrol (29) and oligomycin was instead
independent of CyPD (Fig. S3). These results highlight a striking
analogy between the effects of Bz-423 on PTP and ATP synthase.
ATP Synthase Activity and OSCP Affect the PTP.Adenine nucleotides
are inhibitors of the PT (6), but their mechanism of action is
unknown. We explored the hypothesis that nucleotides affect
the Ca2+ sensitivity of the PTP through the catalytic activity of
the FOF1 ATP synthase. We incubated mitochondria either (i)
with ADP and respiratory substrates in the presence of an ATP-
hydrolyzing system based on hexokinase plus glucose (so that
mitochondria were energized by the respiratory chain, the ADP
concentration was constant, and rotation of the ATP synthase
was clockwise when viewed from the membrane side) (30) or (ii)
with ATP in the presence of an ATP-regenerating system based
on phosphocreatine and creatine kinase in the absence of sub-
strates (so that mitochondria were energized by ATP hydrolysis
at constant levels of ATP, and rotation of the ATP synthase was
in the opposite direction) (30). In either case, mitochondria
developed a membrane potential as shown by accumulation of
Rhodamine 123 (Fig. 3A), which responded appropriately to the
addition of oligomycin [i.e., with hyperpolarization in ATP-syn-
thesizing mitochondria (Fig. 3A, trace a) and depolarization in
ATP-hydrolyzing mitochondria (Fig. 3A, trace b)] and the un-
coupler carbonylcyanide-p-triﬂuoromethoxyphenyl hydrazone.
PTP opening in ATP-hydrolyzing mitochondria (constant ATP
levels) required two times the Ca2+ load of ATP-synthesizing
mitochondria (constant ADP levels) (Fig. 3B). The mean ratio
between ATP-hydrolyzing and -synthesizing mitochondria was
2.06 ± 0.27 in four independent experiments per condition, an
effect that matches the effect of CsA in mouse liver mitochon-
dria (20). This difference was not due to the nucleotides per se,
Fig. 1. CyPD interacts with OSCP and is displaced by
Bz-423. (A) Extracts and immunoprecipitates of BHM
with anti-OSCP or b or d subunit antibodies were
immunoblotted as indicated. Lane 1, mitochondria;
lane 2, immunoprecipitateswithOSCP (Left), b (Center),
and d (Right) antibodies; lanes 3, IgG antibody. (B) Total
cell extracts (Left) and complex V immunoprecipitates
(Right) of mitochondria from cells either untreated
(lane 1) or treated with scrambled siRNA (lane 2) or
OSCP siRNA (lane 3) probed for F1 α,β-subunits, OSCP,
and CyPD. (C) Heart mitochondria were treated with
the indicated concentrations of Bz-423 (μM), immuno-
precipitated with anticomplex V antibodies, and
immunoblotted with antibodies against β-subunit or
CyPD. Ratio between CyPD and β-band intensities is
reported (n = 3 ± SE). *P ≤ 0.02; **P = 0.0015, Student
t test.
Fig. 2. Bz-423 decreases the mitochondrial Ca2+ re-
tention capacity. Isolated WT (A and B) or Ppif−/−
mouse liver mitochondria (C) were incubated in the
presence of 1 (open symbols) or 5 mM (closed symbols)
Pi·Tris and Bz-423 as indicated. In B only, 1.6 μM CsA
was added. Extramitochondrial Ca2+ was monitored,
and CRC was determined by stepwise addition of
10 μM Ca2+ pulses. The measured CRC (i.e., the amount
of Ca2+ accumulated before onset of Ca2+-induced Ca2+
release) was normalized to that obtained in absence of
Bz-423 (CRC0), and data are average of triplicate experi-
ments± SE. Absolute CRC values (nmol Ca2+/mg protein)
at 1mMPiwere 120±0, 160±20, and166.7±30.6 forA,
B, andC, respectively; absoluteCRCvalues (nmolCa2+/mg
protein) at 5 mM Pi were 86.7 ± 11.5, 126.7 ± 30.6, and
160 ± 20 for A, B, and C, respectively (n = 3 ± SD).
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because in the presence of oligomycin ADP was actually slightly
more effective than ATP (Fig. 3C, traces a and b, respectively).
We could exclude any contribution from endoplasmic reticulum
contaminants, because no Ca2+ uptake was seen in the presence
of ATP plus oligomycin (Fig. S4). These results indicate that the
catalytic activity of ATP synthase (synthesis vs. hydrolysis) affects
the Ca2+ sensitivity of the PTP.
We also tested the effect of OSCP knockdown on the sensitivity
of the PTP to Ca2+ in permeabilized HQB17 cells using ATP
hydrolysis to generate the proton gradient. Lowered OSCP ex-
pression decreased the threshold Ca2+ required for opening (Fig.
3D). It should be noted that OSCP-depleted mitochondria did
take up a sizeable amount of Ca2+ before onset of the PT (Fig.
3D), consistent with a conserved catalytic activity of ATP synthase
and the buildup of the proton gradient (27). Thus, lack of the stalk
subunit OSCP increases the Ca2+ sensitivity of the PTP, sug-
gesting that the FOF1 ATP synthase is involved in its formation.
This hypothesis was tested in ATP synthase preparations.
Puriﬁed ATP Synthase Dimers Have PTP Channel Activity. We sepa-
rated mitochondrial proteins by blue native electrophoresis
(BNE) (31) and identiﬁed the ATP synthase by in-gel activity
(Fig. 4A). SDS/PAGE of dimers and monomers eluted from
BNE gels (Fig. 4B) displayed the same subunit pattern previously
shown in high-resolution gels (32). Western blotting detected the
occasional presence of some respiratory complexes I and III in
the dimers (the I + III supercomplex runs very close to complex
V dimers in BNE) but not VDAC, CyPD, or ANT (Fig. 4C),
which in BNE with digitonin migrates with the electrophoretic
front as an individual protein (31).
The gel-puriﬁed ATP synthase dimers or monomers were in-
corporated in planar lipid bilayers. Addition of Bz-423 to the dimer
in the presence of Ca2+ elicited channel activity, whereas no such
activity was observedwhen the drug was added to themonomer (Fig.
5A). Addition of phenylarsine oxide (PhAsO), one of the most
powerful sensitizers of the PTP to Ca2+ (1), was not sufﬁcient to
induce channel opening, but the subsequent addition of Bz-423 in-
duced activity with similar characteristics to Bz-423 alone (Fig. 5B
and Fig. S5). Moreover, γ-imino ATP (AMP-PNP), a nonhydro-
lyzable ATP analog (33), inhibited current conduction even in the
presence of PhAsO (Fig. 5B). The characteristics of the pore closely
matched the features of MMC-PTP (10–12): the maximal chord
conductance was 1.0–1.3 nS in 150 mM KCl, and various subcon-
ductance states were commonly entered (Fig. 5 C and D). Tran-
sitions of about 1.0 and 0.5 nS, typical of MMC-PTP activity, are
shown in Fig. S6A. Again in keeping with the properties of MMC,
the activity could be largely inhibited byMg2+ and nearly completely
inhibited by Mg2+ plus ADP (Fig. 5C); however, it could not be
inhibited by CsA, like the MMC of Ppif−/− mitochondria (23), co-
herently with the lack of CyPD in the preparation (Fig. 4C). Other
inducers beside Pi and Ca2+ were not strictly necessary to induce
PTP currents, as shown in Fig. S6B, where Ca2+ was added at 3 mM
and theATP synthase dimer was extracted in the presence of 10mM
Pi, which sensitizes the PTP even in the absence of CyPD (1).
Fig. 3. ATP synthase catalysis and OSCP knockdown
affect the Ca2+ sensitivity of the PT. (A) Membrane po-
tential was measured in mitochondria incubated with
respiratory substrate and ADP plus an ATP-consuming
system (trace a) or no substrate, ATP, and an ATP-
regenerating system (trace b) as detailed in Materials
and Methods. Where indicated, 2 mg mouse liver mi-
tochondria (MLM), 1 μg/mLoligomycin (oligo), and1 μM
carbonylcyanide-p-triﬂuoromethoxyphenyl hydrazone
(FCCP). (B) Conditions for traces a and b were exactly as
in A, but Ca2+ was measured. (C) The incubation me-
dium contained respiratory substrate and 1 μg/mL oli-
gomycin, and it was supplemented with 0.4 mM ADP
(trace a) or 0.4 mM ATP (trace b); one experiment rep-
resentative of three is shown. (D) Scrambled siRNA- or
OSCP siRNA-treated cells (closed and open bars, re-
spectively)were permeabilizedwith digitonin, and their
CRC was measured in the presence of an ATP-regener-
ating system. Data are average ± SD of nine in-
dependent determinations per condition. *P = 0.0025
(Student t test). The blots display the levels of OSCP and
F1 β-subunits in the two batches of cells used (lanes 1,
scrambled siRNA; lanes 2, OSCP siRNA).
Fig. 4. Puriﬁcation of FOF1 ATP synthase. (A) BHM were subjected to BNE to
separate oligomers (O), dimers (D), andmonomers (M) of ATP synthase, which
were identiﬁed by Coomassie blue (lane 1) and in-gel activity staining (lane 2).
Dimers and monomers were excised, eluted, subjected to SDS/PAGE, and
stained with colloidal Coomassie (B), or they were transferred to nitrocellu-
lose and tested for respiratory complexes and ATP synthase, subunit-β of F1,
ANT, VDAC, and CyPD (C). T, D, and M refer to total extract, dimer, and
monomer, respectively. One experiment representative of three is shown.
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Channel openings were still observed in the presence of bongkrekic
acid and could not be elicited by atractyloside, selective inhibitors of
ANT. Rather, in some cases, atractyloside induced a small con-
ductance (Fig. S7). Of note, channels were not observed with gel-
puriﬁed complex I, indicating that this occasional contaminant
also cannot be responsible for the current that we observe in the
puriﬁed dimers of FOF1 ATP synthase (Fig. S7). The ATP synthase
preparations still possessed enzymatic activity after extraction from
the gels for incorporation in the bilayers, which was shown by
a second BNE and activity staining (Fig. S8).
Discussion
We have shown that CyPD interacts with the ATP synthase at
OSCP subunit. This observation, which builds on our previous
work on regulation of the ATP synthase by CyPD (24), led to
identiﬁcation of the elusive PTP as a dimer of the FOF1 ATP
synthase. The electrophysiological features displayed by our ATP
synthase preparation are very different from the currents of the
ANT, which has been proposed to take part in PTP formation
(15) and is still included in models of the PTP in association with
the Pi carrier (34). The ANT exhibits a conductance ranging
between 50 and 700 pS in 100 mM KCl (35), which is lower than
the currents displayed by the MMC (9–12); it shows low proba-
bility of current ﬂuctuation at voltages lower than 150 mV at
variance from the reconstituted ATP synthase dimers (Fig. 5),
and it can be inhibited only by ADP and bongkrekic acid together,
whereas ADP alone had a marginal effect (35–37). Patch-clamp
experiments with the reconstituted, functionally active mito-
chondrial Pi carrier revealed an anion channel function with
a mean conductance as low as 40 ± 10 pS, which was decreased to
25 ± 5 pS by Ca2+ and Mg2+, inhibited by Pi, and unaffected by
ADP (38). These features make the Pi carrier a very unlikely
candidate as a PTP component, and they rule out that the cur-
rents observed here may be related to this protein.
Bz-423 was discovered and characterized as an apoptosis-in-
ducing agent acting through mitochondria (39); identiﬁcation
of OSCP as its target was achieved through the screening of a
human cDNA T7 phage display library (27) and the interaction
with ATP synthase resulting in inhibition of enzyme activity con-
ﬁrmed by NMR (28). The striking selectivity of action of Bz-423
Fig. 5. Dimers of FOF1 ATP synthase generate currents matching MMC-PTP. (A) A bilayer experiment in 50 mM KCl, 1 mM Pi, and 0.3 mM Ca
2+ (Ca2+ only
in trans; Vcis= −60mV). After addition of dimeric ATP synthase, no activity could be observed (Upper) until immediately after the addition of 0.1 mMBz-423
to the trans side (Lower; arrow). When monomers were used, the recording was identical to Upper, which was not modiﬁed by the addition of Bz-423.
(B) A similar experiment in the presence of 0.1 mM PhAsO in trans. Activity (Upper) was elicited by the addition of Bz-423 as in A and inhibited by 0.1 mM
AMP-PNP in trans (Lower; arrow). Corresponding current amplitude histograms from gap-free 60-s traces are shown in Right. (C ) Current traces (150 mM
KCl; Vcis as indicated) with dimeric ATP synthase and 0.3 mM Ca
2+, 0.1 mM Bz-423, and 50 μM PhAsO added to the trans side. Note numerous substates.
(D, Left) Activity (Vcis = −80 mV) recorded as in C (ﬁrst trace) and after sequential additions of Mg2+ (0.6 mM) and ADP (0.6 mM) to the trans side; (D, Right)
corresponding amplitude histograms from gap-free 100-s traces. Representative experiments are shown of a total of 28 experiments performed under
various conditions using six different ATP synthase dimer preparations.
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on OSCP and its ability to trigger channel activity of ATP synthase
dimers, together with the lack of activity of monomer prepa-
rations, argues against the possibility that the currents that we
observe are caused by unidentiﬁed contaminating proteins. This
conclusion is strengthened by the inhibitory effect of AMP-PNP
and Mg2+/ADP on channel activity.
The PTP-inducing effect of Bz-423 and CyPD (which both act
through OSCP on top of the lateral stalk in the matrix) is nec-
essarily indirect, because it impinges on the permeability prop-
erties of the inner membrane. Because a current is only seen with
the dimers, it is logical to conclude that the PTP forms at the
membrane interface between two adjacent FO sectors, which
would be in keeping with the well-characterized effects of fatty
acids and lysophospholipids on the PTP (1). The essential role of
matrix Ca2+ in PTP formation is intriguing. Ca2+ is able to sus-
tain ATP hydrolysis by complex V with a similar Km as Mg
2+ and
to compete with Mg2+ for the catalytic sites (40). Interestingly
and in contrast with other divalent metal–ATP complexes, the
ATPase activity is not coupled to proton translocation when Ca2+
is bound, suggesting that Ca2+ induces conformational changes in
FO, which could then mediate PTP formation and explain the
inability of Ca2+ to sustain ATP synthesis (41). As shown here,
accessibility of the PTP Ca2+ binding sites is inﬂuenced by en-
zyme catalysis and OSCP. One possible explanation is that the
OSCP subunit affects the afﬁnity of the metal binding sites of
ATP synthase, and thus the ease with which matrix Ca2+ can
replace Mg2+, causing PTP opening. OSCP as such would be
a negative modulator, and its effect would be counteracted by
binding of the positive effector CyPD (which indeed increases the
Ca2+ afﬁnity of the PTP). Removal of OSCP, or CyPD binding to
OSCP, would induce similar conformational effects, consistent
with the data presented here as well as with previous ﬁndings on
CyPD interactions with the lateral stalk (24).
Although deﬁning the detailed mechanism of PTP formation
requires additional work, the demonstration that the PTP forms
from dimers of the FOF1 ATP synthase solves a long-lasting is-
sue in cell biology and readily accommodates key pathophysi-
ological effectors of the PT. Indeed, Ca2+, Mg2+, adenine
nucleotides, and Pi bind the catalytic core at F1, and the membrane
potential and matrix pH, which are key PTP modulators (1), are
also key regulators of the ATP synthase. Channel formation by
puriﬁed ATP synthase dimers conﬁrms our long-standing stance
that the PT is an inner membrane event that does not require outer
membrane components (1), which is also in keeping with recent
results that we obtained in mitoplasts (42). The present ﬁndings
suggest a dual function for complex V, i.e., ATP synthesis and PTP
formation. The enzyme of life seems, therefore, to be also the
molecular switch that may signal the presence of fully depolarized,
dysfunctional mitochondria to stimulate cell death (1) and/or
mitophagy (43). The detailed mechanisms through which this
transition is achieved can now be addressed with the powerful tools
of genetics, and we have little doubt that clariﬁcation of the mo-
lecular determinants of PTP formation will provide the solution to
outstanding problems on the role of PTP in pathophysiology.
Materials and Methods
Immunoprecipitation and Western Blotting. Immunoprecipitation (IP) of ATP
synthase was performed from 0.5 mg bovine, mouse heart, or human osteo-
sarcomaHQB17 cellsmitochondria prepared by standardmethods (44, 45) using
anticomplex V monoclonal antibody covalently linked to protein G-Agarose
beads (MS501 immunocapture kit; Abcam) as reported (24). For isolated sub-
units, 30 μL Staphylococcus aureus protein A-Sepharose 4B (Sigma) were cou-
pledwith 10 μgOSCP subunit antibody, 2 μg b subunit, or nonimmune antibody
in IP buffer (15mMTris, 10mMPi·Tris, 2mMEDTA·Tris, 1.8mMEGTA·Tris, 0.5%
vol/vol Triton X-100, 0.005%wt/vol BSA, 0.25% SDS, pH 7.4) and incubated for
2 h at 4 °C. Then, 0.5 mg bovine heart mitochondria (BHM) solubilized and
precleared in IP buffer were added with protein A-coupled antibody and in-
cubated overnight at 4 °C. For d subunit, BHM was suspended in IP buffer, in-
cubated for 1hat4 °Cwith4 μganti-dor rabbit anti-mouseantibodies, and then
incubated for 3h at4 °Cwith 30μL proteinA. IP supernatantswere separatedby
SDS/PAGE followed byWestern blot analysis. Antibodieswere polyclonal rabbit
anti-α and -β F1 subunit, anti-b subunit (a gift from John Walker, Medical
Research Council—Mitochondrial Biology Unit, Cambridge), anti-ANT Q18
(Santa Cruz Biotechnology), monoclonal anti-β, anti-d subunit, anti-OXPHOS
(Mitoscience), anti-CyPD (Calbiochem), anti-OSCP (Abcam), and anti-VDAC1 (a
gift from F. Thinnes, Max-Planck-Institut für ExperimentelleMedizin, Abteilung
Immunchemie, Göttingen, Germany). Immunoreactive bands were detected by
enhanced chemiluminescence (Pierce). CyPD is expressed as CyPD/β-ratio of
bands analyzed with Quantity One software (Biorad). Statistics were calculated
by GrafPad software.
Transfection with siRNAs. HQB17 cells (26) were transfected with an siRNA du-
plex OSCP oligo ribonucleotides pool (Invitrogen) as follows: ATP5OHSS100870
(-GGA ACC CAA AGU GGC UGC UUC UGU U-, -AAC AGA AGC AGC CAC UUU
GGG UUC C-), ATP5OHSS100872 (-CAG GGC UAU GCG GGA GAU UGU CUA A-,
-UUA GAC AAU CUC CCG CAU AGC CCU G-), or scrambled sequence at 0.2 μM.
Before treatment, cybrids were cultured without antibiotics for 24 h and then
transfected with siRNA and Lipofectamine 2000 in Opti-MEM (Invitrogen). After
6 h, the medium was replaced with culture medium without siRNA for 66 h
before preparation of mitochondria.
Mitochondrial CRC and Membrane Potential. Extramitochondrial Ca2+ was
measured by Calcium Green-5N (Molecular Probes) ﬂuorescence (46) using
a Fluoroskan Ascent FL (Thermo Electron) plate reader at a mitochondrial con-
centration of 1 mg × mL−1. Membrane potential was measured at 25 °C using
a Perkin-Elmer LS50B spectroﬂuorometer based on the ﬂuorescence quenching
of 0.15 μM Rhodamine 123 (46). For measurements of CRC and membrane po-
tential during ATP synthesis at constant [ADP] (Fig. 3 A, trace a and B, trace a),
the incubationmedium contained 0.1Mglucose, 80mMKCl, 10mMMops·Tris,
5mM succinate·Tris, 4mMMgCl2, 1mMPi·Tris, 0.5mMNADP
+, 0. 4mMADP,
50 μMP1,P5-di(adenosine-5′) pentaphosphate, 10 μMEGTA, 2 μM rotenone,
4 U/mL glucose-6-phosphate dehydrogenase, and 3 U/mL hexokinase. We
ascertained that mitochondrial respiration was maximally stimulated and
that the added enzymes were in excess by measuring O2 consumption with
a Clark oxygen electrode. For measurements of CRC and membrane po-
tential during ATP hydrolysis at constant [ATP] (Fig. 3A, tracebandB, traceb),
the incubationmediumcontained0.1Msucrose, 80mMKCl, 10mMMops·Tris, 4
mMMgCl2, 2mMphosphocreatine, 1mMPi·Tris, 0.4mMATP,10μMEGTA, 2μM
rotenone, and 1.5 U/mL creatine kinase. We ascertained that the ATP-
regenerating activity was in excess by measuring the mitochondrial mem-
brane potential, which was sustained at the maximal value beyond the
duration of the CRC experiments. For all other CRC measurements (Figs. 2
and 3C and Fig. S4), the incubationmedium contained 0.1M sucrose, 80mM
KCl, 10 mMMops·Tris, 5 mM succinate·Tris, 4 mMMgCl2, 1 mM Pi·Tris, 10 μM
EGTA·Tris, 2 μM rotenone, 0.5 μM Ca2+ Green-5N, and 1 mg/mL mitochon-
dria. Additional modiﬁcations or additions are speciﬁed. Measurements of
ATP hydrolysis were performed according to published methods (47, 48).
BNE Gel and Sample Preparation for Electrophysiology. Pellets of mitochondria
were suspended at 10mg/mL in 1M aminocaproic acid and 50mMBis·Tris, pH
7.0 (24), solubilized with 2% (wt/vol) digitonin, and immediately centrifuged
at 100,000 × g for 25 min at 4 °C. The supernatants were supplemented with
Coomassie Blue G-250 (Serva) and rapidly applied to 1D 4–11% poly-
acrylamide gradient BNE (Invitrogen). After electrophoresis, gels were
stained with Coomassie Blue, used for in-gel activity staining, or prepared
for an overnight native complex protein elution from BNE gel as follows.
Bands corresponding to monomers and dimers of complex V or monomer of
complex I were excised and diluted with 25 mM tricine, 7.5 mM Bis·Tris, and
1% (wt/vol) n-heptyl β-D-thioglucopyranoside, pH 7.0 (49) supplemented
with 8 mM ATP·Tris and 10 mM MgSO4. After overnight incubation at 4 °C,
samples were centrifuged at 20,000 × g for 10 min at 4 °C, and supernatants
were (i) used directly for reconstitution in electrophysiological studies, (ii)
subjected to 2D-SDS PAGE separation followed by Western blotting, or (iii)
loaded in 2D-BNE followed by Coomassie Blue or in-gel activity staining
(ATPase activity was ampliﬁed as in ref. 50).
Electrophysiology. Planar lipid bilayer experiments were performed as de-
scribed (51). Brieﬂy, bilayers of about 150–200 pF capacity were prepared
using puriﬁed soybean azolectin. The standard experimental medium was
150 mM KCl and 10 mM Hepes, pH 7.4. Control experiments with empty
membrane or detergents used for the puriﬁcation showed no activity. All
voltages reported refer to the cis chamber, zero being assigned by con-
vention to the trans (grounded) side. Currents are considered as positive
when carried by cations ﬂowing from the cis to the trans compartment. Data
were acquired at 100 μs/point, ﬁltered at 500 Hz, and analyzed ofﬂine using
the pClamp program set (Axon Instruments). Histograms were ﬁtted using
the Origin7.5 program set.
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Electrostatic Calculations. The molecular structures of the membrane extrinsic
region of the bovine ATP synthase (Protein Data Bank ID code 2WSS, chains)
(25) and human CyPD complexed with CsA (Protein Data Bank ID code
2Z6W) (52) were used for the calculation of surface potential with the
Generalized Born model (53) and isopotential surfaces within the Poisson–
Boltzmann theoretical framework (54). The calculations performed on the apo-
form of CyPD and OSCP in the ATP–synthase complex did not reveal apparent
complementarity in the surface potential and isopotential curves because of the
complexity and extension of OSCP in the context of ATP synthase. For CyPD, the
dominant surface contribution is positive and located at a region ﬂanking
the binding site for CsA. The face of CyPD opposite to the CsA binding site shows
less extended but negative potential. The overall charge at pH 7.0 of CyPD,
based on the sequence (GenBank accession no. NP_005720.1, mature peptide),
is strongly positive (six proton charges), and therefore, we expected that the
target region on OSCP should be at negative potential. By using the software
BLUUES (53), we identiﬁed the lowest potential regions on OSCP (calculations
performed in the ATP–synthase complex). In particular, we considered the
atoms listed in Fig. S1C with lowest average surface potential.
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